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Abstract
Protein-protein interactions (PPIs) play central roles in most biological processes.
Studying PPIs is a fundamental step in understanding the molecular basis of cellular
processes such as cell-cell contact, enzyme activity, and transient assembly of signaling
complexes or cellular structures. In this work, we employed a combination of biophysical
and biochemical methods to characterize PPIs, with a focus on interactions between
structured domains and intrinsically disordered regions or peptide substrates.
The subject of Chapter two is prolyl isomerase Ess1, which is an essential enzyme
found in Saccharomyces cerevisiae. Ess1 regulates the transcription and cotranscriptional RNA processing by catalyzing the isomerization of serine-proline bonds
within the carboxy-terminal domain (CTD) of RNA polymerase II. We confirmed that,
unlike its human ortholog Pin1, Ess1 has a rigid linker between its substrate-binding
WW and catalytic domains. The rigid linker enforces a distance constraint and requires
a minimum substrate length for bivalent CTD binding at the WW and catalytic domains
simultaneously (> 4 heptad CTD repeats). Our binding results suggest that the Ess1
WW domain anchors the proximal end of the CTD substrate during isomerization and
that linker divergence between Ess1 and Pin1 may underlie evolution of substrate
specificity.
Chapter three studied the interdomain interactions that mediate the liquid-liquid
phase separation (LLPS) of ubiquilin-2 (UBQLN2). UBQLN2 is a shuttle protein for the

proteasome that functions by binding to proteasomal receptors and ubiquitinated
substrates via its N-terminal ubiquitin-like (UBL) and C-terminal ubiquitin associated
(UBA) domains, respectively. UBQLN2 forms liquid droplets in vitro via a biophysical
mechanism called liquid-liquid phase separation. We found that UBQLN2 LLPS is
mediated by its middle intrinsically disordered region (IDR). The two folded domains of
UBQLN2, the UBL and UBA domains, asymmetrically modulate LLPS by interacting with
the IDR. We characterized the LLPS-inhibiting UBL-IDR interaction to be relatively
strong and involves the STI1-I, linkers, and the C-terminal LLPS-mediating regions of
UBQLN2. In contrast, the LLPS-enhancing UBA-IDR interaction is much weaker and
involves mainly a middle linker and the C-terminal regions of the IDR after the STI1-II.
Our results support a model in which binding partners could regulate UBQLN2 LLPS
and its LLPS-associated functions in cells by interacting with either the UBL or UBA
domains of the protein.
In chapter four, we characterized and compared the temperature-dependent LLPS
behaviors of UBQLN1 and UBQLN2 C-terminal constructs. UBQLN1 exhibits upper
critical solution temperature (UCST) phase transition behavior; the protein condenses
into liquid-like droplets at low temperature and returns to one soluble phase at high
temperature. In contrast, UBQLN2 exhibits upper and lower critical solution temperature
(UCST+LCST) phase transition; liquid droplets form at intermediate temperature and
dissipate at high and low temperatures. We compared the sequences of UBQLN1 and

UBQLN2 and identified a small glycine-rich region with significant sequence disparity
between the two proteins. The glycine-rich region in UBQLN1 is rich in polar amino
acids, whereas the same region in UBQLN2 is rich in hydrophobic residues. Using a
chimera construct of UBQLN1, our data suggest that the dissimilar amino acid
compositions of the glycine-rich region likely give rise to the different temperaturedependent LLPS behaviors of UBQLN1 and UBQLN2.
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Chapter I: Introduction

Portions of this chapter have been previously published and reprinted with permission
from the publisher. References: (Zheng, Yang et al., 2020) (Namitz, Zheng et al., 2021).

Zheng, T.*, Yang, Y.*, and Castañeda, C.A. (2020). Structure, dynamics and functions of
UBQLNs: at the crossroads of protein quality control machinery. Biochem J 477, 3471–
3497.
Namitz, K.E.W.*, Zheng, T.*, Canning, A.J., Alicea-Velazquez, N.L., Castañeda, C.A.,
Cosgrove, M.S., and Hanes, S.D. (2021). Structure analysis suggests Ess1 isomerizes
the carboxy-terminal domain of RNA polymerase II via a bivalent anchoring mechanism.
Communications Biology 4, 1–14. *These authors contributed equally.

1

1.1 Proteins are the building blocks of life
The complex biological processes of life arise on the foundation of simple molecules
like amino acids. Amino acids form polypeptides or proteins. Each protein, despite its
unique composition, is synthesized from the same set of 20 amino acids, joined by
peptide bonds between the C-terminal carboxylic acid and the N-terminal amino group
of the amino acids.
Evolution has provided proteins a great variety of functions, including transporting
small molecules, supporting structural integrity of the cells, transmitting signals, and
catalyzing important chemical reactions (Pereira-Leal et al., 2006). The collective
actions of proteins and other biomacromolecules such as nucleic acids and lipids at the
molecular level enable the macroscopic life we observe.

1.1.1 Protein-protein interactions are the foundation of biomolecular processes
Multiple proteins or multiple copies of the same protein can form complexes in the
cellular environment (Hartwell et al., 1999). These complexes are the molecular
machinery that performs most biological functions in cells and are modulated mainly by
non-covalent protein-protein interactions (PPIs) (Hartwell et al., 1999; Pereira-Leal et
al., 2006). Considering the millions of proteins in the cells, the sum of PPIs is
undoubtedly a vast and complex network (Cusick et al., 2005; Ponomarenko et al.,
2016). To avoid error in the heterogeneous and crowded cellular environment, PPIs
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must be highly selective and finely tuned. Aberrant PPIs are associated with severe
consequences such as cancer and neurodegenerative diseases (Venkatesan et al.,
2009; Vidal et al., 2011).
PPIs often rely on specific regions of the proteins known as binding sites. Noncovalent interactions, including electrostatic interaction, dipolar interaction, cation-π
interaction, hydrogen bonding, and hydrophobic effects, are mediated by key amino
acids within the binding sites and combine to give rise to the highly specific chemical
and physical characteristics of the sites (Contreras-García et al., 2011; Mattos and
Ringe, 1996; Zhou and Qin, 2007).

1.1.2 Proteins are composed of structured domains and intrinsically disordered
regions
Domains are subunits of protein that can form self-stabilizing 3D structures (Ponting
and Russell, 2002). Typically, domains perform a particular function or mediate specific
interactions; domains combine to give multidomain proteins their overall structures and
functions. From an evolutionary perspective, highly conserved domains that evolved
from the same origin can be found in different molecular contexts across species
(Chothia et al., 2003). For example, the WW domain is a small protein domain that folds
into a meandering triple-stranded beta-sheet structure (Fig.1A). The WW domain is
found in seemingly unrelated proteins such as cytoskeletal protein Dystrophin,
3

transcription-factor activator FE65, and peptidyl-prolyl isomerase PIN1 (Jäger et al.,
2006; Meiyappan et al., 2007; Rentschler et al., 1999). It is also highly conserved
across species; the WW domain found in human PIN1 and the Saccharomyces
cerevisiae ortholog Ess1 have near-identical folds and over 40% sequence similarity
(Fig.1B).
In addition to structured domains, a large proportion of the proteome consists of
amino acid sequences that are unlikely to form stable 3D structures on their own
(Dunker et al., 2008). Referred to as intrinsically disordered regions (IDRs), these
polypeptides can serve as flexible linkers that connect folded domains or as functional
units that mediate PPIs (Sørensen and Kjaergaard, 2019; Wright and Dyson, 1999). In
recent years, an increasing number of IDRs that interact with or function as hubs in PPI
networks have been identified. These IDRs perform central roles in the regulation of
cellular processes such as transcription, translation, and protein degradation (Galea et
al., 2008; Iakoucheva et al., 2002; van der Lee et al., 2014). Unlike folded domains,
which rely on well-defined binding surface to mediate interactions, IDRs are highly
flexible and therefore, can sample more potential conformations and interact with a
broader spectrum of binding partners with increased promiscuity and dynamics (Dunker
et al., 2008; Wright and Dyson, 1999).

4

Figure 1.1. Structure and sequence alignments of WW domains.
(A) The WW domain is structurally conserved between species (Ess1 and Pin1) and
between different protein families (Pin1 and FE56). (B) Sequence alignment shows high
compositional similarity across WW domains found in different proteins.
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1.2 Cells organize their biochemistry by creating membrane-bound
organelles and biological condensates
Inside of the cell, the biochemical reactions between components form a vastly
complex library; the regulation of where and when some of these interactions occur is
challenging but essential for proper cellular functions and cell survival (Hyman et al.,
2014). Cells create compartments, or organelles, with distinctive chemical environments
that prohibit or encourage specific interactions to meet the challenge. Many organelles
are membrane-bound, such as mitochondria, ribosomes, and lysosomes (Fig. 1.2); the
lipid bilayers that surround these organelles create separation between the internal
chemical environments and cell cytoplasm. In contrast, some organelles like P bodies
(Luo et al., 2018) and stress granules (Buchan and Parker, 2009) lack the membrane
structure and rely on other mechanisms to create separate chemical environments, i.e.
are membraneless organelles (MLOs). Unlike their membrane-bound counterparts,
MLOs (sometimes also referred to as biomolecular condensates) are not surrounded by
lipid bilayers, thus rendering them dynamic, liquid-like, and allowing them to exchange
content with their surroundings rapidly (Brangwynne et al., 2009). These biophysical
properties confer condensates the ability to form and dissipate on a much faster time
scale than membrane-bound organelles (Brangwynne et al., 2009; Gomes and Shorter,
2019). For example, cytoplasmic stress granules rapidly assemble in response to
external stressors, such as oxidative stress, heat shock or proteasomal inhibition
6

(Boeynaems et al., 2018; Buchan and Parker, 2009; Hyman et al., 2014; Wheeler et al.,
2016).
MLOs are involved in a variety of cellular processes, including stress response,
signal transduction, gene regulation, and protein quality control (Alberti et al., 2017;
Chong and Forman-Kay, 2016; Su et al., 2016; Wheeler et al., 2016). Among the many
types of MLOs, two are particularly relevant in later chapters of this work, i.e.,
transcription factories (or transcription foci) and stress granules (Fig. 1.2).
Transcription factories are submicron MLOs found within the nucleus (Cho et al.,
2018; Osborne et al., 2004). All necessary components for transcription are recruited to
transcription factories including RNA polymerase (especially RNA polymerase II
(RNAPII)), transcription factors and DNA templates (Osborne et al., 2004). Despite the
lack of a membrane-bound structure, components are enriched within transcription
factories thus creating clustered environments for efficient transcription (Cho et al.,
2018; Papantonis and Cook, 2011). In Chapter 2, we study the peptidyl-prolyl isomerase
Ess1, which catalyzes the cis-trans isomerization of specific prolines in the carboxyterminal domain (CTD) of RNAPII (Boehning et al., 2018). The CTD is an intrinsically
disordered region critical for transcription and RNA processing (Hsin and Manley, 2012).
A previous study revealed that RNAPII clustering through CTD self-interaction likely
underlies the formation of transcription factories (Boehning et al., 2018). As proline
isomerization provided by Ess1 alters the backbone structure of CTD peptides, and
7

Ess1 modulates co-factor binding to RNAPII (Jasnovidova and Stefl, 2013), we
speculate that Ess1 may also play a role in the regulation of transcription factories.
RNA and RNA binding proteins compose a number of MLOs in cells (termed RNP
granules due to their enriched protein and RNA content), including nuclear granules
such as Cajal bodies and cytoplasmic granules such as stress granules (SGs) and
processing bodies (P-bodies) (Fig. 1.2) (Protter and Parker, 2016). As the name
suggests, SGs form in response to cellular stress when translation is largely inhibited
(Treeck et al., 2018). It is hypothesized that SGs protects RNAs from degradation in
harmful conditions (Nover et al., 1989). SGs disassemble when stress is removed
releasing its content before re-initiation of translation can occur (Buchan and Parker,
2009).
The subject protein of Chapter 3, Ubiquilin-2 (UBQLN2), is a shuttle protein for the
proteasome (Zheng et al., 2020). In cells, UBQLN2 modulates stress granule formation
and is recruited to stress granules (Alexander et al., 2018; Dao et al., 2018). UBQLN2
interacts with SG components including hnRNPA1, hnRNPA3, hnRNPU, and FUS
(Alexander et al., 2018; Gilpin et al., 2015) and modulates the protein-RNA interaction
dynamics that is crucial for SG formation (Alexander et al., 2018). Mutations in SG
components including UBQLN2 are associated with neurodegenerative diseases
neurodegenerative diseases (Alexander et al., 2018; Bertram et al., 2005; Chen et al.,
2018a; Deng et al., 2011; Fahed et al., 2014; González-Pérez et al., 2012; Molliex et al.,
8

2015; Patel et al., 2015). Studying UBQLN2 and its involvement in SGs is key to
deciphering the molecular mechanisms and regulation of SGs and may provide
potential therapeutic targets for neurodegenerative diseases.

Figure 1.2. Different types of organelles in the cell.
Cells form membrane-bound and membraneless organelles to compartmentalize
biomolecules and create distinct chemical environments.
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1.2.1 Protein liquid-liquid phase separation underlies the forming mechanism of
biomolecular condensates
While the exact molecular mechanisms underlying the formation of MLOs are still
open for discussion, it is generally believed that the liquid-liquid phase separation
(LLPS) of component proteins modulates the process (Boeynaems et al., 2018; Gomes
and Shorter, 2019; Nott et al., 2015; Poudyal et al., 2018).
Under physiological conditions, many proteins (and other macromolecules) in
aqueous solution condense into a dense phase that resembles liquid droplets while
coexisting with a dilute phase outside of the droplets. This physical phenomenon is
called liquid-liquid phase separation (LLPS) (Fig. 1.3A) (Alberti et al., 2019). In recent
years, especially since the publication of the groundbreaking work by Brangwynne et al.
in 2009 on P granules (Brangwynne et al., 2009), protein LLPS has become a thriving
field drawing increasing interest among researchers. Studies by the pioneers of this field
have shed light on the physical basis as well as biological significance of LLPS (Aguzzi
and Altmeyer, 2016; Alberti et al., 2019; Brangwynne et al., 2009; Hyman et al., 2014;
Lin et al., 2015). Mounting evidence suggests that defective LLPS is related to the
formation of insoluble aggregates or protein inclusions that are characteristics of
neurodegenerative disorders, such as ALS, FTD, and Alzheimer’s disease (Lin et al.,
2015; Molliex et al., 2015). When a disease related-mutations occur in MLO
components, it causes the phase-separated protein to undergo liquid-to-solid transitions
10

over time (Fig. 1.3B) (Murakami et al., 2015; Patel et al., 2015; Peskett et al., 2018).
The resulting aggregates introduce additional stress to the PQC mechanisms and can
be toxic to the cells (Lamark and Johansen, 2012; Stefani and Dobson, 2003).
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Figure 1.3. Liquid-liquid phase separation underlies the forming mechanism of
membraneless organelles.
(A) Soluble protein condenses to form a dense “droplet-like” phase, a process known as
liquid-liquid phase separation. (B) MLO components undergoes liquid-liquid phase
separation (LLPS) which then leads to the formation of MLOs. Dysregulation or
mutation can cause MLO components to form aggregation in cells.
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1.2.2 Flory-Huggins theory describes the thermodynamic basis of protein LLPS
The concept of liquid-liquid phase separation has been extensively studied in the
field of polymer science (Dobry and Boyer‐Kawenoki, 1947; Flory, 1942; Hooper and
Schweizer, 2006; Huggins, 1941; Johansson et al., 1998; McGuire et al., 1995; Tanaka,
1993). With proteins being polymers of amino acid monomers, researchers in the
protein LLPS field has been successfully applying principles from polymer science to
explain and predict solution behaviors of different protein systems (Brady et al., 2017;
Brangwynne et al., 2015; Harmon et al., 2017; Molliex et al., 2015).
Among all the lessons that we have learned from polymer science, Flory-Huggins is
perhaps the most critical theory that protein scientists have adopted. It provides a
statistical method that connects microscopic molecular interactions within the phase
behavior of a macroscopic polymer solution. Independently developed by Maurice L.
Huggins in 1941 and Paul J. Flory in 1942, the Flory-Huggins theory assumes a lattice
model where the free energy of mixing can be calculated for a homopolymer solution
(Flory, 1942; Huggins, 1941). Specifically, for a random walk on a lattice (Fig 1.4A), if we
define the length of the homopolymer (i.e., number of monomers in a molecule) as N,
the volume fraction of the polymer as 𝜙 (thus the volume fraction of the solvent as 1𝜙), the Flory-Huggins free energy of mixing can be calculated by the following equation:
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𝜙
Δ𝐺𝑚 = −𝑇Δ𝑆𝑚 + Δ𝐻𝑚 = 𝑘𝑏 𝑇[ 𝑙𝑛𝜙 + (1 − 𝜙)𝑙𝑛(1 − 𝜙) + 𝜒𝜙(1 − 𝜙)]
𝑁

Here, the first two terms represent the entropy of mixing, an approximation following
mean-field assumptions, while the third term represents the energy, or enthalpy of
mixing. The Flory-Huggins parameter  quantifies the contribution of three types of
molecular interactions: polymer-solvent (𝑢𝑝𝑠 ), polymer-polymer (𝑢𝑝𝑝 ), and solventsolvent (𝑢𝑠𝑠 ), (Fig 1.4B).

𝜒=

z

1
[𝑢𝑝𝑠 − (𝑢𝑝𝑝+ 𝑢𝑠𝑠 )]
𝑘𝑏 𝑇
2

The value of 𝜒 here depends on the chemical potentials of the three types of
interactions. In general, when polymer-solvent interaction is energetically favorable over
polymer-polymer and solvent-solvent interactions, the system prefers the “mixed” state.
Conversely, when the polymer-polymer interaction is strongly attractive, or when the
polymer-solvent interaction is repulsive, the system favors the “demixed” state,
separating into a condensed phase and a dilute phase (Flory, 1953; Gennes and
Gennes, 1979).
As biopolymers, a protein solution should largely follow the Flory-Huggins theory,
meaning that energetically favorable protein-protein interaction or strong protein-solvent
repulsion can overcome entropic costs and result in a “demixed” or phase-separated
14

protein solution (Ahlers et al., 2021). However, the Flory-Huggins theory is not a perfect
solution for studying protein LLPS. Unlike homopolymers, which the Flory-Huggins
theory was originally based on, proteins are heteropolymers consisting of 20 different
amino acids, each of which brings unique molecular interactions. Therefore, the FloryHuggins theory is not sufficient and has to be complemented with other theories when
used to study protein LLPS.

15

Figure 1.4. Flory-Huggins theory provides a thermodynamic model for better
understanding polymer mixing in solution.
(A) The Gibbs free energy for mixing a polymer with a solvent is represented by Gm.
(B) The Flory parameter  is determined by the energetic balance between polymerpolymer, polymer-solvent, and solvent-solvent interactions.
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1.2.3 Multivalent interactions mediate protein LLPS
One important aspect to consider for biopolymers like proteins is the complexity of
interactions that they participate in, which includes not only strong, specific interactions
mediated by specific binding sites; but also weak, non-specific interactions that are
transient and more dynamic (Sukenik et al., 2017).
Weak interactions are utilized by nature in many processes throughout biology,
serving essential roles in signaling pathways, immune response, and transcription, just
to name a few (Mammen et al., 1998). More importantly for our discussion, weak
interactions among proteins can build multivalent networks, which constitute the main
driving forces of LLPS (Brangwynne et al., 2015; Posey et al., 2018). As discussed
above, whether a protein solution undergoes LLPS or not under a certain condition is
related to the energetic balance between protein-protein, protein-water, and water-water
interactions. Despite stable, specific protein-protein interactions (PPIs) often being
stronger individually, the sum of the weak, non-specific interactions can often be more
significant statistically (Mammen et al., 1998).
Therefore, characterizing multivalent interactions is important in studies of protein
LLPS systems. This can be difficult due to their transient nature and weak individual
strength. As a compromise, a ‘sticker and spacer’ framework was developed, which
generalizes and categorizes polypeptides within a protein to either stickers or spacers
regions (Choi and Pappu, 2020; Choi et al., 2019; Harmon et al., 2017; Martin et al.,
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2020; Yang et al., 2019). ‘Stickers’ include residues involved in multivalent, intra-and
intermolecular cross-link interactions that drive LLPS, whereas ‘spacers’ are residues
that either enable or suppress interaction between stickers (Fig.1.5) (Choi et al., 2019;
Martin et al., 2020; Yang et al., 2019). Depending on the system, stickers can be
patches on the surface of a folded protein (e.g. the hydrophobic patch on the UBA
domain of UBQLN2 (Dao et al., 2019; Yang et al., 2019)) (Fig. 1.5A), individual domains
in a multi-domain protein (e.g. SH3 and RPM domains in the SH3-RPM model system
(Li et al., 2012)) (Fig. 1.5B), or specific residues and sequence motifs within an
intrinsically disordered protein (short linear motifs, or SliMs in IDR-driven LLPS systems
(Brangwynne et al., 2015)) (Fig. 1.5C) (Choi et al., 2020; Martin et al., 2020). The amino
acid composition of stickers can also vary greatly; for example, arginine and tyrosine
constitute key amino acids in stickers of FUS (Wang et al., 2018), whereas hydrophobic
residues are found in stickers of UBQLN2 (Dao et al., 2019; Yang et al., 2019). Sticker
regions can be identified using biophysical methods that are capable of probing
transient, weak interactions such as solution NMR or can be predicted using
computational methods (Choi et al., 2019; Martin et al., 2020; Yang et al., 2019). Our lab
has previously adopted the sticker-spacer framework to characterize UBQLN2 LLPS in
vitro and found that mutations in stickers, but not linkers, significantly impact the LLPS
behavior of UBQLN2 (Dao et al., 2019; Yang et al., 2019).

18

Figure 1.5. Schematics of different types of sticker regions.
(A) Stickers can be patches on folded protein domains, (B) entire domains in
multidomain proteins, or (C) residues or short motifs in intrinsically disordered proteins.
Recreated based on Figure 2 of (Choi et al., 2020). Stickers are colored orange, while
spacers are colored black.
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1.2.4 Sequence determinants of protein LLPS
Decoding how amino acid sequence dictates LLPS properties is a current question
within the LLPS field. The goal is to predict the LLPS behavior of a protein from its
amino acid sequence or to design protein sequences that exhibit a specific LLPS
behavior. There is no doubt that the amino acid composition and sequence of the
protein dictate its LLPS behavior (Lin et al., 2018; Nott et al., 2015; Pak et al., 2016).
However, there is no method yet that can fully predict the LLPS behavior of a protein
system from its sequence.
The 20 amino acids that compose most proteins post significant challenge in the
studies of the sequence determinants of protein LLPS. Each amino acid brings a unique
combination of conformational and chemical characteristics to the overall protein. The
side chain and backbone of chemical groups of the amino acid residues can participate
in molecular interactions such as charge-charge, cation-π, π-π, and hydrophobic
interactions. It is the sum of these transient and weak interactions within the protein that
form the thermodynamic basis of protein LLPS (Posey et al., 2018). However, all
interactions do not contribute to LLPS equally; recent studies have highlighted the
contribution of π-π interactions in particular to the driving forces of LLPS (Choi et al.,
2019; Martin et al., 2020; Vernon et al., 2018). Vernon et al. identified the π-π contact to
be a prevalent and effective feature in proteins that undergo LLPS. The π orbitals of
bonded sp2-hybridized atoms in sidechains of Trp Tyr, Phe, His, Arg, Asn, Gln, Asp, and
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Glu were found to frequently stack with each other within van der Waals contact
distance, suggesting effective attractions between these residues. Additionally, πorbitals-containing amino acid residues are highly represented in proteins that undergo
LLPS. Therefore, it was proposed that the π-π interaction is a critical molecular
interaction that mediates protein LLPS. Amazingly, the study showed that the LLPS
propensity of a protein could be roughly estimated by simply analyzing the long-range
π-π interactions between amino acid side chains (Vernon et al., 2018). Based on these
results, an algorism (PScore) was developed and has been adopted widely and
successfully by the field (Vernon et al., 2018). However, despite being helpful in
identifying protein sequences that can potentially drive LLPS, the current generation of
algorithms still lacks the ability to fully predict the LLPS of full-length proteins or predict
the conditions under which the proteins phase separate.
1.2.5 Temperature-dependence of protein LLPS
Molecular interactions that drive LLPS respond differently to the change of
environmental conditions such as pH, salt, and temperature. For example, a recent
computational study found that within the temperature range of 300-350K, aromatic and
hydrophobic interactions increase in strength, whereas polar and electrostatic
interactions weaken as temperature increases (Dignon et al., 2019). Consequently, the
temperature dependence of a protein’s LLPS behavior can vary depending on its amino
acid composition and the molecular interactions involved in driving the process (Dignon
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et al., 2019). While some proteins are homogeneous in solution at low temperature and
demix at high temperature (a temperature-dependent behavior known as lower critical
solution temperature (LCST) phase transition); other demix at low temperature and
exhibit upper critical solution temperature (UCST) phase transition (Fig. 1.6). Dignon et
al. combined empirical information about the size and amino acid contact for each
amino acid type with calculated temperature-dependent solvent-mediated interaction
strengths to computationally predict whether an intrinsically disordered protein exhibits
UCST or LCST phase transition based on its sequence (Dignon et al., 2019). Despite
the relatively short sequences used, the study shows promising signs that might be
applicable to predicting the thermoresponsive LLPS behavior of larger-scale systems
and full-length proteins in the near future.

22

Figure 1.6. Two types of thermoresponsive phase separations.
(left) the binodal curve for systems that show upper critical solution temperature (UCST)
behavior. (right) the curve for systems that show lower critical solution temperature
(LCST) behavior. Recreated based on Figure 1 in (Ruff et al., 2018).
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1.3 Solution NMR - a powerful tool to probe protein structure,
dynamics, and interaction
While a number of methods are capable of probing PPIs, solution nuclear magnetic
resonance (NMR) stands out as a method that interrogates both the structural and
molecular basis of PPIs (Zuiderweg, 2002). Modern protein NMR utilizes multidimensional experiments to collect information about protein backbone and sidechain
atoms which exhibit unique chemical environments (Sattler, 1999). Perturbations to the
micro-environments as the results of physical and chemical interactions can then be
analyzed in extraordinary detail. Unlike X-ray crystallography, solution NMR studies
PPIs in their native, in-solution states, making NMR an excellent tool for studying PPIs.
Additionally, solution NMR is uniquely positioned to investigate protein structure and
dynamics of proteins, which are often related to PPIs as well (Göbl and Tjandra, 2012).

1.3.1 Probing protein secondary structure using solution NMR
Modern multi-dimensional NMR methods collect 1H and 15N chemical shifts of amino
acid backbone, as well as 13C chemical shifts of the C C and C’ atoms (Fig. 1.7).
These information-rich parameters can be used to measure the conformational state of
the protein. A routinely used empirical method that converts chemical shifts to protein
structure information is the Chemical Shift Index (CSI) (Wishart et al., 1992). The
method has been revised and developed since its early days; the current version
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compares the observed H C C and C’ chemical shifts to a random coil value, or
the CSI reference value. In practice, an H chemical shift that is greater than the CSI
reference value +0.1ppm or smaller than the CSI reference value -0.1ppm is assigned
an index value of +1 or -1, and the process is repeated for the other chemical shifts. Any
group of three or more consecutive +1 values is identified to be in a -strand;
conversely, a group of three or more consecutive -1 values is identified to be in an helix (Mielke and Krishnan, 2009).
Although the CSI method has been widely used, researchers have since developed
more sophisticated, probability-based methods that utilize all of backbone and sidechain
1H, 15N,

and 13C chemical shifts as input to semi-empirically determine the secondary

structure of the sequence. One such method is TALOS+ (Shen et al., 2009). As an
extension of the CSI method, TALOS+ utilizes a neuronal network classification
scheme, combined with a large database of 200 proteins to quantitatively predict the
protein backbone angles phi and psi, with ~89% prediction accuracy. In chapter two, we
utilized TALOS+ to determine the secondary structure of a key linker region in solution,
whose -helical structure turned out to play a significant role in its substrate binding.
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Figure 1.7. Multi-dimensional NMR measures the 1H, 15N, and 13C chemical shifts
of backbone and sidechain atoms of amino acid residues in a protein.
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1.3.2 Probing protein dynamics using solution NMR
In solution, proteins adopt a set of conformations that undergo continuous exchange
within a wide range of temporal and spatial scales ranging from femtoseconds to hours
and from nanometers to micrometers (Kleckner and Foster, 2011). These dynamic
properties of proteins are highly relevant to their functional properties, such as binding
and folding (Berendsen and Hayward, 2000). While many methods struggle to capture
these fast and nuanced changes, NMR provides a powerful toolkit for measuring these
essential features of proteins.
NMR relaxation experiments are a subset of NMR experiments often used to study
the dynamic properties of proteins in solution. In a typical NMR relaxation experiment, a
radio frequency pulse is used to perturb the equilibrium state of a nuclear spin. The
spins are monitored during their relaxation process back to equilibrium; the way in which
they relax provides information about their molecular geometry and mobility (Wagner,
1993). Dynamics of proton-bound 15N nuclei are measured via longitudinal (R1) and
transversal (R2) relaxation rates (Ishima and Torchia, 2000), as well as via the
heteronuclear nuclear overhauser effect (hetNOE) of the backbone HN vectors. These
three parameters are sensitive to protein motions on the picosecond to nanosecond
scale (Palmer, 2004). Analysis of the collected parameters using programs like
DYNAMICS and ROTDIF can further determine dynamic properties of the protein such
as rotational tensors, the rigidity of the bond vectors S2, and the overall timescale of
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molecular tumbling c (Berlin et al., 2013; Fushman, 2012).

1.3.3 Probing protein-protein interactions using solution NMR
As discussed, solution NMR monitors the microenvironments of individual atoms in
a protein, making it a powerful tool for studying protein-protein interactions at the
atomic-level resolution. In practice, we monitor the 15N-1H HSQC spectrum of the
protein of interest (15N labeled) and record chemical shift changes as an NMR invisible
(unlabeled) binding partner is titrated in. The recorded perturbations reflect interactions
that alter the microenvironment on the protein interfaces, where the interactions happen
(Zuiderweg, 2002). This method, called Chemical Shift Perturbation (CSP) mapping, is
perhaps the most frequently used NMR technique and is commonly known as the bread
and butter of protein NMR.
In the following chapters, we utilize solution NMR together with other biochemical
and biophysical methods to study the biophysical properties of two multidomain
proteins: the peptidyl-prolyl isomerase Ess1 and proteasome shuttle protein UBQLN2.
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1.4 Ess1 is a yeast peptidyl-prolyl isomerase that modulates DNA
transcription
Peptidyl-prolyl cis/trans isomerases (PPIases) regulate the folding and activity of
target proteins by catalyzing a 180° rotation of the peptide bond preceding proline. The
subject protein of Chapter 2, Saccharomyces cerevisiae essential 1 (Ess1), is the
founding member of the eukaryotic parvulin-class of PPIase. Ess1 is highly conserved
among eukaryotes and plays a key role in transcription by regulating the activity of RNA
polymerase II (RNAPII) (Wu et al., 2000).
In the same parvulin-class of PPIase, Ess1 has a well-studied human ortholog
called Pin1 (Lu et al., 1996). Discovered after Ess1, it was so named following its
identification as a Protein Interacting with NIMA (Pin1) (Lu et al., 1996). Human Pin1
has the same domain architecture as the yeast enzyme, where the N-terminal substrate
binding (WW) domain and the C-terminal catalytic (PPIase) domain are connected by a
linker region (Fig. 1.8). Human Pin1 was originally discovered as a mitotic regulator and
later found to be involved in other cellular processes, including cell differentiation,
senescence, and apoptosis. The dysregulation of Pin1 has been associated with
neurodegenerative disorders, as well as cancers (Chen et al., 2018b).
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Figure 1.8. Domain architectures of the parvulin-class PPIase family proteins
Ess1 and Pin1.
Ess1 and its human ortholog Pin1 share highly similar domain architectures, including a
substrate binding (WW) domain, a catalytic (PPIase) domain, and a linker connecting
the two.
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1.4.1 The biological functions of Ess1
Ess1 targets the largest subunit of RNAPII, RPB1. The RPB1 subunit forms the
DNA binding domain of the polymerase with several other polymerase subunits (Acker
et al., 1997). The DNA binding domain is a groove in which the DNA template
is transcribed into RNA (Hanes, 2014). RPB1 contains a carboxy-terminal
domain (CTD) composed of up to 52 heptapeptide repeats (YSPTSPS).
Ser2 and Ser5 of the CTD are often modified by phosphorylation (Pineda et al.,
2015). Ess1 recognizes and regulates RNA polymerase II by catalyzing the cis/trans
conversion of two peptide bonds, pSer5–Pro6 bond and pSer2–Pro3 bond, within the
CTD (Hanes, 2014). By shifting the cis/trans conformation of the prolines, Ess1
drastically changes the ternary structure of the CTD peptide as the direction of the
backbone makes a 180° turn with the isomerization. This controls the competition for
binding to the CTD peptide (Hanes, 2014). For example, CTD binding partners like
Pcf11 (Grzechnik et al., 2015) and Nrd1 (Kubicek et al., 2012), two 3’-processing
factors, show strong and distinct isomer-specific preferences, and the isomerization
process thus modulates the activities of these transcription factors (Fig. 1.9).
Loss of Ess1 has widespread deleterious consequences on RNAPII transcription,
including cryptic transcription and defects in elongation, termination/3’-RNA-processing,
and histone modification (Hani et al., 1995; Krishnamurthy et al., 2009; Ma et al., 2012;
Singh, 2009; Wilcox et al., 2004). Similarly, Pin1 is also implicated in the regulation of
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RNAPII transcription (Lu et al., 1996; Xu et al., 2003). Both Pin1 and the Drosophila
melanogaster ortholog of Ess1 (called Dodo) can substitute for Ess1 in yeast, indicating
functional conservation (Lu et al., 1996; Maleszka et al., 1996).

Figure 1.9. Schematic of the biological function of Ess1.
Ess1 targets the CTD of RNA Polymerase II and catalyzes the Cis-Trans isomerization
of specific proline residues, modulating the interactions between CTD-binding cofactors
and RNA polymerase II, and subsequently regulates RNA transcription. Figure
recreated based on Figure 4 in (Hanes, 2015).
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1.4.2 Structure of Ess1
Ess1 consists of a substrate-binding domain called the WW domain and a prolylIsomerase (PPIase) domain. Both the WW and PPIase domains are conserved across
species. In Pin1, the WW domain and PPIase domains are connected by a flexible
linker region (Fig.1.10). In contrast, our collaborators from Steve Hanes and Micheal
Cosgrove’s lab have illustrated that in the yeast enzymes Ess1, the linker region
between the WW and PPIase domains has a well-defined α-helix structure (Fig. 1.10)
(Namitz et al., 2021). The unique linker domain of the protein leads to intriguing
questions about the dynamics and CTD substrate recognition. In chapter 2, we used
solution NMR to study the dynamics of the entire Ess1 protein, including the linker
region and studied the substrate binding of Ess1 using CTD peptides of different
lengths.
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Figure 1.10. Comparison of X-ray crystal structures of ScEss1 (PDB:7KKF) and
HsPin1 (PDB:1PIN).
Structures of both the WW and PPIase domains are highly conserved. However, where
a flexible linker between the two domains is found in human PIN1, there is an α-helical
linker in yeast Ess1 instead.
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1.5 Ubiquilins are shuttle proteins involved in the protein quality
control mechanisms
Cells must maintain intricate protein homeostasis to maintain proper function and
survival. The protein flux of the cell must remain in balance despite being continuously
challenged by limited protein folding capacity (Levine et al., 2005), environmental
stress, and aging. Maintenance of protein homeostasis is particularly important in
neurons due to their unique morphology and long lifespan (O’Leary and Wyllie, 2011).
Dysregulation of homeostasis is associated with neurodegenerative diseases such as
Amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), Alzheimer’s disease
(AD), and Frontotemporal dementia (FTD) (Douglas and Dillin, 2010; Renaud et al.,
2019; Taylor et al., 2016). Cells have developed protein quality control (PQC)
mechanisms to surveil proteome balance, facilitate protein folding and respond to the
accumulation of protein aggregates.
Due to the highly complex and crowded nature of the cellular environment,
substrate targeting in the PQC pathways can be challenging. Cells rely on shuttle
proteins that have the dual capability to interact with substrate and PQC components to
facilitate this process, closing the gap between substrates and degradation machinery
(Jantrapirom et al., 2019). Ubiquilins (UBQLNs) are multifaceted shuttle proteins, as
they can chaperone misfolded proteins but also facilitate degradation of substrates
through the ubiquitin-proteasome system (UPS), autophagy, and endoplasmic35

reticulum-associated protein degradation (ERAD) pathways (Ko et al., 2004; Lee et al.,
2013; Lim et al., 2009; Stieren et al., 2011). UBQLNs are invoked during cellular stress
responses, as evident by their localization into stress granules (Alexander et al., 2018;
Dao et al., 2018). UBQLNs also localize to cellular aggregates and aggresomes to help
the cell sequester misfolded protein into separate locations (Deng et al., 2011; Heir et
al., 2006). Understanding the structure, dynamics, and function of UBQLNs is therefore
essential to elucidating PQC mechanisms in cells.
Mutations in the human UBQLN proteins have been reported to associate with or
cause a variety of diseases, including neurodegenerative disorders and cancers. The
most well-characterized pathological mutations are extensively related to
neurodegenerative diseases, specifically amyotrophic lateral sclerosis (ALS),
frontotemporal dementia (FTD), and Alzheimer’s disease (Bertram et al., 2005; Deng et
al., 2011; Edens et al., 2017; Fahed et al., 2014; Gellera et al., 2013; Kamboh et al.,
2006; Mah et al., 2000), among others such as Brown-Vialetto-Van Laere syndrome
(BVV LS) (González-Pérez et al., 2012). Dysregulation of UBQLN1 expression levels
also causes symptoms associated with Huntington’s (Wang et al., 2006). While the
underlying molecular mechanisms associated with disease mutations of UBQLNs
remain unknown, many studies show that mutant UBQLN pathology often involves
compromised PQC mechanisms (UPS and autophagy) and/or the formation of diseaserelated aggregates (Alexander et al., 2018; Chang and Monteiro, 2015; Chen et al.,
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2018a; Deng et al., 2011; Hjerpe et al., 2016; Kim et al., 2018; Sharkey et al., 2018).
To date, five human UBQLN proteins are known (1, 2, 3, 4, and L). Among these
five UBQLN proteins, UBQLN3 and UBQLNL are specific to testes (Conklin et al., 2000;
Yuan et al., 2015), whereas UBQLN1, 2, and 4 are widely expressed in all tissues
(Marín, 2014). Notably, UBQLN2 expression is elevated in the nervous system, whereas
UBQLN1 and UBQLN4 are relatively evenly expressed throughout all tissue types
(Marín, 2014; Wu et al., 1999, 2002). In this thesis, our work focuses on two members
of the UBQLN family: UBLQN1 and UBQLN2.

1.5.1 Domain architecture of UBQLNs
UBQLN1 and 2 comprise 589 and 624 amino acids, respectively (Fig. 1.11A);
UBQLN1 is 74% identical to UBQLN2. UBQLN1 and UBQLN2 share similar domain
architecture, consisting of an N-terminal Ubiquitin (Ub)-like (UBL) domain, a C-terminal
Ub-associated (UBA) domain, and two STI1 regions in the middle (Fig. 1.11A). The
UBL-UBA construct of the UBQLNs is similar to other Ub-binding protein shuttles, such
as Rad23B/HR23B and Ddi1 (Bertolaet et al., 2001; Chen et al., 2001). Located
between the two folded UBL and UBA domains, the middle region is largely intrinsically
disordered (Fig. 1.11B). UBQLN2 contains a unique proline-rich region (PXX), where
neurodegenerative disease-related mutations are found disproportionately. This
multidomain architecture of UBQLNs enables a rich pool of diverse binding partners that
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include PQC components, such as the proteasome, autophagic proteins, misfolded
proteins, and ubiquitinated substrates. The largely intrinsically disordered segments
confer flexibility and dynamics to UBQLNs that contribute to functionality.
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Figure 1.11. Domain architecture of UBQLN1 and 2.
(A) Domain architecture map of UBQLN1 and UBQLN2 with UBL, STI1-I, STI1-II, PXX,
and UBA domains colored as red, dark blue, blue, magenta, and green, respectively.
PXX is a proline-rich region unique to UBQLN2. (B) Predictions for UBQLN disorder
propensity. PONDR-FIT (Xue et al., 2010) and DISOPRED3 (Jones and Cozzetto,
2015) predict intrinsically disordered regions. PONDR-FIT is a meta-predictor that
produces prediction scores by combining results from a series of algorithms;
DISORPRED3 is a separate program trained on conserved sequence features of
intrinsically disordered regions, identified by missing residues in high-resolution X-ray
structures (Jones and Cozzetto, 2015; Xue et al., 2010). For both programs, higher
values represent protein regions likely to be disordered.
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1.5.2 Physiological Functions of UBQLNs
UBQLNs are truly versatile, multifaceted proteins that carry out diverse cellular
functions (Fig. 1.12A). UBQLNs participate in multiple PQC pathways, including the
ubiquitin-proteasome system (UPS), autophagy, and endoplasmic-reticulum-associated
protein degradation (ERAD). Additionally, UBQLNs exhibit molecular chaperone
functions to prevent specific protein substrates from misfolding. UBQLNs also
participate in DNA/RNA metabolism, cell differentiation/development, and DNA damage
response (Fig. 1.12A).
The most well-studied function of the UBQLNs is perhaps the substrate shuttling
role that they play in the UPS. The UPS is a vital protein degradation mechanism in
eukaryotes. Its proper functions rely on many components, including enzymes (E1, E2,
E3) responsible for the ubiquitination of substrates, shuttle proteins that direct
ubiquitinated substrates to the proteasome, and ultimately the proteolytic activity of the
proteasome. Ubiquitination is a post-translational modification that covalently attaches
mono- or polyUb chains onto protein substrates at specific positions (often lysines).
These Ub markers act as signaling tags for various cellular pathways. K48-linked
polyUb is the common tag for proteasomal degradation; K63-linked polyUb, on the other
hand, signals for DNA repair, trafficking, and autophagy (Pickart, 2000). However, these
signals are not exclusive, as evidence exists that K48-linked chains can associate with
autophagy and K63-linked chains with UPS (Chen et al., 2019; Saeki et al., 2009).
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UBQLN1 and UBQLN2 bind proteasomal subunits and ubiquitinated proteins via
their UBL and UBA domains, respectively (Fig. 1.12B). UBQLN UBL domain transiently
associates with the proteasome, primarily via Rpn10 and Rpn13 receptors (Chen et al.,
2016; Wang and Monteiro, 2007), while the UBA domain binds both monoUb and
polyUb chains (Harman and Monteiro, 2019; Zhang et al., 2008). Therefore, UBQLNs
are characterized as shuttle proteins that transport ubiquitinated substrates to the
proteasome.
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Figure 1.12. physiological functions of the UBQLNs.
(A) UBQLNs are involved in multiple PQC pathways and other cellular processes. (B)
The UBQLN UBL domain interacts with the proteasome, whereas the UBA domain
interacts with ubiquitinated substrates. Thus, UBQLN shuttles substrate to the
proteasome for degradation. Modified from Figure 5 in (Zheng et al., 2020).
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1.6 Aims of this work
In this work, we utilize a combination of biochemical and biophysical methods to
answer the following questions regarding Ess1 and the UBQLN family proteins,
respectively: 1. What are the bivalent substrate-binding mechanisms for Ess1 to bind to
CTD peptides, and 2. What are the molecular mechanisms that modulate the LLPS of
UBQLNs. Although similarities are seemingly rare between the two subject families of
proteins, the methodologies used in their respective studies echo each other. We used
solution NMR as our main tool of choice, taking advantage of its atomic-level resolution
in characterizing the structure and dynamic of the proteins and probing the proteinprotein interactions. The Ess1 work highlights the functional significance of structural
rigidity in the linker region, while the work on the UBQLNs highlights the involvements of
both structured and intrinsically disordered regions in the context of LLPS. This work
can provide a template for future studies that aim to decipher the structure, dynamics,
and interactions of multidomain proteins.
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Chapter II:
NMR study of Ess1 Prolyl Isomerase with CTD peptides suggests a
bivalent anchoring mechanism by the Ess1 prolyl isomerase

Portions of this chapter have been previously published and reprinted with permission
from the publisher. Reference: (Namitz, Zheng et al., 2021).

Namitz, K.E.W*., Zheng, T*., Canning, A.J., Alicea-Velazquez, N.L., Castañeda, C.A.,
Cosgrove, M.S., and Hanes, S.D. (2021). Structure analysis suggests Ess1 isomerizes
the carboxy-terminal domain of RNA polymerase II via a bivalent anchoring mechanism.
Communications Biology 4, 1–14. * Co-first authors

In this chapter, there were experimental contributions from Dr. Kevin Namitz, Ashley
Canning, and Dr. Nilda Alicea-Velazquez, on experiments including X-ray
crystallography, fluorescence anisotropy, and sedimentation velocity analytical
ultracentrifugation data collection and analysis.
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Abstract
Accurate gene transcription in eukaryotes depends on isomerization of serineproline bonds within the carboxy-terminal domain (CTD) of RNA polymerase II.
Isomerization is part of the "CTD code" that regulates recruitment of proteins required
for transcription and co-transcriptional RNA processing. Saccharomyces cerevisiae
Ess1 and its human ortholog, Pin1, are prolyl isomerases that engage the long heptad
repeat (YSPTSPS)26 of the CTD by an unknown mechanism. Here, we used an
integrative structural approach to decipher Ess1 interactions with the CTD. Ess1 has a
rigid linker between its WW and catalytic domains that enforces a distance constraint for
bivalent interaction with the ends of long CTD substrates (> 4-5 heptad repeats). Our
binding results suggest that the Ess1 WW domain anchors the proximal end of the CTD
substrate during isomerization, and suggest that linker divergence may underlie
evolution of substrate specificity.
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2.1 Introduction
Saccharoymces cerevisiae Ess1 (essential in yeast 1) is the founding member of
the eukaryotic parvulin-class of peptidyl prolyl cis-trans isomerase (prolyl isomerase;
PPIase). Ess1 is highly-conserved among eukaryotes (Lu, Hanes et al. 1996, Maleszka,
Hanes et al. 1996, Hanes 2014), and plays a key role in transcription by regulating the
activity of RNA polymerase II (RNAPII) (Hanes 2014). However, the mechanism(s) by
which Ess1 binds to RNAPII to carry out its function is not well understood. Specifically,
it is not known how Ess1 engages the long unstructured carboxy-terminal domain (CTD)
of Rpb1, the largest subunit of RNAPII.
Ess1 and other prolyl isomerases (cyclophilins, FK506-binding proteins) regulate
the folding and activity of target proteins by catalyzing a 180° rotation of the peptide
bond preceding proline, causing conformational changes (Fischer, Bang et al. 1984,
Schmid 1993, Schiene and Fischer 2000). Ess1 isomerizes the CTD of Rpb1, facilitating
the recruitment of proteins needed for efficient transcription and RNA processing
(Morris, Phatnani et al. 1999, Wu, Wilcox et al. 2000, Singh 2009 ). Loss of Ess1 has
widespread deleterious consequences on RNAPII transcription, including cryptic
transcription and defects in elongation, termination/3’-RNA-processing and histone
modification (Hani, Schelbert et al. 1999, Wilcox, Rossettini et al. 2004, Krishnamurthy,
Ghazy et al. 2009, Singh 2009, Ma, Atencio et al. 2012). Pin1, the human ortholog of
Ess1 (Lu, Hanes et al. 1996), is also implicated in regulation of RNAPII transcription
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(Xu, Hirose et al. 2003). Both Pin1 and the Drosophila melanogaster ortholog of Ess1
(called Dodo), can substitute for Ess1 in yeast, indicating functional conservation (Lu,
Hanes et al. 1996, Maleszka, Hanes et al. 1996).
The Rpb1 CTD is composed of an unstructured heptad repeat with a consensus
sequence of Y1-S2-P3-T4-S5-P6-S7. There are 26 repeats in yeast (nearly all consensus),
and 52 repeats in humans (about half consensus) (Jeronimo, Collin et al. 2016,
Zaborowska, Egloff et al. 2016). Phosphorylation of Ser2 or Ser5 within the CTD repeat
generates Ess1/Pin1 binding sites (pSer-Pro motifs) (Yaffe, Schutkowski et al. 1997,
Gemmill, Wu et al. 2005). In vitro, Ess1 increases cis/trans isomerization of the pSer2Pro3 and pSer5-Pro6 bonds from a spontaneous rate of <1 turnover/min to about 200
and 1000 turnovers/min, respectively (Gemmill, Wu et al. 2005). Importantly, Ess1 and
other prolyl isomerases act reversibly, providing a kinetic effect, which can effectively
increase the availability of the less abundant (~10%) cis-isomers (Werner-Allen, Lee et
al. 2011, Zhang, Wang et al. 2012, Mayfield, Fan et al. 2015).
Ess1 and Pin1 are small modular proteins (~19.5 kDa) composed of two compact
domains; an N-terminal Type-IV WW domain (Macias, Wiesner et al. 2002) and Cterminal catalytic (PPIase) domain. Both domains bind pSer/pThr-Pro motifs, with the
WW domain having ~10-fold higher affinity (Verdecia, Bowman et al. 2000). How these
domains work together is not known. This is a particularly vexing question because
physiologically-relevant substrates, such as the CTD, usually contain multiple pSer-Pro
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binding motifs. A number of mechanisms including sequential binding, competitive
binding, and cooperative binding have been proposed (Verdecia, Bowman et al. 2000,
Innes, Bailey et al. 2013, Eichner, Kutter et al. 2016, Lee and Liou 2018).
Structure studies of Pin1, and Ess1 from the fungal pathogen Candida albicans
(CaEss1), show the WW and PPIase domains are similar, but that the linker region that
joins them are different (Ranganathan, Lu et al. 1997, Li, Li et al. 2005). In Pin1, the
linker is unstructured and there are dynamic interactions between the WW and PPIase
domains (Bayer, Goettsch et al. 2003, Jacobs, Saxena et al. 2003), which may
contribute to Pin1's broad substrate specificity (Joseph, Yeh et al. 2003, Takahashi,
Uchida et al. 2008, Litchfield, Shilton et al. 2015). By contrast, the highly-structured
linker in CaEss1 restricts the relative orientation between the WW and PPIase domains
(McNaughton, Li et al. 2010). These differences might impact the way in which Pin1 and
CaEss1 engage multivalent substrates.
Our collaborator (Dr. Kevin Namitz) first determined the crystal structure of S.
cerevisiae Ess1 (henceforth called Ess1) (Fig. 2.1A) (Namitz, Zheng et al. 2021). The
globular domains of Ess1 are similar to those in human Pin1 (Ranganathan, Lu et al.
1997) and CaEss1 (Li, Li et al. 2005) (Fig. 2.1A; for an alignment, see Fig. S2.1). The
Ess1 N-terminal WW domain (residues 10-45) forms a three stranded anti-parallel βsheet as described for Type IV WW-domains that recognize phospho-Ser-Pro motifs
(Macias, Wiesner et al. 2002), and is highly similar to those in Pin1 and CaEss1 (Fig.
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2.1B). The PPIase domain of Ess1 (aa 64-170) has a globular α / β -fold structure nearly
identical to that of Pin1 and CaEss1 (Fig. 2.1C). The PPIase domain consists of an antiparallel β-sheet that forms a concave surface bordered by α3 and α5 helices of the
PPIase domain, forming the catalytic core. In summary, the WW and PPIase domains in
Ess1, CaEss1 and human Pin1 are individually nearly identical, consistent with their
similar binding preferences (pSer-Pro), and the functional interchangeability of these
proteins in yeast (Lu, Hanes et al. 1996, Maleszka, Hanes et al. 1996).
To better understand how Ess1 recognizes long, physiologically-relevant substrates
like the CTD. We studied the structure of Ess1 in solution and its interaction with a
series of bivalent CTD peptides of increasing length using solution NMR. Our results
indicate that Ess1 has an elongated structure with a highly-structured linker with a short
-helix. Binding studies using NMR chemical shift analyses revealed simultaneous and
potentially cooperative interaction of the Ess1 WW and catalytic domains with long
bivalent substrates. The results are the first to identify bivalent Ess1-CTD interactions,
suggesting an anchored mechanism of isomerization, and raising the possibility that
during evolution, eukaryotic parvulin-class PPIases gained a broader substrate
specificity by acquiring a flexible linker that generates a more dynamic (and
promiscuous) binding mode.
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A

ScEss1
B

CaEss

HsPin1
C

Figure 2.1. The crystal structure of the S. cerevisiae Ess1 protein reveals an
elongated protein with a well-ordered linker joining the WW and catalytic
domains.
(A) Comparison of S. cerevisiae Ess1 (PDB ID:7KKF) (blue), C. albicans Ess1 (PDB ID:
1YW5) (cyan) and human Pin1 (PDB ID: 1PIN) (green) highlighting the different relative
positions of the two functional domains. Linker regions are highlighted (pink). (B)
Superposition of the WW domains (Cα) of each protein shown in (A). The overall degree
of similarity is very high (RMSD < 0.7 Å). (C) Superposition of the PPIase (catalytic)
domains (Cα) of each protein in (A) shows a high degree of similarity (RMSD < 0.7 Å).
This figure has been reused with permission from reference (Namitz, Zheng et al.,
2021) (Appendix II).
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2.2 Results
2.2.1 NMR spectroscopy and resonance assignment
Sequence-specific assignments of the backbone resonances (HN, N, CO, Cα) and
sidechain (Cβ) of the ScEss1 C120S were obtained based on 2D-HSQC (Fig. 2.2), 3D
HNCO, 3D HNCACO, 3D HNCACB and 3D CBCACONH spectra (Fig. 2.3). This mutant
was chosen because C120S is a known catalytically-deficient mutant that allow us to
separate CTD peptide binding of the protein from its prolyl-isomerization activity.
Despite several instances of signal overlap, manual assignment of backbone N, HN
resonances for 149 non-proline residues (92% of 162 total) were established using the
aforementioned data (Fig. 2.2). Additionally, most of backbone Cα, Cβ and CO
resonances were assigned. Specifically, 95%(154/162) Cα, 93% (141/151) Cβ, 88%
(143/162) CO were assigned. Cα, Cβ and CO resonances of 5 out of 8 proline residues
were also assigned from 13C spectra of their adjacent residues. These assignments
were then visually transferred to NMR spectra of wild-type Ess1 for all subsequent
experiments discussed below (see Methods, Fig. S2.2).
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Figure 2.2. 2D 1H, 15N HSQC spectrum of 15N-labeled scEss1 C120S in NMR buffer
collected at 298 K.
The side chain Asn and Gln resonances are shown connected with lines.
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Cβ

Cα

CO

Figure 2.3. 13C resonance diagram showing the connections of residues in the
linker region.
13Cα , 13Cβ
13CO
13Cα (red), 13Cβ (blue),
i-1
i-1 (purple) and
i-1 (navy) resonances match
i
i
13
and COi (green) of the previous residue.
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2.2.2 NMR studies confirm Ess1 has an elongated, conformationally-constrained
shape with a structured helical linker
The assigned NMR chemical shifts were fed to a secondary structure prediction
program TALOS+ (Shen, Delaglio et al. 2009), the results confirmed the secondary
structure elements of Ess1 (Fig. 2.4A and B), including the -helical structure of the
linker in solution.
We analyzed Ess1 backbone dynamics using standard 15N R1, R2, and hetNOE
experiments (Kato, Ng et al.) (Fig. S2.3). The relaxation rates and hetNOE data suggest
that the majority of residues in Ess1 are in well-defined structural elements, including
the linker region (K46-R59) (Fig. 2.4C). Using the 15N backbone relaxation NMR data,
we calculated the rotational diffusion tensors for the individual domains in Ess1 as well
as for the entire protein (Table S2.1). The diffusion tensor characteristics for the
individual domains are nearly identical to that of the full-length protein, suggesting that
the WW and PPIase domains tumble as a single, associated unit. Furthermore, the
rotational correlation time (c) of 13.5 ns is consistent with the expected c of a compact,
monomeric 20 kDa globular protein (Bernado, Garcia de la Torre et al. 2002). These
data corroborate the analytical ultracentrifugation data from our collaborators as we will
discuss below.
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Figure 2.4. NMR data show Ess1 is fully ordered in solution, including the linker.
(A) TALOS+ secondary structure calculation using NMR backbone HN, N, CO, CA and
sidechain CB chemical shift assignments. TALOS confirms the -helical structure of
linker (residues 46 – 59 in pink). (B) Backbone 1H-15N heteronuclear NOEs show that
the protein is well-structured throughout the WW and PPIase domains, including the
linker region. Errors in NOEs were determined using standard error propagation (see
Methods). This figure has been reused with permission from reference (Namitz, Zheng
et al., 2021) (Appendix II).
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In summary, Ess1 is relatively rigid in solution, similar to CaEss1 (McNaughton, Li et
al. 2010), but different from human Pin1, which is flexible and whose WW and PPIase
domains tumble relatively unconstrained until substrate binds (Jacobs, Saxena et al.
2003). The key differences between fungal Ess1 proteins and mammalian Pin1 map to
the distinct linker regions that join the highly-conserved functional domains. The fungal
linkers are highly structured and constrain the WW and PPIase domains, resulting in a
more rigid structure than in the mammalian enzyme. Secondary structure predictions
based on fungal and metazoan sequences are consistent with this idea (Li, Li et al.
2005, Hanes 2014). This divergence between fungal and metazoan Ess1/Pin1 proteins
may have implications for both binding mechanisms and substrate specificities (see also
(Li, Li et al. 2005, Hanes 2014)).

2.2.3 How do Ess1 and Pin1 bind to multivalent CTD substrates?
Both the WW and PPIase domains of Ess1 and Pin1 bind pSer/pThr-Pro motifs.
This dual-binding capacity, and the fact that most substrates contain multiple binding
motifs complicates affinity measurements. Deciphering the mechanism of action of
these proteins has been challenging and controversial. Early models suggested the WW
domain tethers Ess1/Pin1 to protein substrates, increasing the local concentration of the
PPIase domain, which then isomerizes nearby pSer-Pro motifs. This is based on the >
10-fold higher binding affinity of the WW domain for single-site peptides in vitro (Yaffe,
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Schutkowski et al. 1997, Verdecia, Bowman et al. 2000). However, it is not known
whether the WW and PPIase domains bind multisite (multivalent) substrates
simultaneously and/or cooperatively, or whether the domains compete with each other
for occupancy. Nor has the stoichiometry and arrangement of Ess1/Pin1 proteins on
long, physiological relevant substrates been determined. To address these questions
and gain a mechanistic understanding of how Ess1 interacts with its major in vivo target,
the Rpb1 CTD, we determined the affinity of Ess1-CTD interaction using multiple
orthogonal approaches, including solution NMR, a competition fluorescence anisotropy
assay and sedimentation velocity analytical ultracentrifugation, the latter two were
contributed by our collaborators.

2.2.4 Ess1 binds better to longer CTD peptides
Prior studies of Ess1/Pin1-CTD interaction were limited to peptides bearing only a
single heptad repeat (Y1S2P3T4S5P6S7). To provide a more realistic model of CTD
interaction, we generated a series of CTD peptides of increasing length ranging from 15 heptad repeats (1R – 5R) (Table 2.1). To simplify the analysis, phosphorylation
(incorporated during synthesis) was restricted to only the outermost repeats, and
positioned exclusively on the Ser5-Pro6 motif. The pSer5-Pro6 position was chosen
because it has a higher binding affinity and turnover rate than does pSer2-Pro3
(Verdecia, Bowman et al. 2000, Gemmill, Wu et al. 2005), and because mutations of
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Ser5 show a stronger genetic interaction with Ess1 in vivo (Wilcox, Rossettini et al.
2004).
To estimate the affinity of different length CTD peptides, our collaborators used a
competition fluorescence anisotropy assay in which they measured the ability of
unlabeled 1R to 5R CTD peptides to compete for Ess1 binding with an FITC-labeled
1R-CTD peptide (Fig. 2.5, Table 2.2A). As expected, a 2R peptide (IC50 = 59 ±17 M)
and 3R peptide (IC50 = 60 ±17 M), which have two binding sites, competed better than
the control 1R peptide (IC50 = 259 ±33 M). However, the 4R (IC50 = 35.9 ± 0.5 M) and
5R (IC50 = 41 ± 5.0 M) peptides competed even better, despite all having 2 binding
sites. The results are consistent with a model in which Ess1 occupies both sites
simultaneously on the longer CTD-peptide substrates (4R, 5R).
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Name
BLI-1R
FITC1R
FITC2R
FITC3R
FITC4R
FITC5R
NMR1R
NMR2R
NMR3R
NMR4R
NMR5R

Sequence
biotin-GGSGGS(YSPTpSPS)YS
FITC-AS(YSPTpSPS)YS

Source
NeoBioLab
Genscript

FITC-AS(YSPTpSPS)(YSPTpSPS)YS

Abclonal

FITC-AS(YSPTpSPS)(YSPTSPS)(YSPTpSPS)YS

Abclonal

FITC-AS(YSPTpSPS)(YSPTSPS)(YSPTSPS)(YSPTpSPS)YS

Genscript

FITCAbclonal
AS(YSPTpSPS)(YSPTSPS)(YSPTSPS)(YSPTSPS)(YSPTpSPS)YS
AS(YSPTpSPS)YS
Abclonal
(YSPTpSPS)(YSPTpSPS)

Abclonal

(YSPTpSPS)(YSPTSPS)(YSPTpSPS)

Abclonal

AS(YSPTpSPS)(YSPTSPS)(YSPTSPS)(YSPTpSPS)YS

Abclonal

AS(YSPTpSPS)(YSPTSPS)(YSPTSPS)(YSPTSPS)(YSPTpSPS)YS Abclonal

Table 2.1. Peptides used in this study.
This table has been reused with permission from reference (Namitz, Zheng et al., 2021)
(Appendix II).
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Figure 2.5. Fluorescence anisotropy measurements indicate that Ess1 binding
favors longer CTD substrates.
Our collaborators performed a competition assay using unlabeled 1R-5R CTD peptides
to compete with an FITC-labeled 1R-CTD peptide (1uM) for Ess1 (50uM) binding. IC50
values were calculated and shown in Table 2.2. This figure has been reused with
permission from reference (Namitz, Zheng et al., 2021) (Appendix II).
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A. Competition Anisotropy (vs. FITC-1R)
IC50 (µM)
Competitor peptide
1R
261
2R
59
3R
60
4R
36
5R
41
B. Titration by SV-AUC
Ligand
Two-site model
Kd1 (µM)
FITC-1R
279
FITC-4R
101
FITC-5R
21.5
C. Titration by NMR
Ligand
Average Kd (µM)
1R
154.7
4R
46.8
5R
9.1

SD (µM)
33
17
17
0.5
5

Kd2 (µM)
>14,000
8,330
5,990
SD (µM)
44
74
8

Table 2.2. Summary of Ess1-CTD binding affinities.
This table has been reused with permission from reference (Namitz, Zheng et al., 2021)
(Appendix II).
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2.2.5 Ess1 binds as a monomer, favoring 5R-CTD peptides
Ess1-CTD interactions were also analyzed using sedimentation velocity analytical
ultracentrifugation (SV-AUC) by our collaborators, a method that maintains the
equilibrium between free and bound species as the complex sediments in a gravitational
field (Schuck 2013). As such, it is possible to measure binding affinities, stoichiometry,
cooperativity and potential conformational changes upon binding (Schuck 2013). Ess1
is a stable globular protein that sediments as a monodisperse monomer that did not
change over a 4-fold concentration range (Fig. 2.6A). The sedimentation coefficient of
Ess1 (s ~ 1.45; f/f0 ~ 1.35) indicates there is added hydrodynamic drag consistent with
an elongated shape in solution, vs. a spherical protein of this size, which would have a
higher s value (s =1.65; SEDNTERP)(Laue 1992), consistent with our NMR results.
Unbound FITC-labeled CTD peptides did not sediment appreciably (s ~0.0-0.5), as
monitored by absorbance at 490 nm (Fig. 2.6B). However, upon addition of Ess1, the
majority of a 1R CTD peptide sedimented (s ~1.5) coincident with monomeric Ess1 (Fig.
2.6B). Sedimentation analysis for 4R with Ess1 also suggest the majority of the peptide
is bound by Ess1 (shifted to s > 1.5) (Fig. 2.6C). Interestingly, the proportion of shifted
5R peptide (Fig. 2.6D) is higher than that of 4R peptide, indicating a more favorable,
potentially cooperative interaction of Ess1 with the 5R peptide.
To better understand the mechanism of interaction, our collaborators titrated Ess1
into a fixed amount of each peptide and integrated each distribution to determine the
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signal-weighted average sedimentation coefficient (sw), which was plotted against Ess1
concentration (Fig. 2.6E). To fit the data, our collaborators constrained the minimum and
maximum sw values to the same range for each peptide, and simulations were
performed using Kintek Explorer software (Johnson, Simpson et al. 2009) using a twosite binding model. Good fits were obtained for the 5R and 1R CTD peptides, which
showed that 5R bound with an affinity for the first site that was an order of magnitude
greater than that of the 1R peptide (Table 2.2B). Second site binding affinities also
showed a preference for 5R (and 4R) over 1R, but with much weaker affinities and with
smaller differences among the peptides (Table 2.2B). Fitting of the 4R-CTD peptide with
the same model produced a poor fit to the data (Fig. 2.6E, black dashed line). However,
releasing the constraint for the maximum sw value significantly improved the fit for the
4R titration, and resulted in an intermediate Kd between that of 1R and 5R (Fig. 2.6E,
black line; Table 2.2). This indicates that the hydrodynamic properties of the 4R:Ess1
complex are distinct from that of the 1R- and 5R-complexes, and likely reflects
conformational differences in Ess1 upon binding the 4R peptide. Thus, binding of Ess1
to the 4R peptide, while better than that of 1R, is somewhat compromised in
comparison to binding to the 5R peptide. These and our NMR data presented below are
consistent with the idea that binding interactions with the 5R peptide are more favorable
than with the 4R peptide, in which some protein distortion may occur to enable
simultaneous binding by the WW and PPIase domains (Fig. 2.6F).
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Importantly, for both 4R and 5R peptides, there is no indication of a 2:1
protein:peptide stoichiometry, as might be expected if two Ess1 molecules bound to the
same peptide, one at each end. If this occurred, the resulting ternary complex would
likely increase in mass by ~19.5 kD (the size of an Ess1 monomer) and appear as a
peak with higher sedimentation value (s ~3). Therefore, the simplest interpretation is
that the 4R and 5R complexes have a 1:1 (Ess1:CTD peptide) stoichiometry. We cannot
formally rule out a 1:2 ratio, where a different peptide binds to each of the two protein
domains. For the smaller peptides, particularly the 1R and 2R, this scenario be might be
difficult to detect due to their relatively small molecular weights for SV-AUC. However,
we do not favor this interpretation because the experiments were done with limiting
peptide concentrations (10:1 molar excess of protein).
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Figure 2.6. SV-AUC reveals potential cooperative binding of Ess1 to a 5-repeat
CTD peptide.
(A) Ess1 alone at three different concentrations, showing it is a stable, monodisperse
monomer. (B-D) Binding of Ess1 to FITC-labeled CTD peptides as revealed by c(s)
distributions: (B) FITC-1R-CTD peptide, (C) FITC-4R-CTD peptide, and (D) FITC-5RCTD peptide. Each panel shows the position of 200M Ess1 alone at 290nm (black
dotted line), or 20M CTD peptides alone (red line) or a mixture of Ess1 + CTD peptide
at 10:1 (blue line) at the indicated wavelenths of absorbance. Note the larger fraction of
the 5R peptide migrating at the bound position vs. the 4R peptide. (C vs. D). (E). swisotherms of 50M 1R-CTD (green), 4R-CTD (black) or 5R-CTD (blue) with a titration of
ScEss1 (0.5-1000M) . The black dashed line shows the fit to the 4R-CTD data with the
constrained maximum sw value (see text). (F) Cartoon model of Ess1 binding to 4repeat and 5-repeat CTD peptides phosphorylated at the terminal Ser5-Pro6 repeats.
The model is based on the higher affinity of the 5R peptide compared to the 4R peptide
(panels C vs. D; E), and supported by SV-AUC and NMR chemical-shift data (see text).
This figure has been reused with permission from reference (Namitz, Zheng et al.,
2021) (Appendix II).
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2.2.6 WW and PPIase domain contacts are enhanced with longer CTD peptides
To identify individual residues associated with the binding interface on Ess1, we
titrated unlabeled CTD peptides and used NMR to monitor the backbone amide
chemical shifts of residues in Ess1. From these spectra, we calculated chemical shift
perturbations (CSPs) and mapped these onto the structure of Ess1 (Fig. 2.7A). For the
1R peptide, residues with the strongest CSPs mapped almost exclusively to the WW
domain, including residues S20, K21, S22, K23, Y27, F29, S36 and E39 (Fig. 2.7A).
These residues correspond to the same residues in the Pin1 WW domain (S16, R17,
Y23, F25, S32) that interact with a single CTD repeat (Verdecia, Bowman et al. 2000,
Daum, Lucke et al. 2007, Rogals, Greenwood et al. 2016). Unlike in Pin1, however,
residues 130-137 in the PPIase domain of Ess1 were also perturbed in the presence of
the 1R peptide. These residues are spatially close to the WW domain, thus we suspect
that the observed CSPs are sensitive to CTD binding in the WW domain (Fig. 2.7A).
CSPs for the 2R and 3R peptides (taking into account the differences in stoichiometry of
binding sites) were generally similar to 1R results, both in terms of CSP magnitudes and
overall CSP pattern (Fig. S2.4).
Interestingly, addition of the 4R and 5R peptides resulted in significantly larger
CSPs in the WW domain, suggesting stronger overall binding (Fig. 2.7A). These
included residues 25-29 and 34-41. Higher CSPs were also observed with 4R and 5R
peptides in a PPIase patch consisting of residues D102-S118 and R125. These
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residues are not in the active site of the catalytic domain, but could be involved in
stabilizing binding of the two-site simultaneously bound peptides (see below). CSPs in
the active-site region were relatively minor, but include residues E136, E142, S159 and
G162, which overlay with residues in the Pin1 active site engaged with peptide mimetics
(PDB ID 3TCZ) (Zhang, Wang et al. 2012). These experiments suggest that the longer
CTD peptides (4R, 5R) enhance contacts with both WW and PPIase domains,
simultaneously.
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Figure 2.7. NMR chemical shift data reveal simultaneous binding on long CTD
peptides.
(A) 1H-15N chemical shift perturbations (CSPs) in Ess1 upon binding 1R, 4R, or 5R-CTD
peptide at 2:1 peptide:protein stoichiometric ratios (4:1 for 1R-CTD). Since the 1R-CTD
has only one binding site, whereas 4R and 5R each have two binding sites, we plot 1RCTD CSPs at double the stoichiometric ratio as the other CTDs. (Right) CSPs are
mapped onto the structure of Ess1, and color-coded orange and red for CSPs > 0.03
ppm and 0.1 ppm, respectively. Residues highlighted in blue are those amide
resonances that were broadened beyond detection. Gray bars indicate those
resonances for which assignments were ambiguous and therefore not analyzed for CSP
plots. (B) Normalized titration curves of Ess1 residues as unlabeled CTD peptide was
added. Residues are color-coded indicating where the residue is located in Ess1: red
(WW), blue (linker), and black (PPIase). (C) Chemical shift trajectories for WW residues
30 and 35 following titration with 1R, 4R and 5R CTD peptides (see Methods). This
figure has been reused with permission from reference (Namitz, Zheng et al., 2021)
(Appendix II).
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2.2.7 Five CTD repeats is the minimal optimal length for Ess1 binding.
To determine Ess1 binding Kds on a residue-by-residue basis, we performed NMR
titration experiments using 1R, 4R and 5R CTD peptides (Table 2.2C, overall Kds; Table
S2.2, Kds for all residues, Figure S2.5). The results suggest that the 1R CTD binds
preferentially to the WW domain of Ess1, as most of the CSPs localize to this region.
Using a single-site binding model on residues with CSPs > 0.03 ppm at the titration
endpoint, we determined that the Kd was 154.7 +/- 44 M, in general agreement with FA
and SV-AUC results above (and a published Kd of ~60 M) (Gemmill, Wu et al. 2005).
While we observed some CSPs near or at the active site of the PPIase domain, they
were generally < 0.05 ppm for these residues (e.g. K70, T84, S159, G162). As others
have reported weak peptide binding to the PPIase domain (>500 M) (Verdecia,
Bowman et al. 2000), our NMR titration experiments, which used 100 M Ess1 protein,
would not be sensitive to such weak binding. Therefore, the observed CSPs in the
PPIase domain are either weakly reporting on structural perturbations resulting from 1R
binding to the WW domain, or on transient interactions between the 1R and the active
site.
In the presence of 4R or 5R peptides, we observed larger CSPs in the WW domain
as well as near the PPIase active site, specifically residues E111 and R125 (residues
E104 and A118 in Pin1). In addition, a number of WW residues underwent intermediate
exchange during the titration, indicative of stronger binding to 4R or 5R (Fig. S2.6).
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Indeed, the NMR titration with the 5R peptide indicated that residues throughout the
protein (both WW and PPIase domains) titrated with significantly stronger binding
affinity of 9.1 +/- 8 M compared to 1R when assuming a single-site binding model.
These binding affinities are consistent with those observed by SV-AUC (Table 2.2C).
The results for the 4R titrations were intermediate to those of the 1R and 5R (Fig. 2.7B),
with an average Kd of 46.8 +/- 74 M. Curiously, variable 4R binding affinities were
reported across the protein, giving rise to the high standard deviation for the K d value
(Fig. 2.7B). While most of the residues in the WW domain titrated with 5R-like binding
affinity, residues K23 and H35 did not, together with PPIase residues D103, N108,
D119, and Y123 (Fig. 2.7B, Table S2.2). Importantly for the 4R titration, we observed
non-linear or distinct (from 1R and 5R) chemical shift trajectories for WW residues N30
and H35, linker -helix residue L49, and PPIase residues G130 and D143 (Fig. 2.7C;
Fig. S2.7), suggesting a secondary event occurs during the course of the titration. We
suspect that the 4R peptide is slightly shorter than the optimum length for two-site
binding, and consequently Ess1 may undergo a slight conformational change across the
protein to accommodate it (Fig. 2.6F), in agreement with SV-AUC data presented
above. This would also explain the lower apparent binding affinity for 4R vs. 5R in the
SV-AUC analysis (Fig. 2.6E). Notably, all chemical shift trajectories were linear in the
presence of 5R, consistent with the idea that no significant conformational change
occurs in Ess1 when interacting with 5R-CTD.
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2.2.8 A model of anchored prolyl isomerization
To better understand the interactions between Ess1 and the CTD, we modeled
binding of different length CTD peptides. We docked a 1R-CTD peptide in the Ess1 WW
domain (Fig. 2.8A) based on a prior co-crystal structure of the Pin1-WW with a CTD
peptide (PDB 1F8A)(Verdecia, Bowman et al. 2000). Next, we docked a 1R-CTD
peptide in the Ess1 PPIase active site (Fig. 2.8A) based on the pSer-Pro motif of a
peptidomimetic inhibitor in Pin1 (PDB 3TCZ) (Zhang, Daum et al. 2007). The docking
shows that a 2 or 3 repeat CTD could not reach both WW and PPIase binding sites,
consistent with our affinity measurements from FA, SV-AUC and NMR. Modeling 2RCTD peptides into each of the WW and PPIase domains indicates that a 4R-CTD might
span that distance (Fig. 2.8B). This is supported by the directionality of the CTD
peptides: the C-terminus of the 2R-CTD emerges from the WW domain near the Nterminus of a 2R-CTD in the PPIase domain.
We also constructed a structural model of how a 5R-CTD peptide could interface
with both the WW and PPIase domains simultaneously (Fig. 2.8C). The modeling
implies that while a 4R peptide could simultaneously occupy both sites, a 5R peptide
would do so without requiring any conformational change in Ess1. Importantly, the
orientation and positioning of the 5R peptide in the PPIase domain of Ess1 in our model
is fully consistent with an NMR study of the Pin1 catalytic mechanism (Labeikovsky,
Eisenmesser et al. 2007), which indicated that during cis/trans isomerization, the proline
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and residues C-terminal to it are held in a fixed position deep within the active site, while
the upstream, N-terminal portion extends outwards toward the basic loop of the peptide
and rotates 180° during isomerization. To further illustrate this point, we generated a
structural model of the 5R-CTD such that the C-terminal pSer-Pro motif was in the cis
conformation (see Methods). This cis model in conjunction with the trans model shown
in Fig. 2.8C highlight the ability of Ess1 domains to simultaneously interact with nonadjacent CTD repeats and catalyze cis/trans proline isomerization.
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Figure 2.8. Model of Ess1 interactions with CTD peptides.
(A) 1R-CTD or 2R-CTD was docked to the WW domain or the PPIase domain of Ess1
using PDB 1F8A or PDB 3TCZ, respectively (see text). Top ten docking structures were
superpositioned with peptide direction denoted by labels for N and C-termini. (B) Model
of simultaneous binding of two 2R-CTD peptides to the WW and Ess1 domains. Note
that the C-terminus of the 2R-CTD bound to the WW domain is near the N-terminus of
2R-CTD bound to the PPIase domain. (C) Model of 5R-CTD peptide interacting with
Ess1 using docking results from parts A and B. This figure has been reused with
permission from reference (Namitz, Zheng et al., 2021) (Appendix II).
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Finally, we overlaid Ess1 CSPs obtained from 5R-CTD titration experiments onto
the structural model (Fig. 2.9). Remarkably, the CSPs map out a putative binding
interface between the 5R-CTD and Ess1, including residues D103, E111, A112, K115
and R125 in the PPIase domain. Notably, CSPs for these residues only appeared when
4R or 5R CTD was titrated, but not with shorter length CTDs (Fig. 2.7A). Importantly, the
docking results did not use experimental NMR data as structural constraints. Thus, our
NMR data, in conjunction with SV-AUC and FA results, suggest that the Ess1 WW and
PPIase domains bind simultaneously to a long, physiologically-relevant substrate. We
propose that the 5R-CTD is the minimal length for optimal, simultaneous binding to
Ess1. That a dual binding mode would increase the overall affinity of Ess1 interaction
with a 5R-CTD peptide is consistent with studies using artificial bivalent substrates for
Pin1 (Daum, Lucke et al. 2007) although in the case of Pin1, that length was
significantly shorter (~9 residues between Pin1 binding sites, vs. 28 residues between
Ess1 binding sites in the 5R peptide).
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Figure 2.9. Model of Ess1 binding to a 5R-CTD peptide.
(A) This panel shows the orientation of Ess1 in this figure relative to that in Fig. 2.1A.
The structure of Ess1 is from Fig. 2.1A, and the peptide model is from Fig. 2.8C. The Nand C-termini of the peptides are marked as shown. (B) CSPs are mapped onto the
space-filling structure of Ess1, and color-coded orange and red for CSPs > 0.03 ppm
and CSPs > 0.1 ppm, respectively. Residues highlighted in blue are those amide
resonances that were broadened beyond detection. The black slash marks demarcate
the five individual CTD heptad repeat units. Note the C-terminal portion of the peptide
containing the pSer-Pro motif lies deep in the active site. The residues N-terminal to the
peptidyl-prolyl bond in the active site would be able to rotate 180° as suggested by NMR
studies with Pin1. This figure has been reused with permission from reference (Namitz,
Zheng et al., 2021) (Appendix II).
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2.3 Discussion and Conclusions
2.3.1 Structural and functional differences between Ess1 and Pin1.
The structure of the S. cerevisiae Ess1 reveals conserved folds for the WW
domains and PPIase domains, consistent with the fact that orthologs ranging from C.
albicans Ess1 to human Pin1 complement ess1 deletion mutants in S. cerevisiae.
However, the elongated structure of Ess1 and distinct linker region raises a number of
important questions. How does the more rigid structure of the fungal enzymes and
distinct juxtaposition of the two protein domains influence (or restrict) substrate
interactions? Put another way, why does the mammalian Pin1 enzyme lack a highlystructured linker found in the fungal Ess1 enzymes, and what possible evolutionary
advantage might that confer? Finally, what is the role of the prominent linker -helix
found in the fungal enzymes?
We suggest that the interdomain flexibility of the mammalian orthologs of Ess1
increases the diversity of substrates that can be recognized using a concerted
simultaneous binding mechanism. Indeed, human Pin1 is thought to recognize
hundreds of potential targets, while multiple genetic studies in yeast have only revealed
a limited number of targets (Wu, Wilcox et al. 2000, Steger, Murina et al. 2013, Atencio,
Barnes et al. 2014). For more rigid proteins like Ess1 and CaEss1, the flexibility
required for simultaneous binding may instead reside in the substrates themselves, for
example, in long polymeric targets like the CTD, whose pSer-Pro binding motifs are less
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spatially constrained than in globular proteins. The potential differences in substrate
preferences makes the explicit prediction that, unlike the ability of Pin1 to complement
in yeast, the fungal enzymes would not be capable of fully substituting for Pin1 in
mammals. Finally, the prominent solvent-exposed -helix found in the Ess1 and CaEss1
enzymes could mediate fungal-specific protein-protein interactions.
A model for interdomain communication has been proposed for Pin1 (Wang,
Mahoney et al. 2015), whereby the WW domain, upon binding substrate, transmits an
allosteric signal via a hydrophobic interface to the PPIase domain, inhibiting its catalytic
activity. Not all studies support this model (Matena, Sinnen et al. 2013, Eichner, Kutter
et al. 2016, Jinasena, Simmons et al. 2019). For both the S. cerevisiae and C. albicans
Ess1s, this mechanism is not likely because the positioning of the domains is quite
distinct, the proposed interface is absent, and many of the key residues proposed to
mediate this allostery (Pin1 I28, N30, S138, A140) are not conserved (Ess1 P31, K34,
A145, Q147). Instead, we suggest that the fungal Ess1 enzymes are “constitutively
active,” and only the mammalian Pin1 enzymes may be subject to this regulation.

2.3.2 Dual binding mechanisms for targeting the CTD.
The long length of the CTD in organisms ranging from yeast (26 repeats) to humans
(52 repeats) is likely to enable simultaneous occupancy of distinct protein co-factors to
the transcribing RNAPII complex to promote transcription and RNA processing
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(Buratowski 2009, Hsin and Manley 2012, Jeronimo, Collin et al. 2016). The repeated
nature of the CTD also provides the opportunity for proteins with multiple CTD-binding
domains to interact simultaneously with multiple repeats of the CTD. This has been
observed for C. albicans capping enzyme, Cgt1, which binds to non-adjacent heptad
repeats in a pSer5-phosphorylated CTD peptide, effectively looping out an intervening
heptad (Fabrega, Shen et al. 2003). The yeast termination factor, Nrd1, also binds
multiple CTD repeats, and in this case binding to the first of two repeats requires a
pSer5-Pro6 motif in the cis conformation (Kubicek, Cerna et al. 2012). The human
negative elongation factor PHF3 protein, related to yeast Bye1 (a suppressor of Ess1)
(Wu, Rossettini et al. 2003), uses a newly-identified SPOC domain to simultaneously
engage two adjacent CTD repeats (Appel 2020). The yeast RNA processing enzymes,
Pcf11 and Rtt103 bind cooperatively (as homodimers) to long pSer2-phosphorylated
CTD peptides (4R), but not to short CTD peptides (2R) with the Rtt103 showing a higher
degree of cooperativity (Lunde, Reichow et al. 2010). These and other examples
provide evidence that the repetitive nature of the CTD is utilized for simultaneous
binding via multi-domain and multimeric protein interactions.
Here, we have presented data consistent with a model (Fig. 2.9) in which the Ess1
WW and PPIase domains bind simultaneously to non-adjacent CTD repeats. We
suggest that the length of a 5-repeat CTD peptide would (i) allow simultaneous binding
without conformational strain on the Ess1 protein and (ii) provide a sufficient substrate
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length and flexibility to allow a 180° rotation around the pSer-Pro bond while the Nterminus of the peptide remains anchored to the WW domain. Isomerization of a shorter
substrate (e.g. 4R) would generate strain on both the CTD and isomerase that would
reduce overall affinity. The data also imply that in vivo, Ess1 (and potentially Pin1) could
simultaneously engage distal sites within in the 26-repeat CTD present in yeast (or 52 in
human), generating loops that might sequester CTD-binding proteins, or generate
intermolecular bridges between CTDs from distinct RNAPII Rpb1 subunits that might
influence RNAPII condensation.
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2.4 Material and Methods
2.4.1 CTD peptides
The 1R, 2R, 3R, 4R, and 5R CTD peptides were purchased, synthesized with
phosphorylation on specific serine residue(s), and HPLC purified to >90% by ABclonal
(Table 2.1). NMR peptides were capped with N-acetyl and C-amide functional groups.
FITC peptides were C-amidated. Peptides were resuspended in buffer (20 mM NaPhos,
150 mM NaCl, 3 mM TCEP, 0.02% NaN3, pH 6.8). Peptide concentrations were
determined by measuring A280 values using a Nanodrop ND-1000 spectrophotometer
and using sequence-determined molar extinction coefficients (e.g. 1280 M-1 cm-1 for
each Tyr residue).

2.4.2 Double Labeled Ess1 C120S expression and purification
The labeled scEss1 protein was provide by our collaborators from Michael
Cosgrove group, Upstate Medical University, experimental details as following. Fulllength wild-type Saccharomyces cerevisiae Ess1 cDNA was subcloned into a pHis
parallel expression vector (Sheffield, Garrard et al. 1999) and site-directed mutagenesis
(QuikChange II XL; Agilent) was used to replace Cys120 with serine to create the
catalytically defective C120S enzyme. The C120S plasmid was used to transform
Escherichia coli cells (Rosetta II (DE3) pLysS; Novagen) with Chloramphenicol and
Carbenicillin selection. Following overnight incubation at 37°C single colonies were
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selected and grown in 50mL terrific broth (TB II) media initially at 37°C overnight (16h).
Cells were harvested from the TB II media by centrifugation at 4,000 x g for 30 minutes
at 4°C to remove all carbon and nitrogen sources, then re-suspended in 25mL M9
minimal media, then transferred to a flask containing the remainder of the 1L M9 media
for growth and expression (50mM Na2HPO4, 50mM KH2PO4, 5mM Na2SO4, 2mM
MgSO4•7H2O, pH 7.4) supplemented with antibiotics, 3g/L 15N-ammonium chloride
and 4g/L 13C-D-glucose (Cambridge Isotope Laboratories, Inc.). Minimal media cultures
were grown at 37°C in a shaking incubator at 200RPM until they reached an OD600 of
approximately 0.6, and expression was induced with 1mM isopropyl β-D-1thiogalactopyranoside (IPTG). Expression of 6xHis-ScEss1 was carried out in a shaking
incubator at 200 RPM at 16°C for 20 hours and the cells were harvested by
centrifugation at 4000 x g for 30 minutes at 4°C. The pelleted cells were re-suspended
in Buffer 1 (500mM NaCl, 5mM Tris, 1mM DTT, 20mM imidazole, pH 8.0) supplemented
with cOmpleteTM protease inhibitor tablets (Roche Applied Science) and 0.1 mM PMSF.
Lysis of the cells was carried out on a microfluidizer following by centrifugation at 4,000
RPM for 30 minutes at 4°C. Clarified lysates were then subjected to FPLC affinity
chromatography over a 5mL HisTrap column (GE Healthcare) to purify the 6xHis-Ess1
protein. The protein was eluted in a 25-column volume gradient from 20-500mM
imidazole in buffer one. Pooled fractions were treated with 3.1mg (2.5mL of 1.26mg/mL)
GST-tagged tobacco etch virus protease (GST-TEV) to cleave the His tag from Ess1
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while simultaneously removing excess imidazole by dialysis against Buffer 1. Dialyzed
protein was then passed through the HisTrap column for a second affinity purification to
separate the untagged Ess1 from the remaining tagged protein and GST-TEV. As a final
step of purification, proteins were passed through a HiLoad 16/60 S200 size exclusion
column (GE Healthcare) that was pre-equilibrated with Buffer 2 (20mM Tris, 150mM
NaCl, 3mM tris(2-caboxyethyl) phosphine, pH 8.0). Pooled fractions were concentrated
to 1.4mM using a 10 kDa MWCO spin concentrator (Millipore) and dialyzed into Buffer 3
(9.1mM Na2HPO4, 10.7mM NaH2PO4, 150mM NaCl, 3mM TCEP, 0.02% w/v NaN3,
pH 6.8), resulting in a final concentration of 1.6mM 15N,13C-Ess1 which was stored at 80°C prior to NMR experiments.

2.4.3 NMR Experiments
NMR experiments were performed at 298K on a Bruker Avance III HD 800MHz
spectrometer, equipped with TCI Cryo Probe. All NMR data were processed using
NMRPipe (Delaglio, Grzesiek et al. 1995) and analyzed using CCPNMR 2.4.2 (Vranken,
Boucher et al. 2005).

2.4.4 Resonance assignments for Ess1
To obtain chemical shift assignments, NMR samples consisting of 500 M 15N,13Clabeled Ess1 C120S were prepared in pH 6.8 buffer with 20 mM NaPhosphate, 150 mM
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NaCl, 3 mM TCEP, 0.02% w/v NaN3, and 5% D2O. All experiments were obtained at 298
K. Chemical shift assignments of the backbone resonances (HN, N, CO, Cα, and Cβ)
were obtained using 2D 1H-15N, HSQC, and standard triple resonance experiments
(HNCO, HNCACO, HNCACB and CBCACONH) spectra. Acquisition times for the triple
resonance experiments were 92 ms in the direct 1H dimensions, 17-19 ms in the indirect
15N

dimensions, 16-20 ms in the indirect 13CO dimensions and 6 ms in the indirect

Cα/Cβ dimensions. Spectral widths were 12 ppm in 13CO, 65 ppm in
13C/C

dimension, 26 ppm in indirect 15N. Non-uniform sampling (NUS) was employed

for all triple resonance experiments. Experiments were acquired with 20-25%
(CACBCONH 20%; HNCACO, HNCO, and HNCACB 25%) sampling using the Poisson
Gap sampling method (Hyberts, Takeuchi et al. 2010) NUS spectra were processed
using SMILE and NMRPipe (Delaglio, Grzesiek et al. 1995, Ying, Delaglio et al. 2017)
and employed standard apodization parameters and linear prediction in the indirect
dimensions. Using these experiments, we successfully assigned amide backbone
resonances (HN, N) for 92% of all residues. For 13C chemical shifts, 95% (154/162) Cα,
93% (141/151) Cβ, 88% (143/162) CO were assigned.

2.4.5 Wild-type Ess1 NMR spectroscopy
All relaxation or titration NMR experiments using CTD peptides were collected using
wild-type (WT) Ess1, not the C120S mutant described above. For this reason, we
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transferred backbone 15N and 1H chemical shift assignments to WT. We prepared a
wild-type (WT) NMR sample of scESS1 using 430 μM 15N labeled WT Ess1 in 20 mM
NaPhos pH 6.8, 150 mM NaCl, 0.02% NaN3, 3 mM TCEP, 5% D2O (the same conditions
used for chemical shift assignment of Ess1 C120S). 2D 1H-15N HSQC spectra were
collected, and the vast majority (151/153) of the backbone amide assignments were
transferred to WT from the C120S Ess1 spectra. Approximately 22% (~34 out of 153) of
15N-1H

amide backbone assignments were shifted slightly, and these were for residues

spatially near C120S (Fig. S2.2).

2.4.6 NMR relaxation measurements
Backbone amide 15N R1 and R2 relaxation rates and heteronuclear 1H-15N NOE
were measured for 15N-labeled WT Ess1 using 235 μM protein in pH 6.8 buffer
consisting of 20 mM NaPhosphate, 150 mM NaCl, 3 mM TCEP and 0.02% NaN3. We
used established pseudo-3D interleaved relaxation pulse sequences and protocols (Hall
and Fushman 2003). The following time delays were used for R1 experiments: 4 ms (x
2), 1000 ms (x 2), and 1600 ms (x 2). For R2 experiments, we used time delays of 8 ms
(x 2), 24 ms, 32 ms, 48 ms (x 2), 64 ms (x 2), and 88 ms. The heteronuclear 1H-15N
NOE experiments were collected with an interscan delay of 5 s. For 15N R1 and R2
relaxation experiments, the 1H and 15N acquisition times were 100 and 29 ms, with
spectral widths of 12 and 24 ppm for the 1H and 15N dimensions, respectively. For
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heteronuclear 1H-15N NOE experiments, the 1H and 15N acquisition times were 100 and
29 ms, with spectral widths of 12 and 28 ppm for the 1H and 15N dimensions,
respectively. Relaxation rates were determining using RELAXFIT (Fushman, Cahill et al.
1997). The overall rotational diffusion tensors for Ess1 and individual WW and PPIase
domains were determined using ROTDIF (Walker, Varadan et al. 2004, Berlin, Longhini
et al. 2013) and the crystal structure of Ess1 described here. Residues only in welldefined secondary structure elements were used for ROTDIF calculations. The ratio of
relaxation rates was determined for each residue as  = (2R2’/R1’ – 1)-1, where R1’ and
R2’ are modified 15N R1 and R2 rates with the high frequency components subtracted
(Fushman, Varadan et al. 2004). Errors in 15N R1 and R2 relaxation rates were
determined using 500 Monte Carlo trials in RELAXFIT. Errors in heteronuclear 1H-15N
NOE measurements were determined using the standard error propagation formula.

2.4.7 CTD peptide titration experiments with Ess1
Mixed NMR samples of Ess1 and CTD peptides (1R, 2R, 3R, 4R, or 5R CTD)
consisted of 100 μM 15N WT Ess1 and 50-200 μM CTD peptide. Samples were mixed at
1:2, 1:1, and 2:1 protein to peptide ratios in pH 8 buffer containing 20 mM Tris, 0.02%
NaN3, 3 mM TCEP, and 5% D2O. A series of 2D 1H-15N HSQC spectra were collected at
the different protein to peptide ratios, and chemical shifts were reassigned by visual
inspection as titration experiments were conducted in a different buffer than used for
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chemical shift assignments (see above). HSQC experiments were collected with
acquisition times of 90 ms and 36 ms in the 1H and 15N dimensions, respectively.
Spectral widths were 14 and 34 ppm for 1H and 15N, respectively.

2.4.8 Ess1-CTD peptide NMR Kd determination experiments
1R, 4R, and 5R CTD peptides used in the Kd titration experiments were the same as
above. The peptides were titrated from concentrated stocks (1.0-7.6 mM) into 100 μM
samples of WT 15N Ess1, with peptide to protein ratios ranging from 0 to 6 (for 1R) and
0 to 3 (for 4R and 5R-CTD). Binding was monitored by recording 1H-15N HSQC spectra
at different peptide to protein ratios. For each backbone amide, we assumed that the
chemical shift perturbation (CSP) was a weighted average between the free ( = 0)
and ligand-bound ( = bound) states, such that  = bound * [PL]/[Ptotal]. Here, [PL]
and [Ptotal] represent the ligand-bound protein concentration, and Ptotal is the total protein
concentration of Ess1. The CSP for each amide was calculated using the equation
𝐶𝑆𝑃 = √(∆𝛿𝐻 )2 + (

∆𝛿𝑁 2
)
5

where H and N represent the change in chemical shift in

the 1H and 15N dimensions, such that  = 0 when calculating the CSP for the reference
spectrum (in the absence of ligand). To obtain the dissociation binding constant, K d, we
used the single-site binding equation, [𝑃𝐿] = (([𝑃𝑡𝑜𝑡𝑎𝑙] + [𝐿𝑡𝑜𝑡𝑎𝑙] + 𝐾𝑑) −
√([𝑃𝑡𝑜𝑡𝑎𝑙] + [𝐿𝑡𝑜𝑡𝑎𝑙] + 𝐾𝑑)2 − 4 ∗ [𝑃𝑡𝑜𝑡𝑎𝑙] ∗ [𝐿𝑡𝑜𝑡𝑎𝑙])/2, where [Ptotal] and [Ltotal] are
total protein (Ess1) and ligand (CTD peptide) concentrations, respectively. Fitting was
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performed using an in-house Matlab script. Overall Kd was determined by averaging
residue-specific Kd values for those residues with CSP > 0.03 ppm at the titration
endpoint (Table S2.2). Errors represent standard deviation of residue-specific Kd values.

2.4.9 Mass spectrometry
The molecular weights of the 1R, 4R and 5R CTD peptides (used for NMR titration
experiments, see Table 2.1) were verified by Dr. Ebbing de Jong (SUNY Upstate
Medical University) using electrospray ionization MS (ESI-MS) (Fig. S2.8). Peptides
were cleaned up using a C18 solid phase extraction cartridge. For positive or negative
mode ESI-MS, 10 μM peptide in 50% acetonitrile, 0.1% formic acid was injected at 10
μL/min into an Orbitrap LUMOS mass spectrometer.

2.4.10 Molecular docking and 5R-CTD Ess1 complex modeling
Starting models of Ess1 bound to CTD peptides were generated as described
below, and refined using the program, Rosetta-FlexPepDock (Raveh, London et al.
2010). Approximately 200-300 high-resolution structures were generated from starting
models that were submitted to the Rosetta-FlexPepDock webserver
(http://flexpepdock.furmanlab.cs.huji.ac.il/index.php). No additional constraints were used.
All prolines were in trans conformation unless otherwise noted below. The starting
model of Ess1 WW domain bound to 1R-CTD was based on the crystal structure of
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Pin1 WW-CTD complex (Verdecia, Bowman et al. 2000). The Pin1 crystal structure
(PDB code 1F8A) was aligned to the structure of Ess1, with the two WW domains
aligning with a C RMSD of 0.553 Å. The extra phosphate group on Ser-2 of the CTD
peptide from Pin1 crystal structure was manually removed. The starting model of Ess1
PPIase domain bound to 1R-CTD was prepared using the crystal structures of Pin1
PPIase domain bound to a peptidomimetic inhibitor in the active site (PDB codes 3TCZ
and 3TDB) (Zhang, Wang et al. 2012). The inhibitors in these crystal structures mimic
the cis and trans conformers of the phosphoserine-proline (pSP) motif in the CTD
peptide. Using Pymol 2.0, a 1R-CTD peptide (YSPTpSPS) was built and its pSP motif
was structurally aligned to the pSP section of the trans inhibitor (PDB code 3TDB). (The
cis inhibitor has similar local structure). The rest of the peptide was manually adjusted to
avoid steric clashes with the protein, then the complex was optimized using RosettaFlexPepDock. Models of Ess1 bound to 2R-CTD peptides were generated using 1RCTD optimized structures. To generate the starting model of 2R-CTD bound to the WW
domain of Ess1, another repeat of CTD peptide not containing a pSP motif (YSPTSPS)
was built onto the C-terminus of the existing peptide using the build function in Pymol.
To generate the starting model of 2R-CTD bound to the PPIase domain of Ess1,
another repeat of CTD peptide (YSPTSPS) was built onto the N-terminus of the existing
peptide. From each of the 2R-CTD Rosetta-FlexPepDock results for the WW and
PPIase domains, one structure was selected to be representative of the top 10
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structures. Using Pymol’s build function, one additional CTD repeat (YSPTSPS) was
added and shaped to connect the two 2R-CTDs to form a complete 5R-CTD peptide
spanning across both the WW and PPIase domains.
A separate 5R-CTD model with cis conformer of the pSP motif in the PPIase domain
active site was built using the same method described above, except that we used the
pSP section of the cis inhibitor (PDB code 3TCZ).
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2.5 Supplementary Material

Figure S2.1. Sequence alignments.
Protein sequences of S. cerevisiae Ess1 (Uniprot ID P22696), C. albicans Ess1 (Uniprot
ID Q59KZ2) and H. sapiens Pin1 (Uniprot ID Q13526). The WW, linker and PPIase
(catalytic) domains are indicated. Note the sequences of the structured linkers in the
fungal enzymes vs. the unstructured linker in the human protein. The sequence
alignment was performed using T-Coffee (DOI: 10.1006/jmbi.2000.4042) and visualized
with Jalview (DOI: 10.1093/bioinformatics/btp033), and residues colored according to %
identity. This figure has been reused with permission from reference (Namitz, Zheng et
al., 2021) (Appendix II).
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Figure S2.2. Wild-type and C120S scEss1 1H-15N HSQC spectra.
(A) Wild-type amide chemical shift assignments were visually transferred from C120S
spectra. The majority of resonances superpose between the WT and C120S spectra,
allowing direct transfer of assignments. The remaining 34 residues (22% of total
assigned and marked with residue number) were transferred visually. (Right) Residues
that required visual assignment transfer were mapped on Ess1 structure and colored in
orange (CSPs < 0.067 ppm), and red (CSPs between 0.067 and 0.215 ppm). Residue
120 is colored cyan. This figure has been reused with permission from reference
(Namitz, Zheng et al., 2021) (Appendix II).
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Figure S2.3. Backbone 15N relaxation data of Ess1 shows that the protein tumbles
as a single unit.
(A) 15N R1, 15N R2, {1H}-15N hetNOE for backbone amides, plotted as a function of
residue numbers. (B) 15N  values, plotted as a function of residue number, represent
the experimental data (black) and back-calculated values (red) using a fully anisotropic
diffusion tensor (see Table S2.1). Error bars for R1 and R2 rates are standard errors of
the mean from 500 Monte Carlo trials. Errors in hetNOE and  values were determined
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using standard error propagation. This figure has been reused with permission from
reference (Namitz, Zheng et al., 2021) (Appendix II).

Figure S2.4. NMR Chemical shift changes with different-length CTD peptides.
(Left) 1H-15N chemical shift perturbations (CSPs) in Ess1 upon binding 1R, 2R, 3R, 4R,
or 5R-CTD peptide at 2:1 peptide:protein stoichiometric ratios (4:1 for 1R-CTD).
Orange: CSP>0.03, red: CSP>0.1, blue: peak broadened beyond detection. (Right)
CSPs are mapped onto the structure of Ess1, and color-coded accordingly. This figure
has been reused with permission from reference (Namitz, Zheng et al., 2021) (Appendix
II).
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Figure S2.5. Representative titration curves of Ess1 residues interacting with CTD
peptides of different lengths.
A representative selection of Ess1 NMR titration curves used for Kd determination is
shown, plotted as CSP vs. ligand:protein ratio. The best fit, using a single-site binding
model, is shown as a black line (see Methods). This figure has been reused with
permission from reference (Namitz, Zheng et al., 2021) (Appendix II).
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Figure S2.6. Peak broadening observed for WW domain residues in Ess1 when
interacting with CTD peptides.
15N-1H HSQC spectra of several residues in the WW domain highlight peak broadening
during the course of titration experiments with 4R and 5R-CTD peptides; peak
broadening was generally not observed for 1R, 2R, and 3R-CTD peptide. NMR spectra
at the start and end of the titration are colored blue and green, respectively. Arrows
denote amide peak trajectory as peptide ligand was titrated. Contour settings were kept
identical across all NMR spectra. This figure has been reused with permission from
reference (Namitz, Zheng et al., 2021) (Appendix II).
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Figure S2.7. Residue-by residue chemical shift trajectories as CTD peptides were
titrated.
(Left) Linear chemical shift trajectories for marked residues were observed for 1R, 2R,
3R and 5R-CTD titrations. Note that non-linear trajectories, trajectories with different
directions, or large CSPs were observed only for 4R-CTD peptide. The 2R and 3R-CTD
peptides were titrated up to 2:1 peptide:protein stoichiometric ratio, while 1R-CTD was
titrated to 6:1 ratio, and 4R and 5R up to 3:1 ratio. NMR spectra at the start and end of
the titration are colored blue and green, respectively. (Right) Marked residues were
mapped onto the Ess1 structure in red. This figure has been reused with permission
from reference (Namitz, Zheng et al., 2021) (Appendix II).
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Figure S2.8. ESI-MS spectra of CTD peptides.
Shown are positive-mode ESI-MS spectra for 1R, 4R and 5R CTD peptides that were
used in NMR titration experiments. For 4R-CTD, we also provide negative-mode ESI
spectra. This figure has been reused with permission from reference (Namitz, Zheng et
al., 2021) (Appendix II).
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Table S2.1. Rotational diffusion tensor characteristics of Ess1.
a Rotational diffusion tensors were determined for either full-length Ess1 or the
individual domains in Ess1 by selecting the subset of domain-specific residues.
b Principal values of the fully anisotropic diffusion tensor, in 107 s-1. Errors (in
parentheses) were estimated using 1000 Monte Carlo trials.
c Euler angles (in degrees) according to the y-convention characterize the principal axes
frame of the diffusion tensor with respect to the PDB coordinate frame of Ess1.
d
Overall rotational correlation time.
e Calculated as defined in (Fushman et al., 2004, ref. 18).
This table has been reused with permission from reference (Namitz, Zheng et al., 2021)
(Appendix II).
Diffusion tensor a
Dxx b

Dyy

Dzz

c





c (ns)d

Anisotropy e

Rhombicity e

WW domain

0.95
(0.14)

1.11
(0.13)

1.76
(0.20)

145
(11)

117
(9)

156
(27)

13.08
(0.95)

1.71
(0.25)

0.308
(0.067)

PPIase domain

1.01
(0.08)

1.08
(0.07)

1.59
(0.12)

159
(9)

116
(8)

171
(41)

13.60
(0.59)

1.52
(0.14)

0.214
(0.034)

Full-length

1.00
(0.05)

1.09
(0.06)

1.61
(0.10)

159
(6)

115
(5)

172
(30)

13.48
(0.47)

1.54
(0.11)

0.215
(0.026)
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Table S2.2. Ess1 binding dissociation constants (Kd) for 1R, 4R and 5R-CTD
peptides determined by NMR titrations.
Assuming 1 to 1 binding, individual Kds were determined by following residues with CSP
>0.03 ppm at the final titration point (6:1 peptide:protein stoichiometric ratio for 1R-CTD,
and 3:1 for 4R and 5R-CTD peptides). This table has been reused with permission from
reference (Namitz, Zheng et al., 2021) (Appendix II).
Kd (M)
Kd (M)
Residue
1R
4R
5R
Residue
1R
4R
5R
16
119.2
6.9
3.8
84
119.4
2.2
4.5
17
111.1
3.1
2.1
87
180.8
20.6
18
151.9
20.8
7.2
102
9.3
19
153.7
24.3
4.4
103
230.7
23
148.5
140.1
24.0
109
6.8
25
124.8
24.0
11.1
112
31.8
14.7
26
196.0
113
23.2
27
128.9
4.2
6.9
115
66.8
32.2
28
161.3
10.8
9.8
123
227.8
236.3
35.8
29
141.4
2.3
3.6
127
8.7
3.8
30
103.1
1.6
130
175.2
11.4
7.4
34
233.3
51.3
6.8
131
207.7
35
274.5
244.7
16.0
133
166.8
37
153.0
24.5
6.4
134
2.8
38
102.8
135
9.4
10.5
39
153.9
25.1
136
16.5
40
157.5
6.1
4.4
137
128.3
4.1
47
1.8
145
205.8
1.8
48
156.8
146
235.1
49
216.2
149
100.8
1.7
52
132.6
2.2
1.8
150
113.4
1.7
54
4.4
157
151.8
58
96.2
1.7
158
122.1
59
156.4
21.7
3.0
159
176.3
15.1
64
134.1
3.2
8.3
162
71.8
11.8
70
111.0
164
188.7
73
89.4
168
48.4
83
2.9
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Abstract
Shuttle protein UBQLN2 functions in protein quality control (PQC) by binding to
proteasomal receptors and ubiquitinated substrates via its N-terminal ubiquitin-like
(UBL) and C-terminal ubiquitin-associated (UBA) domains, respectively. Between these
two folded domains are intrinsically disordered STI1-I and STI1-II regions, connected by
disordered linkers. The STI1 regions bind other components, such as HSP70, that are
important to the PQC functions of UBQLN2. We recently determined that the STI1-II
region enables UBQLN2 to undergo liquid-liquid phase separation (LLPS) to form liquid
droplets in vitro and biomolecular condensates in cells. However, how the interplay
between the folded (UBL/UBA) domains and the intrinsically-disordered regions
mediates phase separation is largely unknown. Using engineered domain deletion
constructs, we found that removing the UBA domain inhibits UBQLN2 LLPS while
removing the UBL domain enhances LLPS, suggesting that UBA and UBL domains
contribute asymmetrically in modulating UBQLN2 LLPS. To explain these differential
effects, we interrogated the interactions that involve the UBA and UBL domains across
the entire UBQLN2 molecule using NMR spectroscopy. To our surprise, aside from wellstudied canonical UBL:UBA interactions, there also exist moderate interactions between
the UBL and several disordered regions, including residues 555-570, which binds to
UBA and mediate UBQLN2 LLPS. Our findings are essential for the understanding of
both the molecular driving forces of UBQLN2 LLPS and the effects of ligand binding to
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UBL, UBA, or disordered regions on the phase behavior and physiological functions of
UBQLN2.
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3.1 Introduction
Protein degradation by the ubiquitin-proteasome system (UPS) involves recognition
of ubiquitinated substrates by receptors located on the proteasomal regulatory particle
or extraproteasomal receptors called ubiquitin (Ub)-binding shuttle proteins (MartinezFonts et al., 2020; Zientara-Rytter and Subramani, 2019). UPS shuttle proteins are
defined by a UBL-UBA domain architecture, whereby the UBL (Ubiquitin-Like) domain
interacts with proteasomal receptors and the UBA (Ubiquitin-associated) domain
interacts with ubiquitin chains on ubiquitinated substrates marked for degradation (Chen
et al., 2019; Ko et al., 2004). One such shuttle protein is ubiquilin-2 (UBQLN2), which
undergoes liquid-liquid phase separation and is recruited to cytoplasmic stress
granules, biomolecular condensates with liquid-like properties (Alexander et al., 2018;
Dao et al., 2018). As Ub binds to UBQLN2 UBA to drive disassembly of UBQLN2
condensates, we hypothesize that LLPS contributes to UBQLN2’s functionality in UPS
and protein quality control (PQC) (Dao and Castañeda, 2020; Zheng et al., 2020).
Recently, other UBL-UBA shuttle proteins including hHR23B and p62/SQSTM1 have
been reported to undergo LLPS in the presence of polyUb chains (Sun et al., 2018;
Yasuda et al., 2020; Zaffagnini et al., 2018). Aside from in vitro evidence that these
shuttle proteins phase separate, hHR23B and SQSTM1 colocalize with nuclear
proteasomal foci and autophagosome precursors, respectively. Therefore, it is critical to
delineate the contributions of the UBL and UBA domains to LLPS to understand the role
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of phase separation to the functionality of shuttle proteins.
UBQLN2 is a 624-amino acid multidomain protein composed of an intrinsicallydisordered region (IDR) capped by N-terminal UBL and C-terminal UBA domains
(Figure 3.1A). Since UBL and UBA domains are common features of many PQC
proteins, their structures have been studied extensively (Chen et al., 2001, 2019; DíazMartínez et al., 2006; Heir et al., 2006; Ohno et al., 2005; Walters et al., 2002; Zhang et
al., 2008). The middle IDR of UBQLN2, consisting of residues 109-576, includes the
STI1-I, STI1-II and PXX regions connected by disordered linkers. The STI1 regions are
presumed to mediate interactions with chaperone proteins such as HSP70,
autophagosomal components such as LC3, and even client proteins (Hjerpe et al.,
2016; Kurlawala et al., 2017; Lee et al., 2013; Zheng et al., 2020). However, specific
interactions involving the IDR are largely unknown.
Our lab previously found the STI1-II region to be essential for the oligomerization
and LLPS of UBQLN2. Constructs that lack the STI1-II regions do not oligomerize or
undergo LLPS under physiological conditions (Dao et al., 2018). On a molecular level,
we used a C-terminal construct of residues 450-624 to show that multiple transient
interactions exist among the STI1-II, PXX and UBA domains (Dao et al., 2018, 2019) to
collectively drive UBQLN2 self-association and phase separation. Ubiquitin-binding to
the UBA significantly reduces the driving forces for UBQLN2 phase separation by
decreasing the number of multivalent “stickers” needed for LLPS, thus driving the
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disassembly of UBQLN2 condensates in vitro. Importantly, it is well-established that
UBL and UBA domains interact with each other (Lowe et al., 2006; Nguyen et al., 2017).
How interplay among these folded domains and the middle region of UBQLN2 mediates
phase separation remains poorly understood.
In this study, we systematically mapped out the interactions that occur between the
folded UBL, UBA domains and the middle parts of the UBQLN2 protein using NMR
spectroscopy and a library of domain deletion constructs, and determined how these
interactions modulate UBQLN2 phase separation. Unexpectedly, our results indicated
that the UBL and UBA domains interact with separate parts of 109-576. We uncovered
moderate and specific interactions between UBL and each STI region, and weak
interactions between the UBA domain and linker residues 248-378. Importantly, we find
that these interdomain interactions have opposing effects on the LLPS behavior of
UBQLN2. Deletion of the UBL domain enhances the driving forces for LLPS, whereas
deletion of the UBA domain inhibits LLPS. Our results suggest that the IDR-driven LLPS
behavior of UBQLN2 can be tuned by ligand interactions involving either the UBL or
UBA domains. Given that UBQLN2’s function as a shuttle protein heavily relies on
interactions involving the UBL and UBA domains, our data support the hypothesis that
LLPS contributes to the physiological functions of UBQLN2.
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3.2 Results
3.2.1 UBQLN2 LLPS does not require UBL or UBA domains for phase separation
To determine the contribution of the UBL and UBA domains to UBQLN2 LLPS, we
generated several UBQLN2 constructs with the UBL and/or UBA domains removed:
∆UBL (residues 109-624), ∆UBA (1-576), and ∆UBL∆UBA (109-576) (Figure 3.1B). We
expressed and purified these constructs in E. coli (see Methods, Figure S3.1)).
Importantly, all constructs phase separated with increasing salt and temperature,
consistent with full-length (FL) UBQLN2 phase behavior. Thus, we were able to purify
the proteins without any extra mutations or affinity tags (Dao et al., 2018). We obtained
the low-concentration arm of the temperature-concentration phase diagram for each
UBQLN2 construct using spectrophotometric turbidity assays performed in 20 mM
NaPhosphate buffer with 200 mM NaCl, pH 6.8 (Figure S3.2). The low-concentration
phase boundary denotes the saturation concentration (csat) above which the protein
phase separates (Figure 3.1C). Using fluorescence microscopy, we confirmed that each
construct formed protein-rich, liquid-like condensates (Figure 3.1D). Importantly, our
data showed that UBQLN2 does not require the folded UBL or UBA domains to phase
separate, consistent with prior data from our group and others (Alexander et al., 2018;
Dao et al., 2018).
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3.2.2 UBL and UBA domains contribute asymmetrically to UBQLN2 LLPS
Removal of the UBL domain (∆UBL) and UBA domain (∆UBA) from FL UBQLN2
had opposite effects on the phase behavior of UBQLN2 (Figure 3.1C). Over the 16-60
oC

temperature range, phase separation of ∆UBA required much higher protein

concentrations (high csat values) compared to FL UBQLN2, whereas ∆UBL phaseseparated at much lower protein concentrations (low csat values). The effect of removing
both UBL and UBA domains was not additive, as the phase diagram of 109-576 was
nearly identical to that of ∆UBL. From these observations, we hypothesized that the
asymmetrical contributions of UBL and UBA domains on UBQLN2 LLPS reflect
differences in how these folded domains interact with the rest of the UBQLN2 protein.
To parse these interactions, we constructed a domain deletion library of UBQLN2
constructs, and employed NMR spectroscopy to map the interactions involving the
folded UBL and UBA domains across the entire UBQLN2 protein.
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Figure 3.1. UBL and UBA domains contribute asymmetrically to UBQLN2 LLPS.
(A) Domain architecture of UBQLN2. Disordered propensity predicted using the
program PONDR-FIT (Xue et al., 2010), and DISORPRED3 (Jones and Cozzetto,
2015). (B) Library of UBL and UBA domain deletion constructs used here and colorcoded accordingly. (C) Temperature-concentration phase diagram constructed from
spectrophotometric assays using denoted protein concentrations in pH 6.8 buffer
containing 200 mM NaCl. Data points represent the average of the temperatures at the
inflection point (phase transition temperature) of temperature-based spectrophotometric
turbidity assays (see Figure S3.2 and Methods). Error bars are standard deviation from
at least four measurements. (D) Fluorescence microscopy shows solutions of UBQLN2
domain deletion constructs under identical conditions (100 µM protein, spiked with
Dylight-488 labelled FL-UBQLN2 protein at 1:100 molar ratio, pH 6.8 20 mM
NaPhosphate, 0.5 mM EDTA, 0.02% NaN3, 200 mM NaCl, at 30 oC). Scale bar denotes
5 µm.
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3.2.3 UBQLN2 UBL and UBA domains interact with one another
It is well-established that UBL and UBA domains of Ub-binding shuttle proteins
interact with each other on an intra- and intermolecular basis (Lee et al., 2013; Lowe et
al., 2006; Nguyen et al., 2017). To validate this within our UBQLN2 constructs, we
monitored the interactions between the isolated UBA and UBL domains of UBQLN2
using NMR spectroscopy (Figure 3.2), similar to the experiments employed in (Nguyen
et al., 2017). We used UBQLN2 1-107 and UBQLN2 571-624 as our UBL and UBA
constructs, respectively, with a C-terminal His-tag (see Methods and Table S3.1). We
obtained chemical shift assignments for the UBL construct, and found that the Nterminal 30 residues are disordered, consistent with secondary structure predictions
(Figure 3.1A). As a control, we compared the spectra of the UBL or UBA domains at 50
and 400 µM and observed minimal or no concentration-dependent chemical shift
perturbations (CSPs) (Figure S3.3), which suggest that these constructs do not selfassociate over this concentration range.
We mapped the UBL:UBA binding interface by identifying those residues that
exhibited significant CSPs upon the titration of one folded

15N-labeled

domain with the

other (unlabeled) domain. Consistent with other studies (Lowe et al., 2006; Nguyen et
al., 2017), we observed concentration-independent backbone amide CSPs for UBL
residues 75-82 and 98-103 and UBA residues 591-594 and 612-620 (Figures 3.2A,B).
Together, these residues form a hydrophobic interface across the β sheets on the UBL
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and the loop 1 and ɑ3 helix on the UBA domain (Figures 3.2C). These key amino acids
at the UBL:UBA interface are also essential for UBL:proteasome subunit (Rpn10,
Rpn13) (Chen et al., 2016, 2019), and UBA:ubiquitin interactions (Ohno et al., 2005;
Zhang et al., 2008). By following chemical shift trajectories for amide resonances on
both domains, we determined binding dissociation constants (K d) of 178 +/- 41 µM and
210 +/- 15 µM when monitoring UBL and UBA resonances, respectively (Figure S3.4).
Our experiments are consistent with previous studies showing that UBA and UBL
domains of UBQLN2 interact with weak affinity (Kd ~ 200 µM) (Nguyen et al., 2017).
To test whether UBL-UBA interactions are present in the intact FL UBQLN2 protein,
we collected TROSY-HSQC spectra of FL UBQLN2 and ∆UBL. While we didn’t see UBL
resonances in FL UBQLN2 spectra, UBA resonances were clearly visible (Figure 3.2D
and (Dao et al., 2018)). The UBA peaks in ∆UBL spectra superpositioned well with
those in isolated UBA spectra, whereas UBA peaks in FL UBQLN2 approached
equimolar UBA:UBL peak positions, suggesting that UBA is interacting with the UBL
within or between UBQLN2 molecules in a similar manner as in the isolated UBA:UBL
experiments (Figure 3.2D).
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Figure 3.2. UBQLN2 UBA and UBL domains interact with each other.
(A, B) Chemical shift perturbations (CSPs) of 1H-15N amide resonances of (A) the
isolated UBL domain (left: 50 µM, right: 200 µM) in the presence of equimolar amounts
of UBA domain and (B) the isolated UBA domain (left: 50 µM, right: 200 µM) in the
presence of equimolar amounts of UBL domain. (C) Mapping of UBQLN2 UBL and UBA
CSPs on the UBL:UBA binding surface of yeast ubiquilin homolog DSK2 (PDB ID:
2BWE). UBL residues with CSP > 0.03 ppm and UBA residues with CSP > 0.02 ppm
from panel A are highlighted in red; structures of isolated UBQLN UBL and UBA are
shown on the right (PDB ID: 6MUN, PDB ID: 2JY5). (D) Overlays of (left) FL UBQLN2
and ΔUBL spectra and of (right) isolated UBA and UBA:UBL spectra. All proteins at 50
µM concentration except for UBA:UBL at 1:2 molar ratio where UBL is 100 µM. UBA
peaks in FL UBQLN2 are similarly affected by inter- and intra-molecular UBL binding as
peaks in isolated UBA spectrum in the presence of isolated UBL domain.
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3.2.4 UBA interacts very weakly with the IDR region of UBQLN2
We previously determined from paramagnetic relaxation enhancement (PRE)
experiments that weak and transient interactions existed among the UBA domain, PXX
region, residues 555-570, and C-terminal end of the STI1-II region in a UBQLN2 450624 construct (Dao et al., 2019). To specifically determine whether the UBA domain
interacts with specific regions throughout 109-576, we performed NMR titration
experiments where we used 200 µM 15N-labeled UBA, and added an equimolar amount
of 109-576 (Figure 3.3B, 3.3C). All NMR experiments were conducted under conditions
where the proteins did not phase separate (no added NaCl). UBA peaks were wellresolved in the presence of 109-576, and UBA peak intensities were only slightly
attenuated (60% of their levels) (Figure 3.3C). The UBA CSPs in the presence of 109576 were very small, as the maximum UBA CSP was only 0.02 ppm (Figure 3.3B). The
largest UBA CSPs (≤ 0.02 ppm) are observed for residues 592, 593, 616, and 619
which form the same hydrophobic binding surface involved in interactions with either the
UBL domain or with ubiquitin (Figure 3.1B) (Tse et al., 2011; Zhang et al., 2008).
To probe which part of the 109-576 sequence interacts with the UBA domain, we
built a library of deletion constructs from the N-terminus of 109-576 (Figure 3.3A). These
four constructs are 178-576 (deletion of linker between UBL and STI1-I region), 248-576
(subsequent deletion of STI1-I), 379-576 (subsequent deletion of linker between STI1
regions), 450-576 (subsequent deletion of most of STI1-II). Using 200 µM UBA as our
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reference spectrum, we mixed equimolar amounts of these constructs one at a time,
and measured CSPs and peak intensities. We observed identical overall CSP patterns
and peak intensities for UBA resonances in the presence of 109-576, 178-576, or 248576 constructs (Figure 3.3B). Additionally, only slightly reduced UBA CSPs were
observed in the presence of equimolar amounts of 379-576 and 450-576. These results
suggested very weak interactions between the UBA and linker residues 248-378 as well
as residues 450-576. These latter results are consistent with our prior NMR data where
we observed weak and transient interactions among the UBA and C-terminal end of
STI1-II region (Dao et al., 2019).

3.2.5 UBL interacts with multiple domains of UBQLN2
Given the asymmetric contributions of the UBL and UBA domains to the phase
behavior of UBQLN2, we suspected that the UBL and UBA domains differentially
interacted with the intrinsically-disordered middle region of UBQLN2 (residues 109-576).
To probe the UBL:IDR interactions, we first compared 1H-15N NMR spectra of 200 µM
15N

UBL domain in the absence and presence of equimolar amounts of unlabeled

UBQLN2 109-576. When 109-576 was added to UBL, we noticed that nearly all the UBL
peaks broadened beyond detection, with the exception of the flexible N-terminal
residues 1-30 (Figure S3.5). The strong attenuation of UBL peaks indicates that UBL
binds to the middle region of UBQLN2, which excludes the folded UBA domain, and
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also provides an explanation for why UBL peaks are not visible in FL UBQLN2 spectra.
As a whole, UBL interactions with 109-576 are stronger than UBA interactions as we did
not observe such attenuation of UBA resonances under identical conditions (Figure
3.3C).
We speculated that UBL peak broadening stemmed from slow tumbling of the
UBL:109-576 complex as 109-576 contains the oligomerization-driving STI1-II region
(Dao et al., 2018). To probe which IDR regions bind to UBL and cause broadening of
UBL peaks, we mixed equimolar amounts (200 µM) of the UBL domain with our library
of 109-576-derived constructs. Addition of 178-576 also led to UBL peak broadening, to
a similar extent as addition of 109-576 (Figure S3.5). However, UBL peaks were less
broadened with the addition of 248-576, and to a larger extent, 379-576 or 450-576
(Figure S3.5), enabling measurements of CSPs and peak intensities for UBL in the
presence of these constructs. CSPs were much higher for UBL with 248-576 than with
379-576 and 450-576, which were about the same (Figure 3.3D). Our CSP data
revealed that the UBL residues that interact with these three constructs are identical to
those that interact with the UBA domain, specifically UBL residues 77-80 and 99-101.
Peak intensity ratios were close to 0 for UBL with 248-576 and increased to 40-50% for
UBL with 379-576 and 450-576 (Figure 3.3F). Even though the CSPs for UBL with 379576 and 450-576 were low, they were slightly higher than those observed for UBA/IDR
interactions (Figure 3.3B). Together, the data suggested separate binding of UBL to
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regions between 109-248, 248-378, and 450-576.
We reasoned that lowering 109-576 concentration would reduce oligomerization
and enable tracking of UBL resonances upon binding 109-576 and 178-576. When we
repeated our NMR experiments using 15N 50 µM UBL and added equimolar amounts of
109-576, UBL peaks remained visible, even though we observed a significant reduction
(up to 80%) in amide peak intensity (Figure 3.3G). Our CSP data revealed that the UBL
residues that interact with 109-576 are also identical to those that interact with the UBA
domain (Figure 3.3E). Notably, the UBL:109-576 interactions are specific to the UBL as
Ub (identical fold but different sequence composition) did not interact with 109-576
(Figure S3.6A).
The UBL:109-576 CSPs were reduced in half compared to the UBL:UBA CSPs
under identical conditions. To determine the UBL binding affinity for 109-576, we
attempted a NMR titration experiment where we incrementally added 109-576 to 50 µM
UBL. However, UBL signals attenuated beyond detection when > 70 µM 109-576 was
added, likely owing to the propensity for 109-576 to oligomerize and form a UBL:109576 complex that tumbles too slowly for NMR detection. Notably, the peak trajectories
for UBL resonances are not in the same direction when comparing the UBL:UBA and
UBL:109-576 titration experiments (Figure S3.6B), indicative of differences in binding
modes. Based on the totality of our data, we surmise that the overall UBL:109-576
affinity is of the same order of magnitude but weaker than UBL:UBA interactions.
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Using 50 µM UBL as our reference spectrum, we mixed equimolar amounts of these
constructs one at a time, and measured CSPs and peak intensities (Figures 3.3E and
3.3G). First, CSPs and peak intensities slightly decreased and increased, respectively,
when UBL was mixed with 178-576 compared to 109-576, suggesting that the linker
109-177 weakly interacts with UBL. Strikingly, we saw a significant decrease in UBL
CSPs and increase in peak intensity ratios when the entire STI1-I region was removed
(compare 178-576 to 248-576). UBL CSPs further decreased to a similar degree in the
presence of either 379-576 or 450-576 constructs, as we had seen when 200 µM of
UBL were mixed with these constructs. Notably, UBL does not interact with most of
STI1-II as the UBL CSPs for 379-576 and 450-576 are nearly identical (Figure 3.3E,
3.3G). Together, these data suggest weak binding between UBL and 450-576, but no
significant interactions involving the UBL and STI1-II.
We wondered whether the substantial decrease in UBL CSPs after deletion of STI1I was due to specific interactions with this domain or due to reducing the number of
STI1 regions from two to one. To test this, we cloned and expressed a peptide of the
STI1-I region and monitored UBL CSPs when adding STI1-I (Figure S3.7). Based on the
CSPs, the UBL interacts with STI1-I and to a similar extent as how UBL interacts with
450-576.
To monitor the UBL:109-576 interaction from the 109-576 side, we prepared a 15Nlabeled sample of 109-576. Initial spectral characterization revealed that only ~160
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amide resonances (out of an expected 400) were present (Figure S3.8). Overlay with
our previously-characterized UBQLN2 450-624 indicated that the resonances for the
disordered PXX and linker regions (residues 510-550) superimposed well, but
resonances for residues 450-480 and 555-570 in the C-terminal region of the STI1-II
were not observable (Figure S3.8). Addition of UBL resulted in minimal changes to the
spectra of 109-576, both in terms of peak positions and intensities (Figure S3.8). We
concluded a number of resonances are not observable via NMR, either due to high
oligomerization propensity or other dynamics.
Since most of the expected amide resonances for 450-576 were present (Figure
S3.8B), we thought we might be able to probe the UBL interactions sites directly on 450576. Indeed, we could observe movements of several 450-576 resonances upon
addition of UBL (Figure S3.9A). These CSPs map to the putative helical region
consisting of residues 555-570 (Dao et al., 2018) as the binding surface for the UBL. In
contrast, addition of UBA to 450-576 under identical conditions had little effect on the
450-576 spectrum (Figures S3.9C,D). Interestingly, residues 555-570 was shown to be
a sticker important for driving UBQLN2 LLPS (Dao et al., 2018, 2019; Yang et al., 2019),
suggesting that UBL could further modulate UBQLN2 LLPS by interaction with this
region. In total, our deletion construct data are consistent with a model whereby UBL
interacts with the STI1-I, the linker between the STI1 regions, and residues 555-570.
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Figure 3.3. UBL and UBA domains interact with distinct regions in the intrinsically
disordered segment of UBQLN2.
(A) Library of domain deletion constructs designed to probe UBL/UBA:109-576
interactions. (B) CSPs of UBQLN2 UBA domain upon mixing 200 µM UBA with an
equimolar amount of designated UBQLN2 domain deletion construct. (C) Amide peak
intensity ratios of resonances UBA in the presence of designated UBQLN2 constructs.
(D) CSPs of UBQLN2 UBL upon mixing 200 µM UBL with an equimolar amount of
designated UBQLN2 domain deletion construct. (E) CSPs of UBQLN2 UBL domain
upon mixing 50 µM UBL with equimolar amount of designated UBQLN2 domain deletion
construct. (F, G) Amide peak intensity ratios of resonances in 200 µM (F) and 50 µM (G)
UBL in the presence of an equimolar amount of designated UBQLN2 constructs.
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3.2.6 Molecular mechanisms underlying UBL/UBA effects on UBQLN2 LLPS
Given the differences in interaction strength and binding site preferences between
the UBL/UBA domains with 109-576, we rationalized that titration of the UBL and UBA
domains would exert different effects on UBQLN2 109-576 LLPS. To test this, we
performed our turbidity assays with 10 µM 109-576 and different amounts of isolated
UBL or UBA (Figures 3.4A, 3.4B). Addition of UBL increased the phase transition
midpoint temperature, suggesting a lower propensity for the UBL:109-576 mixture to
phase separate. This result is consistent with the phase diagram of ∆UBA (1-576)
shifting to higher temperatures and concentrations than FL UBQLN2 (Figure 3.1C). In
contrast, titration of isolated UBA to 109-576 only marginally affected UBQLN2 phase
separation, suggesting that UBA:109-576 interactions are weaker than UBL:109-576
interactions in agreement with our NMR data above (Figure 3.4A, 3.4B). Notably, the
effect of UBL/UBA titrations is small, likely due to the low concentration of 109-576 used
(10 µM) and because we titrated UBL/UBA in trans.
Our ΔUBL LLPS data suggest that the UBL “inhibits” UBQLN2 LLPS, as removal of
the UBL domain lowers the protein csat threshold for phase separation. Since UBL binds
to 109-576 at two specific sites, 75-82 and 98-103, we hypothesized that mutations to
these sites might lower the affinity between UBL and 109-576 and reduce the effects of
UBL on UBQLN2 LLPS. To test this hypothesis, we introduced a mutation (I80A) in the
UBL domain that weakens the UBL:109-576 interactions but doesn’t impact the overall
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UBL structure (Figure 3.4C, Figure S3.10A). NMR experiments of I80A UBL with 109576 confirmed that CSPs and peak intensity attenuations are smaller than those for WT
UBL, indicative of weaker binding between I80A UBL and 109-576. To determine the
effects of weakened UBL:109-576 interactions on LLPS, we generated I80A ∆UBA. We
chose the ∆UBA background to eliminate possible UBL:UBA contributions. We predicted
that the weakened inhibitory UBL:109-576 interactions would promote I80A ∆UBA LLPS
over a greater temperature and concentration range relative to ∆UBA. We observed this
exact trend, suggesting that the UBL negatively regulates UBQLN2 LLPS (Figure 3.4E).
Finally, we investigated the contributions of UBA:109-576 interactions on UBQLN2
LLPS. We introduced the L619A mutation in the UBA domain and determined that
L619A reduces the interactions between UBA and 109-576 using NMR spectroscopy
(Figure 3.4D). We expressed and purified L619A ∆UBL and obtained a phase diagram
to compare against ∆UBL. We found that L619A ∆UBL phase separated at higher c sat
values than ∆UBL (Figure 3.4F). These data suggest that the wild-type UBA domain
favorably contributes to UBQLN2 LLPS. Given the weak UBA:109-576 interactions, we
were surprised at the extent to which L619A significantly decreased LLPS propensity of
∆UBL. However, residue 619 is considered a “sticker” for LLPS, therefore the L619A
mutation may also act to reduce phase separation by reducing the multivalency
(number of “stickers”) necessary for LLPS (Yang et al., 2019). Alternatively, the L619A
mutation may destabilize the UBA domain and rebalance the interactions across 109143

576 to modulate phase separation.
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Figure 3.4. UBL:109-576 and UBA:109-576 interactions contribute asymmetrically
to UBQLN2 LLPS.
(A) Turbidity curves showing the change in LLPS behavior of a solution of 10 µM of 109576 as a function of UBL (left) or UBA (right). (B) Temperature-composition component
phase diagram showing the changes in UBQLN2 109-576 transition temperature as a
function of UBL or UBA. (C) CSPs (top) and amide peak intensity ratios (bottom) of WT
(black) or I80A (red) UBL resonances upon mixing 50 µM UBL with an equimolar
amount of 109-576. (D) CSPs (top) and amide peak intensity ratios (bottom) of WT
(black) or L619A (red) UBA resonances upon mixing 200 µM UBA with an equimolar
amount of 109-576. (E) Temperature-concentration phase diagram indicating UBL I80A
mutation promotes UBQLN2 ∆UBA LLPS. (F) Temperature-concentration phase
diagram indicating UBA L619A mutation inhibits UBQLN2 ∆UBL LLPS.
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3.3 Discussion
Here we showed that the two folded domains of UBQLN2 asymmetrically modulate
its IDR-driven phase separation behavior. In elucidating the molecular basis for these
observations, we postulate that differences in interaction strengths and previously
uncharacterized binding site preferences between the folded domains and the middle
region of UBQLN2 (109-576) establish a hierarchy of interactions, some of which
compete with known interactions that promote phase separation of UBQLN2. We have
experimentally mapped and rank-ordered the interactions involving the folded UBL and
UBA domains across UBQLN2, specifically UBL:UBA, UBL:109-576 and UBA:109-576
interactions (Figure 3.5A). Our NMR data suggest that UBA:109-576 interactions are
the weakest of the three, while UBL:109-576 and UBL:UBA are of the same order of
magnitude. UBL:UBA interactions are the strongest as they exhibit the highest CSPs
among the three sets presented here. It is important to note that our experiments
assessed these interactions in trans (intermolecular interactions between designed
UBQLN2 constructs). We speculate that these interactions could be strengthened in cis
due to the domains being tethered together, effectively increasing their local
concentrations (Kjaergaard et al., 2021). This current study sets the foundation to
examine these interactions on an intramolecular level, where structural, enthalpic, and
entropic factors may further modulate the contributions of these interactions to UBQLN2
LLPS.
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3.3.1 UBQLN2 LLPS is modulated by its interdomain interaction network
The intermediate phase behavior of FL compared to ∆UBL and ∆UBA can be
explained by the complex interplay of UBL:UBA, UBL:109-576 and UBA:109-576
interactions (Figure 3.5A). When only the UBA domain is removed from FL (∆UBA
construct, which has the lowest driving forces for phase separation among the three),
two LLPS-driving “sticker” regions (UBA residues 592-594, 616-620) are eliminated,
thus reducing the multivalency required for phase separation (Dao et al., 2018).
Additionally, removing UBA eliminates competing UBL:UBA interactions and enables
UBL to interact with the STI1-1 and 555-570 regions, possibly preventing sticker region
555-570 to participate in phase separation. These two effects combine to reduce phase
separation of ∆UBA compared to FL (Figure 3.5B). Conversely, phase separation of
∆UBL is promoted compared to FL. This behavior stems from at least two contributions:
release of (1) residues 555-570 and (2) UBA from interactions with the UBL enables
these two regions to participate in LLPS-mediating interactions. Together, these
observations suggest that, in FL UBQLN2, the UBL:UBA interactions simultaneously
enhance and inhibit UBQLN2 LLPS by outcompeting UBL:555-570 interactions to free
the 555-570 region to enhance LLPS and by reducing the availability of UBA “stickers”
to participate in LLPS, respectively (Figure 3.5B).
Strikingly, the low concentration arms of the ∆UBL and 109-576 (∆UBL∆UBA) phase
diagrams are almost superimposable (Figure 3.1C). As removal of the UBA domain
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takes away some of the multivalent stickers required for UBQLN2 LLPS, we would
predict decreased LLPS of 109-576 in comparison to ∆UBL. However, 109-576 is
predicted to be largely disordered (Figure 3.1A), whereas ∆UBL still contains the folded
UBA domain. Deletion of both UBL and UBA domains could enhance the ability of the
middle intrinsically-disordered region (IDR) to interact with itself, thus promoting LLPS
(Zhou et al., 2018). These two countering effects could cancel each other to yield similar
phase diagrams for 109-576 and ∆UBL.

3.3.2 Molecular basis of UBL:IDR interactions
For the first time, we identified that the UBL domain interacts with multiple regions in
UBQLN2 IDR (residues 109-576), except for STI1-II. The UBL interaction patch in the
UBL:IDR interface includes the same hydrophobic residues that are in the UBL:UBA
interface, specifically V73, L74, F76, A77, I80, L81, L100, V101, and I102, as well as
basic residues K79 and K103. Notably, the UBL domain is basic (pI ~ 9.4), whereas the
rest of the protein is acidic (pI of 4.5 for 109-576, pI of 4.6 for UBA, see Table S3.5). If
favorable electrostatics contributed to UBL:IDR and UBL:UBA interactions, we would
have expected UBL CSPs to be similar across all 109-576 constructs as all have
identical pI values, but this was not the case (Figures 3.3D, 3.3E). Electrostatics
contributions are expected to be small given the low number of ionizable residues
across UBQLN2. No structural information yet exists for the IDR, but sequence analysis
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reveals that the different regions of the IDR are enriched with hydrophobic (e.g. L, M, P)
and polar (N, Q) residues (Figure S3.11). Therefore, we speculate that the UBL:IDR
interactions largely involve these residues. Interestingly, our data suggest that there is
no binding between UBL and STI1-II, which also comprises mainly hydrophobic and
polar residues. Both STI1 regions include repeating Asn-Pro (NP) motifs that are
separated by ~10 residues. Notably, a recent computational study predicts each of the
STI1-I and STI1-II domains of UBQLN1 to consist of multiple helices that make a
flexible, helical fold similar to other co-chaperone proteins (Fry et al., 2021). Therefore, it
is surprising that STI1-I, but not STI1-II would interact with UBL. For a possible
explanation, we turn to our previous work which showed that STI1-II is responsible for
the high propensity for UBQLN2 to oligomerize (Dao et al, 2018). The strength of STI1-II
self-association would outcompete possible weak UBL-STI1-II interactions, which,
therefore, cannot be observed. It remains to be seen how these UBL-IDR interactions
modulate the functional behavior of STI1 domains in UBQLN2, such as interactions with
HSP70 (Hjerpe et al., 2016).

3.3.3 Implications for how PQC components modulate UBQLN2 phase transitions
Our results imply that UBL- and UBA-mediated interactions modulate UBQLN2
phase transitions in cells (Figure 3.5C). We envision that ∆UBL mimics the UBL-bound
state, e.g. when UBQLN2 UBL is bound to the proteasome via receptors such as Rpn10
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or Rpn13. In such a scenario, our model predicts that UBL:receptor interactions (Kd < 10
µM) (Chen et al., 2019) outcompete both UBL:IDR and UBL:UBA interactions, resulting
in more available 555-570 and UBA regions, respectively, to facilitate LLPS. On the
other hand, the ∆UBA construct mimics when UBA interacts with Ub on ubiquitinated
substrates, making UBA unavailable to contribute to UBQLN2 LLPS. Strong UBA:Ub
interactions (Kd ~ 1-5 µM) outcompete UBA:UBL ones, thus permitting unbound UBL to
engage with the IDR regions and compete with 555-570-mediated interactions as well
as other possible yet-to-be-identified interactions for LLPS. Consequently, UBQLN2
phase separates less when UBA engages with Ub, in support of our prior observations
whereby Ub abrogated UBQLN2 phase separation entirely (Dao et al., 2018). Our
model also conforms with recent observations where UBQLN2 ∆UBA formed less
puncta over time in neurons compared to FL and ∆UBL (Sharkey et al., 2018).
Therefore, strong interactions involving the UBL or UBA domains could outcompete the
interdomain interactions within UBQLN2 to either promote or inhibit LLPS, respectively
(Figure 3.5C). Importantly, our predictions address the effects of low-valency ligands on
UBQLN2 LLPS. This is an important distinction as polyvalent ligands may impart
different effects that substantially alter the driving forces for UBQLN2 phase separation
(Ruff et al., 2020).
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3.4 Conclusions
FL UBQLN2 appears poised to alter its phase behavior in either direction via
interactions with binding partners. Interactions involving UBL- or UBA-binding partners,
therefore, offer a rich and complex energetic landscape to modulate phase separation
of UBQLN2 and other Ub-binding shuttle proteins (Yasuda et al., 2020). Additionally, our
results suggest that client or chaperone proteins that engage with the IDR shift the
balance of UBL/UBA interactions across the entire UBQLN2 protein (Hjerpe et al.,
2016), thus impacting phase separation behavior. Although the presence of folded
domains have been shown to alter the IDR-driven phase separation behavior of many
proteins (FUS, hnRNPA1, LAF1 among others) (Burke et al., 2015; Molliex et al., 2015;
Wei et al., 2017), our study and recent work by Martin and colleagues (Martin et al.,
2021) highlight the need for detailed mapping of the interactions between folded
domains and IDRs to further understand how cellular components affect phaseseparating proteins and their functions. Additionally, elucidation of the relative strengths
of interactions among domains will be critical to predicting how ligands modulate phase
behavior of multivalent systems. Our work also emphasizes the importance of
identifying “stickers” and “spacers” within a protein system to understand how folded
domains and intrinsically-disordered regions work together to modulate LLPS.
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Figure 3.5. Implications of UBL/UBA interactions on UBQLN2 LLPS.
(A) Summary of domain-specific interactions across UBQLN2. (B) Estimated domaindomain interactions and their interaction strengths (arrow thickness) in different
UBQLN2 constructs. Interaction strengths estimated from NMR measurements (this
work unless noted). (C) UBQLN2 binding partners likely modulate the driving forces of
UBQLN2 phase separation depending on where they bind to UBQLN2. As drawn, the
model assumes binding partners are monovalent or exhibit low valency. Throughout the
figure, UBQLN2 domains are colored according to Figure 3.1A.
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3.5 Materials and Methods
3.5.1 Subcloning, Protein Expression and Purification
The gene encoding human UBQLN2, a kind gift from Dr. Peter Howley’s laboratory
(Addgene plasmid 8661), was subsequently cloned into a pET24b plasmid (Dao et al.,
2018). Deletion constructs and mutations were created from this plasmid using the
ThermoFisher Phusion Site-Directed Mutagenesis Kit and phosphorylated primers.
All UBQLN2 constructs (except isolated UBA, UBL, and STI1-I) were transformed
into Rosetta 2 (DE3) pLysS E. coli cells (Table S3.1). The cells were grown in LB media
with final concentration of 50 mg/L kanamycin and 34 mg/L chloramphenicol to OD 600 of
0.6-0.8, induced with 0.5 mM IPTG overnight, pelleted, frozen, then lysed using 20 mL
of 20 mM NaPhosphate pH 6.8 buffer with 0.1 mg/mL DNAse, 5 mM MgCl2, and 0.5 mM
PMSF. The solution was mixed thoroughly using a pipette and centrifuged at 20,000 x g
for 20 min. Supernatant was collected and warmed to room temperature. Solid NaCl
was added to the solution to the final concentration of 0.5-1 M to induce phase
separation, and the protein was then collected by centrifugation at 5000 x g for 20 min
at room temperature. The protein pellet was then washed twice by re-solubilizing using
cold, NaCl-free 20 mM NaPhosphate pH 6.8 buffer and re-precipitated by adding NaCl.
In the final step, protein was solubilized again in 2 mL of cold, NaCl-free buffer, and the
final product was obtained by running the solution through an 5 mL Hi-Trap (GE
Healthcare) desalting column (Figure S3.1).
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Isolated UBQLN2 UBA, UBL, and STI1-I constructs were transformed into NiCo21
(DE3) E. coli cells. The cells were grown in LB with 50 mg/L kanamycin to OD 600 of 0.60.8, induced with 0.5 mM IPTG overnight, pelleted, frozen, then resuspended in 20 mL
of 20 mM NaPhosphate pH 7.2 buffer containing 0.1 mg/mL lysozyme, 0.1 mg/mL
DNAse, 5 mM MgCl2, and 0.5 mM PMSF. The resuspended cells were freeze-thawed for
3 rounds before centrifugation at 20,000 x g for 20 min. Supernatant was loaded onto a
Ni-NTA column (GE Healthcare) equilibrated with the wash buffer (20 mM NaPhosphate
pH 7.2 buffer containing 25 mM imidazole, and 0-100 mM NaCl). The column was
washed with the wash buffer. The protein was then eluted with the elution buffer (20 mM
NaPhosphate pH 7.2 buffer with 500 mM imidazole, and 0-100 mM NaCl), then dialyzed
into 20 mM NaPhosphate pH 6.8 buffer containing 0.5 mM EDTA, 0.02% NaN3
overnight, concentrated, then further purified using a Superdex 75 HiLoad 16/600
column (GE Healthcare) equilibrated with 20 mM NaPhosphate pH 6.8, 0.5 mM EDTA
and 0.02% NaN3. Molecular weights of proteins used in this study were further validated
using electrospray mass spectrometry (ESI-MS) on a Shimadzu 8040 mass
spectrometer.

3.5.2 Temperature-dependent Spectrophotometric Turbidity Assays and Phase
Diagrams
Protein samples were prepared using final concentrations of 5-80 µM protein in 20
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mM NaPhosphate pH 6.8 buffer containing 0.5 mM EDTA, 0.02% NaN 3, and 200 mM
NaCl. Samples (400 µL) were then pipetted into quartz cuvettes (Starna Cells) on ice
before loading into the Agilent Cary 3500 UV-Vis spectrophotometer. After incubating at
16°C for 2 minutes, OD600 values were recorded in 0.1°C increments as the samples
were heated from 16°C to 60°C using a 1°C/minute temperature ramp rate. The OD600
versus temperature data were then fitted to a 4-parameter nonlinear regression curve
y=d+(a-d)/[1+(x/c)^b] using MATLAB R2020a, where a and d are minimum and
maximum absorbance values, b is the Hill slope reflecting steepness of the transition,
and c is the temperature at the inflection point. Temperature-concentration phase
diagrams were obtained by plotting the inflection point temperature (phase transition
temperature) as a function of protein concentration. Plotted values are the average of at
least four replicates (using at least two protein purifications) as described in figure
legends.
Titration samples for turbidity assays were prepared using 10 µM UBQLN2 109-576
and 0-300 µM isolated UBL/UBA. Proteins were first mixed in 20 mM NaPhosphate pH
6.8 buffer containing 0.5 mM EDTA, 0.02% NaN3 on ice. Then a stock solution of 500
mM NaCl in 20 mM NaPhosphate pH 6.8, 0.5 mM EDTA and 0.02% NaN 3 was added to
a final NaCl concentration of 200 mM. Spectrophotometric measurements were carried
out using the same method as described above.
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3.5.3 Fluorescence Microscopy
UBQLN2 constructs were prepared to contain 100 μM protein (spiked with Dylight488 labeled protein, 1:100 ratio) in 20 mM NaPhosphate pH 6.8 buffer with 200 mM
NaCl and 0.5 mM EDTA. Samples were added to concavity microscope slides (Eisco
Labs) and covered with coverslips (MatTek) coated with 5% bovine serum albumin
(BSA) to reduce rapid coating of protein droplets onto the coverslip, and incubated at 30
°C for 20 minutes. Phase separation was imaged on an ONI Nanoimager (Oxford
Nanoimaging Ltd.) equipped with a Hamamatsu sCMOS ORCA flash 4.0 V3 camera
using an Olympus 100 Å/1.4 N.A. objective. Images were prepared using Fiji
(Schindelin et al., 2012) and FigureJ plugin (Mutterer and Zinck, 2013).

3.5.4 NMR Spectroscopy
All NMR samples were prepared using 15N labeled protein (50-400 µM) in 20 mM
NaPhosphate pH 6.8 buffer containing 0.5 mM EDTA, 0.02% NaN3, and 5% D2O. All
spectra were collected using a Bruker Avance III 800 MHz NMR spectrometer equipped
with a TCI cryoprobe at 25°C. The number of scans ranged from 8-64 depending on
signal/noise ratio. All NMR data were processed using NMRPipe (Delaglio et al., 1995)
and analyzed using CCPNMR Analysis 2.5 (Vranken et al., 2005) on NMRBox
(Maciejewski et al., 2017). 2D 1H-15N TROSY-HSQC experiments were acquired using
spectral widths of 12,019 and 2594.7 Hz in the direct 1H and indirect 15N dimensions,
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with 4806 and 240 total number of points, respectively, for 1H and 15N dimensions.
Centers of frequency axes were 4.7 and 117 ppm for 1H and 15N, respectively. 1H-15N
TROSY-HSQC spectra were processed and apodized using a Lorentz-to-Gauss window
function in the 1H dimension, while 15N dimension was processed using a cosine
squared bell function. Chemical shift perturbations (CSPs) were quantified as follows:
𝛥𝛿 = √(𝛥𝛿𝐻 )2 + (𝛥𝛿𝑁 /5)2where 𝛥𝛿𝐻 and 𝛥𝛿𝑁 are the differences in 1H and 15N chemical
shifts, respectively. All experiments using domain deletion constructs were repeated
with protein stocks from at least two protein purifications.

3.5.5 NMR Titration Experiments
Unlabeled ligand was titrated into 200 μM samples of 15N UBL or UBA, and the
binding was monitored by recording 1H-15N TROSY-HSQC or SOFAST-HMQC spectra
as a function of ligand (L) concentration. At each titration point, we assumed that the
chemical shift perturbation (CSP) for each backbone amide was a weighted average
between the free (Δδ = 0) and ligand-bound (Δδ = Δδbound) states, such that Δδ = Δδbound
* [PL]/[Ptotal]. Here, [PL] and [Ptotal] represent the ligand-bound protein concentration,
and Ptotal is the total protein concentration of the 15N-labelled protein. Data fitting for
each amide was performed using an in-house MATLAB program, assuming a single-site
(1:1 stoichiometry) binding model. Only residues with CSP > 0.03 ppm at the titration
endpoint were considered for Kd determination. Reported Kd values were averages of
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residue-specific Kd values with errors reflecting standard deviation of these values.

3.5.6 Resonance assignments for UBQLN2 UBL (1-107)
To obtain chemical shift assignments, NMR samples consisting of 500 mM

15N,13C-

labeled UBL were prepared in pH 6.8 buffer (see above) with 20 mM NaPhosphate, 0.5
mM EDTA, 0.02% w/v NaN3, and 5% D2O. All experiments were collected at 298 K.
Chemical shift assignments of the backbone resonances (H N, N, Cα, and Cβ) were
obtained using 2D 1H-15N, HSQC, and triple resonance experiments (HNCACB,
CBCACONH, and HNN). Acquisition times for the triple resonance experiments were 80
ms in the direct 1H dimensions, 18 ms in the indirect 15N dimensions, and 6 ms in the
indirect Cα/Cβ dimensions. Spectral widths were 16 ppm in 1HN, 68 ppm in 13Ca/Cb
dimension, 27 ppm in indirect 15N. Non-uniform sampling (NUS) was employed for all
triple resonance experiments. Experiments were acquired with 25% (CBCACONH,
HNCACB) or 30% (HNN) sampling using the Poisson Gap sampling method (Hyberts et
al., 2010). NUS spectra were processed using SMILE and NMRPipe (Delaglio et al.,
1995; Ying et al., 2017) and employed standard apodization parameters and linear
prediction in the indirect dimensions. Using these experiments, we successfully assigned
amide backbone resonances (HN, N) for 99% (97/98 assignable) of all residues.
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3.6 Supplementary Material

Figure S3.1. SDS-PAGE gels of UBQLN2 constructs used in this study.
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Figure S3.2. Representative individual spectrophotometric turbidity experiments
used to construct temperature-concentration phase diagrams in Figures 3.1 and
3.4.
A four-parameter regression model (see Methods) was fitted to the absorbance data as
a function of temperature to obtain the inflection point temperature (phase transition
temperature) of each experiment. These temperature values were used to determine
the phase boundary in temperature-concentration phase diagrams. For each protein
concentration, turbidity experiments were repeated using protein from at least two
protein purifications for a total of at least four trials.
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Figure S3.3. Little or no concentration dependence of the isolated UBL and UBA
domains.
CSPs of UBL or UBA backbone amide resonances were measured between NMR
spectra collected using protein concentrations of 50 to 400 µM.
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Figure S3.4. NMR titration data from 15N-1H HSQC spectra for UBQLN2 UBL:UBA
interactions.
Representative amide resonance trajectories for (A) UBL or (B) UBA residues as UBA or
UBL were added, respectively. (C, D) Normalized CSPs were plotted against total ligand
concentrations for (C) UBL and (D) UBA resonances. (E, F) A single-site binding model
(see Methods) was fit to the titration CSP data (black circles) to determine residuespecific Kd. Curve fits for representative residues in the (E) UBL and (F) UBA domains
are shown here.
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Figure S3.5. 15N-1H HSQC spectra for 200 µM UBQLN2 in the absence and
presence of an equimolar amount of designated UBQLN2 constructs.
Addition of either 109-576 or 178-576 caused broadening of all UBL resonances (except
for disordered residues 1-33). Addition of 248-576, 379-576 or 450-576 caused
significantly less broadening of UBL peaks compared to the longer two constructs.

164

165

Figure S3.6. Analysis of UBL interactions with 109-576 (∆UBL∆UBA).
(A) Comparison of UBL CSPs in equimolar UBL:109-576 mixture versus Ub CSPs in
equimolar Ub:109-576 mixture (each protein at 50 μM). UBL and Ub sequences were
structurally aligned and corresponding sequence alignment used for x-axes (top: Ub,
bottom: UBL) (B) Comparison of amide trajectories from 1H-15N HSQC spectra for UBL
residues 77, 79, 80, 82, 101, and 103 when UBA, 109-576, or 379-576 were titrated.
The UBA and 379-576 titrations were performed using 200 μM 15N UBL, whereas the
109-576 titration was collected using 50 μM 15N UBL. UBL resonances broadened
extensively as 109-576 was titrated, unlike in the presence of UBA. UBA concentrations
(left spectra) were 0 μM (red), 20 μM (orange), 40 μM (yellow), 100μM (lime), 190 μM
(green), 370 μM (teal), 540 μM (sky blue), 700 μM (blue), 850 μM (purple). 109-576
concentrations (middle spectra) were 0 μM (red), 10 μM (orange), 30 μM (yellow), 50
μM (green), 70 μM (blue). 379-576 concentrations (right spectra) were 0 μM (red), and
200 μM (purple).
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Figure S3.7. Interactions between UBL and 450-576 (left) and UBL and STI1-I
(right) at 200 µM of each protein (top) and 50 µM of each protein (bottom).
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Figure S3.8. 1H-15N TROSY-HSQC NMR spectra of 50 µM UBQLN2 109-576
(ΔUBLΔUBA) by itself (top) and overlaid with 450-576 (bottom left) or with 109-576
in the presence of 50 µM UBL (bottom right).
Arrows indicate representative resonances that shift with addition of UBL.
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Figure S3.9.
(A) Part of the 1H-15N TROSY-HSQC NMR spectra of 50 µM UBQLN2 450-576 without
(black) and with (red) 200 µM UBL. (B) CSPs for when 200 µM UBL is added to 50 µM
450-576. (C) Part of the 1H-15N TROSY-HSQC NMR spectra of 50 µM UBQLN2 450576 without (black) and with (red) 200 µM UBA. (B) CSPs for when 200 µM UBA is
added to 50 µM 450-576.
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Figure S3.10. Comparison of 1H-15N TROSY-HSQC NMR spectra of (A) 50 µM WT
UBL (black) and I80A UBL (red), (B) 200 µM WT UBA (black) and L619A UBA (red).
Amide resonances that exhibited significant CSPs were highlighted (blue arrows), as
well as residues I80 and L619.
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Figure S3.11. Amino acid composition for linkers and domains within residues
109-576 of UBQLN2.
(A) Pie chart follows the general organization in (Ruff et al., 2018). (B) Fraction of amino
acids in each color-coded region within 109-576. Amino acids ranked in decreasing
hydrophobicity from left to right, according to scale determined by (Urry et al., 1992).
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Table S3.1. UBQLN2 Constructs used for this study.

UBQLN2 Construct

Residues

Extinction
Coefficient
(M-1 cm-1)

Special Notes

FL

1-624

11460

Tagless

ΔUBA

1-576

11460

Tagless

ΔUBL

109-624

11460

Tagless

109-576 (ΔUBLΔUBA)

109-576

11460

Tagless

178-576

178-576

11460

Tagless

248-576

248-576

11460

Tagless

379-576

379-576

1490

Tagless

450-576

450-576

0

Tagless, concentration
measured by gel as described
in Methods

178-247

178-247

0

C-terminal LEHHHHHH,
concentration measured by gel
as described in Methods

UBL

1-107

5500

C-terminal WHHHHHH

UBA

571-624

5500

C-terminal WHHHHHH

I80A UBL

1-107

5500

C-terminal WHHHHHH

L619A UBA

571-624

5500

C-terminal WHHHHHH

I80A ΔUBA

1-576

11460

Tagless

L619A ΔUBL

109-624

11460

Tagless
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Table S3.2. UBL:UBA binding affinity measurements.

Kd
15N

UBL + unlabeled UBA

178 ± 41 μM

15N

UBA + unlabeled UBL

210.1 ± 15.3 μM

15N

UBA + unlabeled UBL (Nguyen et al., 2017)

175 ± 25 μM
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Table S3.3. Residue-by-residue Kd determination from NMR titration curves.
Residue number

Max CSP (ppm)

Kd (mM)

UBL
79

0.6809

0.1629

80

0.3691

0.1607

77

0.1810

0.1654

78

0.1532

0.1474

76

0.1387

0.1838

81

0.1378

0.1713

104

0.1377

0.1645

101

0.1290

0.1583

99

0.1056

0.1789

82

0.1016

0.1677

593

0.3530

0.2110

613

0.2352

0.2023

619

0.2291

0.2143

592

0.1729

0.2072

595

0.1229

0.2194

594

0.1030

0.1663

616

0.0948

0.2073

590

0.0781

0.2170

620

0.0748

0.2336

615

0.0695

0.2096

UBA
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Table S3.4. UBQLN2 equivalent of highlighted DSK2 residues in Figure 2C.

UBL residues

UBA residues

UBQLN2
equivalent

DSK2

UBQLN2
equivalent

DSK2

F76

Y46

M592

M342

A77

S47

G593

G343

G78

G48

L595

F345

K79

K49

A613

G363

I80

I50

E616

D366

L81

L51

L619

L369

V101

V71
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Table S3.5. Calculated isoelectric point (pI) of UBQLN2 constructs.
Construct name

Calculated pI
(Bjellqvist et al., 1993)

FL

5.15

UBL (1-107)

9.35

UBA (577-624)

4.59

109-576

4.54

178-576

4.50

248-576

4.39

379-576

4.36

450-576

4.25

176

3.7 References
Alexander, E.J., Ghanbari Niaki, A., Zhang, T., Sarkar, J., Liu, Y., Nirujogi, R.S., Pandey,
A., Myong, S., and Wang, J. (2018). Ubiquilin 2 modulates ALS/FTD-linked FUS–RNA
complex dynamics and stress granule formation. Proc. Natl. Acad. Sci. 115, E11485–
E11494.
Bjellqvist, B., Hughes, G.J., Pasquali, C., Paquet, N., Ravier, F., Sanchez, J.C., Frutiger,
S., and Hochstrasser, D. (1993). The focusing positions of polypeptides in immobilized
pH gradients can be predicted from their amino acid sequences. Electrophoresis 14,
1023–1031.
Burke, K.A., Janke, A.M., Rhine, C.L., and Fawzi, N.L. (2015). Residue-by-Residue
View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II.
Mol. Cell 60, 231–241.
Chen, L., Shinde, U., Ortolan, T.G., and Madura, K. (2001). Ubiquitin-associated (UBA)
domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain
assembly. EMBO Rep. 2, 933–938.
Chen, X., Randles, L., Shi, K., Tarasov, S.G., Aihara, H., and Walters, K.J. (2016).
Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms
between Substrate Receptors and Shuttle Factors of the Proteasome. Structure 24,
1257–1270.
Chen, X., Ebelle, D.L., Wright, B.J., Sridharan, V., Hooper, E., and Walters, K.J. (2019).
Structure of hRpn10 Bound to UBQLN2 UBL Illustrates Basis for Complementarity
between Shuttle Factors and Substrates at the Proteasome. J. Mol. Biol. 431, 939–955.
Dao, T.P., and Castañeda, C.A. (2020). Ubiquitin-Modulated Phase Separation of
Shuttle Proteins: Does Condensate Formation Promote Protein Degradation?
BioEssays 42, 2000036.
Dao, T.P., Kolaitis, R.-M., Kim, H.J., O’Donovan, K., Martyniak, B., Colicino, E., Hehnly,
H., Taylor, J.P., and Castañeda, C.A. (2018). Ubiquitin Modulates Liquid-Liquid Phase
Separation of UBQLN2 via Disruption of Multivalent Interactions. Mol. Cell 69, 965978.e6.
Dao, T.P., Martyniak, B., Canning, A.J., Lei, Y., Colicino, E.G., Cosgrove, M.S., Hehnly,
H., and Castañeda, C.A. (2019). ALS-Linked Mutations Affect UBQLN2 Oligomerization
and Phase Separation in a Position- and Amino Acid-Dependent Manner. Structure 27,
937-951.e5.
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. (1995).
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J.
177

Biomol. NMR 6, 277–293.
Díaz-Martínez, L.A., Kang, Y., Walters, K.J., and Clarke, D.J. (2006). Yeast UBL-UBA
proteins have partially redundant functions in cell cycle control. Cell Div. 1, 28.
Fry, M.Y., Saladi, S.M., and Clemons, W.M. (2021). The STI1-domain is a flexible alphahelical fold with a hydrophobic groove. Protein Sci. 30, 882–898.
Heir, R., Ablasou, C., Dumontier, E., Elliott, M., Fagotto-Kaufmann, C., and Bedford, F.K.
(2006). The UBL domain of PLIC-1 regulates aggresome formation. EMBO Rep. 7,
1252–1258.
Hjerpe, R., Bett, J.S., Keuss, M.J., Solovyova, A., McWilliams, T.G., Johnson, C., Sahu,
I., Varghese, J., Wood, N., Wightman, M., et al. (2016). UBQLN2 Mediates AutophagyIndependent Protein Aggregate Clearance by the Proteasome. Cell 166, 935–949.
Hyberts, S.G., Takeuchi, K., and Wagner, G. (2010). Poisson-Gap Sampling and
Forward Maximum Entropy Reconstruction for Enhancing the Resolution and Sensitivity
of Protein NMR Data. J. Am. Chem. Soc. 132, 2145–2147.
Jones, D.T., and Cozzetto, D. (2015). DISOPRED3: precise disordered region
predictions with annotated protein-binding activity. Bioinformatics 31, 857–863.
Kjaergaard, M., Glavina, J., and Chemes, L.B. (2021). Chapter Six - Predicting the
effect of disordered linkers on effective concentrations and avidity with the “Ceff
calculator” app. In Methods in Enzymology, M. Merkx, ed. (Academic Press), pp. 145–
171.
Ko, H.S., Uehara, T., Tsuruma, K., and Nomura, Y. (2004). Ubiquilin interacts with
ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like
domains. FEBS Lett. 566, 110–114.
Kurlawala, Z., Shah, P.P., Shah, C., and Beverly, L.J. (2017). The STI and UBA domains
of UBQLN1 are critical determinants of substrate interaction and proteostasis. J. Cell.
Biochem. 118, 2261–2270.
Lee, D.Y., Arnott, D., and Brown, E.J. (2013). Ubiquilin4 is an adaptor protein that
recruits Ubiquilin1 to the autophagy machinery. EMBO Rep. 14, 373–381.
Lowe, E.D., Hasan, N., Trempe, J.-F., Fonso, L., Noble, M.E.M., Endicott, J.A., Johnson,
L.N., and Brown, N.R. (2006). Structures of the Dsk2 UBL and UBA domains and their
complex. Acta Crystallogr. D Biol. Crystallogr. 62, 177–188.
Maciejewski, M.W., Schuyler, A.D., Gryk, M.R., Moraru, I.I., Romero, P.R., Ulrich, E.L.,
Eghbalnia, H.R., Livny, M., Delaglio, F., and Hoch, J.C. (2017). NMRbox: A Resource for
Biomolecular NMR Computation. Biophys. J. 112, 1529–1534.
178

Martin, E.W., Thomasen, F.E., Milkovic, N.M., Cuneo, M.J., Grace, C.R., Nourse, A.,
Lindorff-Larsen, K., and Mittag, T. (2021). Interplay of folded domains and the
disordered low-complexity domain in mediating hnRNPA1 phase separation. Nucleic
Acids Research 49, 2931–2945.
Martinez-Fonts, K., Davis, C., Tomita, T., Elsasser, S., Nager, A.R., Shi, Y., Finley, D.,
and Matouschek, A. (2020). The proteasome 19S cap and its ubiquitin receptors provide
a versatile recognition platform for substrates. Nat. Commun. 11, 477.
Molliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A.P., Kim, H.J., Mittag, T., and
Taylor, J.P. (2015). Phase separation by low complexity domains promotes stress
granule assembly and drives pathological fibrillization. Cell 163, 123–133.
Mutterer, J., and Zinck, E. (2013). Quick-and-clean article figures with FigureJ. J.
Microsc. 252, 89–91.
Nguyen, K., Puthenveetil, R., and Vinogradova, O. (2017). Investigation of the adaptor
protein PLIC-2 in multiple pathways. Biochem. Biophys. Rep. 24055808 9.
Ohno, A., Jee, J., Fujiwara, K., Tenno, T., Goda, N., Tochio, H., Kobayashi, H., Hiroaki,
H., and Shirakawa, M. (2005). Structure of the UBA Domain of Dsk2p in Complex with
Ubiquitin: Molecular Determinants for Ubiquitin Recognition. Structure 13, 521–532.
Ruff, K.M., Roberts, S., Chilkoti, A., and Pappu, R.V. (2018). Advances in Understanding
Stimulus-Responsive Phase Behavior of Intrinsically Disordered Protein Polymers. J.
Mol. Biol. 430, 4619–4635.
Ruff, K.M., Dar, F., and Pappu, R.V. (2021). Ligand effects on phase separation of
multivalent macromolecules. Proc Natl Acad Sci USA 118, e2017184118.
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T.,
Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012). Fiji: an open-source
platform for biological-image analysis. Nat. Methods 9, 676–682.
Sharkey, L.M., Safren, N., Pithadia, A.S., Gerson, J.E., Dulchavsky, M., Fischer, S.,
Patel, R., Lantis, G., Ashraf, N., Kim, J.H., et al. (2018). Mutant UBQLN2 promotes
toxicity by modulating intrinsic self-assembly. Proc. Natl. Acad. Sci. 115, E10495–
E10504.
Sun, D., Wu, R., Zheng, J., Li, P., and Yu, L. (2018). Polyubiquitin chain-induced p62
phase separation drives autophagic cargo segregation. Cell Res. 28, 405–415.
Tse, M.K., Hui, S.K., Yang, Y., Yin, S.-T., Hu, H.-Y., Zou, B., Wong, B.C.Y., and Sze, K.H.
(2011). Structural Analysis of the UBA Domain of X-linked Inhibitor of Apoptosis Protein
Reveals Different Surfaces for Ubiquitin-Binding and Self-Association. PLOS ONE 6,
e28511.
179

Urry, D.W., Gowda, D.C., Parker, T.M., Luan, C.H., Reid, M.C., Harris, C.M., Pattanaik,
A., and Harris, R.D. (1992). Hydrophobicity scale for proteins based on inverse
temperature transitions. Biopolymers 32, 1243–1250.
Vranken, W.F., Boucher, W., Stevens, T.J., Fogh, R.H., Pajon, A., Llinas, M., Ulrich, E.L.,
Markley, J.L., Ionides, J., and Laue, E.D. (2005). The CCPN data model for NMR
spectroscopy: Development of a software pipeline. Proteins Struct. Funct. Bioinforma.
59, 687–696.
Walters, K.J., Kleijnen, M.F., Goh, A.M., Wagner, G., and Howley, P.M. (2002). Structural
studies of the interaction between ubiquitin family proteins and proteasome subunit S5a.
Biochemistry 41, 1767–1777.
Wei, M.-T., Elbaum-Garfinkle, S., Holehouse, A.S., Chen, C.C.-H., Feric, M., Arnold,
C.B., Priestley, R.D., Pappu, R.V., and Brangwynne, C.P. (2017). Phase behaviour of
disordered proteins underlying low density and high permeability of liquid organelles.
Nat. Chem. 9, 1118–1125.
Xue, B., Dunbrack, R.L., Williams, R.W., Dunker, A.K., and Uversky, V.N. (2010).
PONDR-FIT: A Meta-Predictor of Intrinsically Disordered Amino Acids. Biochim.
Biophys. Acta 1804, 996–1010.
Yang, Y., Jones, H.B., Dao, T.P., and Castañeda, C.A. (2019). Single Amino Acid
Substitutions in Stickers, but Not Spacers, Substantially Alter UBQLN2 Phase
Transitions and Dense Phase Material Properties. J. Phys. Chem. B 123, 3618–3629.
Yasuda, S., Tsuchiya, H., Kaiho, A., Guo, Q., Ikeuchi, K., Endo, A., Arai, N., Ohtake, F.,
Murata, S., Inada, T., et al. (2020). Stress- and ubiquitylation-dependent phase
separation of the proteasome. Nature 578, 296–300.
Ying, J., Delaglio, F., Torchia, D.A., and Bax, A. (2017). Sparse multidimensional
iterative lineshape-enhanced (SMILE) reconstruction of both non-uniformly sampled and
conventional NMR data. J. Biomol. NMR 68, 101–118.
Zaffagnini, G., Savova, A., Danieli, A., Romanov, J., Tremel, S., Ebner, M., Peterbauer,
T., Sztacho, M., Trapannone, R., Tarafder, A.K., et al. (2018). p62 filaments capture and
present ubiquitinated cargos for autophagy. EMBO J. 37, e98308.
Zhang, D., Raasi, S., and Fushman, D. (2008). Affinity Makes the Difference:
Nonselective Interaction of the UBA Domain of Ubiquilin-1 with Monomeric Ubiquitin and
Polyubiquitin Chains. J. Mol. Biol. 377, 162–180.
Zheng, T., Yang, Y., and Castañeda, C.A. (2020). Structure, dynamics and functions of
UBQLNs: at the crossroads of protein quality control machinery. Biochem. J. 477, 3471–
3497.
180

Zhou, H.-X., Nguemaha, V., Mazarakos, K., and Qin, S. (2018). Why Do Disordered and
Structured Proteins Behave Differently in Phase Separation? Trends Biochem. Sci. 43,
499–516.
Zientara-Rytter, K., and Subramani, S. (2019). The Roles of Ubiquitin-Binding Protein
Shuttles in the Degradative Fate of Ubiquitinated Proteins in the Ubiquitin-Proteasome
System and Autophagy. Cells 8.

181

Chapter IV:
Ubiquilin-1, a paralog of Ubiquilin-2, undergoes phase separation but
exhibits different temperature dependence

The work presented in this chapter is unpublished.
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Abstract
Ubiquilins (UBQLNs), including UBQLN1 and UBQLN2, are versatile proteins
involved in protein quality control (PQC) pathways in cells. Disease-linked mutations of
UBQLN1 and UBQLN2 are associated with amyotrophic lateral sclerosis (ALS),
Alzheimer’s disease (AD), and other neurodegenerative disorders and cancers. Our lab
has previously described UBQLN2 liquid-liquid phase separation (LLPS) in vitro and
found that UBQLN2’s ability to undergo LLPS is tied to its recruitment to membraneless
organelles in cells. Here, we found that another member of the UBQLN family, UBQLN1,
also exhibits LLPS in vitro. Despite high sequence similarities, UBQLN1 and UBQLN2
equivalent C-terminal construct 387C (residues 379-589) and 379C (residues 379-624,
hereby referred to as UBQLN1 and UBQLN2) showed significant differences in their
temperature-dependent LLPS behaviors under the same conditions. UBQLN2 exhibits
upper critical solution temperature (UCST) and lower critical solution temperature
(LCST) phase transition, whereas UBQLN1 only exhibits UCST phase transition in the
same temperature range. To understand the molecular basis of such difference, we
performed sequence analysis and identified two primary disparities between the
sequences of UBQLN1 and UBQLN2: the proline-rich (PXX) region, which only exists in
UBQLN2; and the amino acid composition of a small glycine-rich region. Within the
glycine-rich region, UBQLN1 contains a large percentage of charged amino acids,
whereas UBQLN2 consists mostly of hydrophobic amino acids. Using deletion and
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chimera constructs of UBQLN1 and 2, we showed that the different temperaturedependent LLPS behaviors of UBQLN1 and UBQLN2 likely stem from the amino acid
composition of the glycine-rich region and not the PXX region.
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4.1 Introduction
Ubiquilin-1 (UBQLN1) is a multifaceted protein involved in diverse protein quality
control (PQC) pathways. Similar to UBQLN2, UBQLN1 is hypothesized to serve as
shuttle protein in the ubiquitin proteasomal system (UPS), with the Ubiquitin-associated
(UBA) domain binding to the polyubiquitin tag of ubiquitinated substrates and the
Ubiquitin-like (UBL) domain interacting with the proteasomal subunits of the 26S
proteasome (Harman and Monteiro, 2019; Kurlawala et al., 2017; Wang and Monteiro,
2007). It is currently unclear whether UBQLN1 and UBQLN2 function differently in the
UPS. Additionally, UBQLN1 is associate with other PQC mechanisms, including
autophagy (Lee et al., 2013; N’Diaye et al., 2009; Rothenberg et al., 2010; Şentürk et
al., 2019), and endoplasmic-reticulum-associated protein degradation (ERAD) (Lim et
al., 2009; Lu et al., 2009). Importantly, studies have found that UBQLN1 can interact
with and function as molecular chaperones, stabilizing client proteins like BCLb, IGF1R,
ESYT2 (Beverly et al., 2012; Kurlawala et al., 2017), and amyloid precursor protein
(APP) (Stieren et al., 2011). Mutations or dysregulation of UBQLN1 is associated with
Alzheimer’s disease (Adegoke et al., 2017; Bertram et al., 2005; Kamboh et al., 2006)
and cancers (Bao et al., 2018; Shah et al., 2015; Yoo et al., 2015).
UBQLN1 and UBQLN2 are both members of the human UBQLN family. Five
members have been identified in the family, including UBQLN1, UBQLN2, UBQLN3,
UBQLN4, and UBQLNL. UBQLN3 and UBQLNL are specific to testes, whereas
185

UBQLN1, 2, and 4 are widely expressed in all tissues. UBQLN1 and 2 share significant
similarities in their amino acid sequences (Fig. 4.1). Both proteins contain two folded
domains, a Ubiquitin-like domain (UBL) on the N-terminus and a Ubiquitin-associated
domain (UBA) on the C-terminal end. Between the two domains is an intrinsically
disordered region (IDR) that consists of several unstructured regions and linkers (Fig.
1.10) (Zheng, Yang et al., 2020). The most noticeable sequence feature that sets apart
UBQLN1 and UBQLN2 is found between the second STI1 region (STI1-II) and the UBA
domain, where A proline-rich (PXX) region exists in UBQLN2 but is absent in UBQLN1.
Mutations in UBQLN2’s PXX region is disproportionally associated with
neurodegenerative diseases such as ALS and FTD (Deng et al., 2011; Gellera et al.,
2013; Teyssou et al., 2017; Williams et al., 2012), which hints at biophysical and/or
functional importance of the region in UBQLN2.
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Figure 4.1. Sequence alignments of UBQLN1 and UBQLN2.
(A) UBQLN1 and UBQLN2 share similar domain architecture, with the exception of the
PXX domain, which only exists in UBQLN2. (B) Sequence alignment of UBQLN1 and
UBQLN2 performed using T-Coffee (Notredame et al., 2000). Visualized with Jalview
(Waterhouse et al., 2009), the residues were colored according to this scheme: beige
for hydrophobic, blue for positive, red for negative, green for polar, magenta for prolines
and glycines, and yellow for aromatic amino acids. The two protein shows 75%
sequence identity and 82% homology. This figure has been reproduced with permission
from (Zheng, Yang et al., 2020) (Appendix I).
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Our lab has previously described UBQLN2 liquid-liquid phase separation (LLPS) in
vitro (Dao et al., 2018); our results suggested that LLPS plays an important role in the
biological functions of UBQLN2 (Dao and Castañeda, 2020; Dao et al., 2018, 2019). As
UBQLN1 and UBQLN2 share highly similar sequences, we expect UBQLN1 to also
undergo LLPS in vitro at physiological conditions.
As discussed in earlier chapters (chapter one and three), protein LLPS is mediated
by a network of weak, multivalent interactions consisting of a myriad of interaction types
such as hydrophobic interactions, electrostatic attraction, π- π and cation-π interactions,
and hydrogen bonding (Lu et al., 2018; Pak et al., 2016; Vernon et al., 2018). Notably,
the temperature dependence of strength varies among the different interactions (Dignon
et al., 2019). For example, a recent computational study has found that within the
temperature range of 300-350K, aromatic and hydrophobic interactions increase in
strength, whereas polar and electrostatic interactions weaken as temperature increases
(Dignon et al., 2019). Consequently, the temperature-dependent LLPS behavior of
proteins can vary depending on the interaction types that compose the system. Some
proteins like TDP-43, FUS, and hnRNPA1 form liquid droplets in solution at lower
temperature and become homogenous when heated, whereas other proteins like
UBQLN2 exhibit the opposite trend (Burke et al., 2015; Dao et al., 2018; Gui et al.,
2019; Li et al., 2018). Despite recent progress, it remains unclear whether the
temperature-dependent LLPS behavior of a protein is determined by the amino acid
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composition of the entire protein or by that of key regions in its sequence.
In this chapter, we investigated and compared the temperature-dependent LLPS
behaviors of UBQLN1 and UBQLN2 constructs. We found that the LLPS of a UBQLN1
C-terminal construct follow contrasting temperature-dependent trends compared to its
UBQLN2 equivalent. Using deletion and chimera constructs, we found that the LLPS
disparity of UBQLN1 and UBQLN2 likely stems from the dissimilar amino acid
compositions of a small glycine-rich region in the proteins.
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4.2 Results
4.2.1 UBQLN1 C-terminal constructs undergo liquid-liquid phase separation in
vitro
In previous studies, our lab has characterized UBQLN2 LLPS in vitro under
physiological conditions (Dao et al., 2018). We found that C-terminal constructs of
UQBLN2, especially a construct that includes UBQLN2 residue 450-576 (450C), closely
mimics the in vitro LLPS behavior of the full-length protein (Dao et al., 2018). Based on
these findings, we hypothesized that UBQLN1 C-terminal constructs should also mimic
the LLPS behavior of full-length UBQLN1 (Fig. 4.2). We designed two UBQLN1 Cterminal constructs, 387-589 (387C), which includes the STI1-II region to the C-term
end of UBQLN1, as equivalent to UBQLN2 379C; and 450-589 (589C) construct, which
is close to UBQLN2 450C construct (fig. 4.2). To characterize the temperature- and saltdependent liquid-liquid phase separation properties of the aforementioned constructs,
an established spectrophotometric assay called turbidity assay was used as a proxy for
droplet formation (Dao et al., 2018).
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Figure 4.2. UBQLN1 and UBQLN2 constructs that were used in this study.
UBQLN1 387C is the equivalent of UBQLN2 379C; both proteins include
domain/regions from the beginning of STI1-II to the C-terminal end of the proteins.
UBQLN1 and UBQLN2 450C are shorter constructs that only include a small portion of
the STI1-II region; UBQLN2 450C is the minimum construct of UBQLN2 that undergoes
LLPS in vitro.
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We measured 600nm absorbance of 50μM (100μM for UBQLN1 450C) UBQLN1
and UBQLN2 proteins in the temperature range of 20-60ºC (starting from 20ºC) (Fig.
4.3). As we expected, both UBQLN1 379C and 450C constructs exhibit LLPS in the
presence of NaCl, evident by positive absorbance readings. LLPS of UBQLN1 and
UBQLN2 constructs were dependent on NaCl concentration (Figs. 4.3). Specifically, all
constructs showed increased absorbance as NaCl concentration increased. Additionally,
UBQLN1 387C and UBQLN2 379C phase separated at a relatively low salt
concentration (75mM), while the 450C constructs, especially UBQLN1 450C, required
higher NaCl concentration (200-500mM) and UBQLN1 450C required increased protein
concentration (100μM) to form measurable LLPS.
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Figure 4.3. Turbidity data of UBQLN1 and UBQLN2 C-terminal constructs.
UBQLN2 constructs reach peak turbidity at around 36-44C, while UBQLN1 387C peak
turbidity appears to occur at a much lower temperature (20C). *The assays were carried
out with 50μM protein concentration, except UBQLN1 450C, which exhibits no LLPS at
50μM protein at these conditions.
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4.2.2 Liquid-liquid phase separation behavior of UBQLN1 differs from UBQLN2
Despite high sequence similarities, our UBQLN1 and UBQLN2 C-terminal
constructs showed drastically different temperature-dependent LLPS behavior at
physiological conditions (Fig. 4.3). Specifically, UBQLN1 387C phase separates at low
temperature (20ºC) and becomes homogeneous as temperature increases between 2060ºC, a trend that is consistent with polymers that exhibit upper critical solution
temperature (UCST) phase transition (see Chapter 1.2.2). In contrast, UBQLN2 379C,
the UBQLN2 equivalent of UBQLN1 387C, is homogeneous at low temperature (20ºC)
and phase separates as temperature increases (20-35ºC). UBQLN2 379C turbidity
decreases again when the temperature increases further (35-60ºC). This biphasic LLPS
behavior of UBQLN2 379C is consistent with polymers that exhibit both lower critical
solution temperature (LCST) and UCST phase transition.
It is important that we investigate the sequence determinants of the different LLPS
behaviors. The main sequence difference between UBQLN1 387C and UBQLN2 379C
rests in the proline-rich (PXX) region, which is unique to UBQLN2, between its STI1-II
region and UBA domain (Fig. 4.4A). Surprisingly, our UBQLN2 379C PXX region
deletion construct, despite 83% sequence identity to UBQLN1 387C, still showed both
UCST and LCST temperature-dependent LLPS trends similar to wild-type UBQLN2
379C (Fig. 16). Additionally, the UBQLN2 PXX construct and wild-type UBQLN1 both
show less sensitivity to temperature change when compared to wild-type UBQLN2
194

379C, suggesting that the proline-rich region may contribute to the cooperativity of the
phase transition, making it more sensitive to temperature changes.
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Figure 4.4. Domain architecture of UBQLN2 379C and UBQLN1 387C.
(A) UBQLN2 has a unique PXX region near the C-terminal UBA domain. The UBQLN2
379C PXX construct closely mimics the domain architecture of UBQLN1 387C. (B)
UBQLN2 379C PXX shows a similar temperature-dependent LLPS trend as UBQLN2
379C; the turbidity first increases with temperature (20-35ºC) and reaches peak turbidity
at 34-36C.
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4.2.3 A small glycine-rich region in UBQLN1 and UBQLN2 modulates temperaturedependent LLPS behavior
As shown, deletion of the PXX region in UBQLN2 did not appear to change the
UCST+LCST characteristics of UBQLN2 LLPS. Therefore, the difference between
UBQLN1 and UBQLN2 must stem from other parts of the proteins. We performed a
sequence analysis that compared UBQLN1 387C and UBQLN2 379C (Fig. 4.5).
Interestingly, while the majority of residues are either identical or similar between
UBQLN1 387C and UBQLN2 379C outside of the PXX region, a short glycine-rich
region (residue 489-501 in UBQLN1, and residue 482-492 in UBQLN2) showed
contrasting amino acid compositions (Fig. 4.5). In UBQLN1, the twelve-residue
polypeptide consists of four glycine, two hydrophobic amino acids (A, L), and six polar
amino acids (S, T). Conversely, the eleven-residue glycine-rich polypeptide found in
UBQLN2 contains only one polar amino acid. We speculate that the sequence
difference in this small region may contribute to the dissimilar overall LLPS behaviors of
the two proteins.
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Figure 4.5. The glycine-rich region marks a significant difference between
UBQLN1 387C and UBQLN2 379C.
UBQLN1 contains a large percentage of charged amino acids (50%), whereas UBQLN2
consists of much less charged (9%) and more hydrophobic amino acids in this region.
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A UBQLN1 chimera construct was created by substituting its own polypeptide
(which is polar-amino-acid rich) with the UBQLN2 polypeptide that is richer in
hydrophobic amino acids (Fig.4.5 and Fig 4.6A). The turbidity data of the chimera
protein showed greatly enhanced LLPS compared to wild-type UBQLN1 (Fig.4.6B); the
chimera not only phase separates at a lower salt concentration (50mM NaCl) but also
exhibit higher A600 at similar temperature/salt concentration compared to both UBQLN1
387C and UBQLN2 379C. Importantly, unlike UBQLN1 387C, which only exhibits UCST
phase transition, at 50mM NaCl concentration, the chimera protein showed a slight
increase in LLPS when the temperature rose from 20-26ºC and the highest OD600 was
reached not at the lowest temperature (20C), but at 26ºC. This trend resembles the
temperature-dependent LLPS behavior of UBQLN2 379C, suggesting that the chimera
protein may exhibit LCST phase transition as well.
Thus, our data suggest that the glycine-rich region may tune the temperaturedependent LLPS behavior of UBQLN1. Note that the glycine-rich region in UBQLN2 is
one amino acid shorter than that of UBQLN1, which may also affect its LLPS behavior.
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Figure 4.6. UBQLN1 glycine-rich chimera shows enhanced LLPS.
(A) The glycine-rich region exists in both UBQLN1 and UBQLN2; in UBQLN2 it
precedes the PXX region. (B) At 50mM NaCl concentration, UBQLN1 387C chimera
LLPS first increases with higher temperature between 20-26C, unlike wild-type UBQLN1
387C.
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4.2.4 UBQLN1 full-length protein expression and purification attempts
So far, UBQLN1 387C and 450C constructs have provided us serviceable platforms
to elucidate the sequence determinants of LLPS in vitro. However, in order to expand
our results to a physiologically relevant context, we need to express and purify fulllength UBQLN1. Previously, the lab has successfully expressed and purified
recombinant full-length UBQLN2 in E. coli cells relatively easily. However, obtaining fulllength UBQLN1 turned out to be more of a challenge.
We originally attempted to express human full-length UBQLN1 DNA in E. coli.
Numerous attempts to express and purify this protein have failed. DNA analysis of the
human sequence identified multiple codons that are rarely used in E. coli; this can stall
translation and decrease efficiency for bacterial expression of the protein. Therefore, we
purchased an E. coli codon-optimization version of UBQLN1 DNA (Genscript). However,
new attempts using the codon-optimized DNA did not result in any detectable
expression despite efforts to modify the expression conditions and change the E. coli
cell lines. Terrific broth (TB) has been shown to enhance the expression of tricky
proteins in E. coli (Rosano and Ceccarelli, 2014). Cell growth and expression in TB did
not result in detectable protein expression either. In a separate attempt, a N-terminal
“SKIK” solubility- and expression-enhancing tag (Ojima-Kato et al., 2017) was
introduced to the full-length DNA but again did not result in any success.
We then hypothesized that part of the full-length protein might be toxic to the
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bacterial cells or trigger degradation immediately after synthesis. As we were able to
obtain C-terminal constructs (387C and 450C) of the protein, we decided to gradually
increase the C-terminal construct length to test for the expression limit. Using the
codon-optimized full-length UBQLN1 DNA, we first successfully cloned, expressed, and
purified the 252C construct, which adds the linker region connecting the first and
second STI1 regions to the existing 387C construct (Fig. 4.7). We then successfully
obtained 182C and 32C using the same methods. The 182C construct adds the first
STI1 region, and the 32C construct includes all of the named domains and regions in
UBQLN1, except the flexible N-terminal end that proceeds the structured UBL domain
(Fig. 4.7). Thus, we were able to obtain near full-length UBQLN1 protein. It should be
noted that all of these constructs were purified using the same method as UBQLN2
(Dao et al., 2018), which involves inducing phase separation by adding NaCl. Therefore,
all of the UBQLN1 constructs should also undergo LLPS in the presence of NaCl.
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Figure 4.7. UBQLN1 constructs that were successfully purified in this work.
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4.3 Discussion and Conclusions
In this work we showed that, like UBQLN2, UBQLN1 C-terminal constructs undergo
LLPS under physiological conditions. However, UBQLN1 C-terminal construct 387C
showed different temperature-dependent LLPS behavior compared to its UBQLN2
equivalent, 379C. Interestingly, UBQLN1 387C exhibit upper critical solution
temperature (UCST) phase transition (Fig.4.7) between 20-60ºC, while UBQLN2 379C
exhibits both upper critical solution temperature (UCST) and lower critical solution
temperature (LCST) phase transitions under the same conditions.
By comparing the turbidity data of UBQLN1 387C, UBQLN2 379C, and UBQLN2
379C PXX, we learned that the different temperature-dependent LLPS profiles of
UBQLN1 and UBQLN2 do not stem from the PXX region found only in UBQLN2, as
deletion of this region still preserved the UCST+LCST characteristics of UBQLN2 379C
LLPS.
Previous studies have shown that the temperature-dependent LLPS behavior of
individual protein is implicated in its amino acid composition and sequence (Dignon et
al., 2019; Quiroz and Chilkoti, 2015). When comparing a variety of protein and peptides
that undergo LLPS, proteins or peptides that contain a larger ratio of charged and polar
amino acids are more likely to show UCST behavior, while those containing more
hydrophobic amino acids generally exhibit LCST behavior (Dignon et al., 2019; Quiroz
and Chilkoti, 2015). Additionally, when comparing the amino acid compositions of
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proteins that have the single UCST phase diagram (UBQLN1 387C is likely in this
category) and those that have the closed-loop shaped phase diagram (UBQLN2 379C
is likely in this category) (Fig. 4.8), the latter showed a lower charged and polar residues
ratio (Dignon et al., 2019). Consistent with these findings, we identified a pair of glycinerich polypeptides with contrasting amino acid composition in UBQLN1 387C and
UBQLN2 379C are likely responsible for their different temperature-dependent LLPS
trends. UBQLN1’s glycine-rich region contains a significantly higher proportion of polar
residues compared to UBQLN2. UBQLN1 chimera construct created by substituting its
polar-amino-acid-rich glycine-rich region with UBQLN2’s hydrophobic-amino-acid-rich
sequence showed distinctive temperature-dependent LLPS trends with both UCST and
LCST-like characteristics, similar to UBQLN2. As the chimera construct only marginally
changed the overall amino acid composition of UBQLN1 387C, our results illustrated
that the temperature-dependent LLPS behavior of a protein could be tuned by changing
a small number of amino acids in key regions.
Also, in this work, we successfully obtained a series of UBQLN1 C-terminal
constructs, including 252C, 182C, and the near full-length 32C protein. These various
constructs will provide powerful platforms for future studies of UBQLN1 inter-domain
interactions, as well as partner binding studies of UBQLN1.
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Figure 4.8. The turbidity data of UBQLN1 387C and UBQLN2 379C suggest
differently shaped phase diagrams.
UBQLN1 387 likely has a USCT only phase diagram, while UBQLN2 379C likely has a
closed-loop phase diagram as it exhibits both UCST and LCST phase transitions.
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4.4 Materials and Methods
4.4.1 PCR mutagenesis
Primers were designed by the author and synthesized by Invitrogen. For UBQLN2
379C, 450C, and all UBQLN1 human and E. coli codon-optimized constructs, 5mM
primers were first phosphorylated using the Thermo PNK enzyme kit. Primers, template,
dNTP, Phusion buffer, and Thermo Phusion enzyme were then combined with the
recommended ratio. A Biorad T100 thermocycler was used for PCR reactions. PCR
program as following: 1, 98C, 0:30. 2, 98C, 0:10. 3, 63-72C, 0:20. 4, 72C, 2:00. 5, go to
step 2, 25X. 6, 72C, 10:00. 7, 12C. The PCR products were then subjected to Dpn1
digestion followed by T4 ligase reactions and used to transform NEB Turbo competent
cells. DNA of all constructs was confirmed using the Genscript DNA sequencing service.

4.4.2 UBQLN1 and UBQLN2 growth and purification
Rosetta 2 (de3) cells were transformed with a pET24b(+) plasmid containing the
desired DNA sequence for the UBQLN1 or UBQLN2 gene. The cells were grown in LB
media with 50mg/L kanamycin and 34mg/L chloramphenicol to OD600 0.6-0.8 before
inducing expression with 0.5mM IPTG. The cells were collected after inducing
expression overnight. The cell pellet was frozen and thawed before cells were
resuspended in 20mL 50mM Tris-Cl pH 8 buffer. To the solution, 0.1mg/mL DNAse,
5mM MgCl2, and 0.5mM PMSF were added. The solution was mixed thoroughly using a
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pipette and centrifuged at 20,000g for 20min. The supernatant was collected and
warmed to room temperature. 500mM-1M NaCl was added to the soluble, and the
salted-out protein was then collected using 5000g centrifugation for 20min at room
temperature. The protein was then washed twice by resolubilizing with no-NaCl, 20mM
NaPhos pH 6.8 buffer (ice-cold buffer for UBQLN2 constructs and room temperature
buffer for UBQLN1 constructs) then re-precipitated by adding NaCl. The final product
was obtained by running the 1.5mL protein solution through a 5mL Hi-Trap desalting
column.

4.4.3 Temperature-dependent turbidity assay
50-100μM protein samples were prepared in 20mM NaPhos pH 6.8, 0.5mM EDTA
and 0.2% Azide buffer with NaCl concentration ranging from 50-200mM. For UBQLN2
constructs, 300uL of samples were then loaded into glass cuvettes and incubated on ice
for 5min before inserting into the Beckman DU640 UV-VIS spectrophotometer. For
UBQLN1 constructs, the room-temperature glass cuvettes containing protein solution
were inserted directly into the UV-VIS spectrophotometer. OD600 values were then
collected at every degree temperature as the spectrophotometer heated the samples
from 20C to 60C using a Peltier heating device with a 2 degree per minute temperature
ramp rate. The OD600 were then plotted as a function of temperature. Separate
turbidity assays were collected at different salt (NaCl) concentrations. Plotted values are
208

the average of two to three repeats.
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Chapter V: Conclusions and future directions

5.1 introduction
According to classical biochemistry, the amino acid sequence of a protein defines its
three-dimensional structure, which determines the functions of the protein. A well-folded
structure is critical in the structure-function paradigm. However, with the development of
modern structure prediction methods, and the influx of protein sequences from a variety
of organisms, it became clear that a significant fraction of the proteome is composed of
amino acid sequences that are unlikely to form well-defined structures, i.e., are
intrinsically disordered, albeit functional (Forman-Kay and Mittag, 2013; van der Lee et
al., 2014; Tompa, 2012; Uversky and Dunker, 2012; Wright and Dyson, 1999). The
intrinsically disordered regions (IDRs) or polypeptides can serve as interaction hubs in
protein-protein interaction networks, contributing to cellular processes such as
transcription, translation, and protein degradation (Galea et al., 2008; Iakoucheva et al.,
2002; van der Lee et al., 2014).
Characterizing protein-protein interactions (PPIs) that involve intrinsically disordered
regions (IDRs) or polypeptides can be challenging, as commonly used methods such as
X-ray crystallography struggle to capture the flexible nature of IDRs. In the work
presented here, we illustrated that by employing a diverse toolbox of biophysical and
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biochemical methods with an emphasis on NMR spectroscopy, we were able to study
the structural basis and the dynamics of multivalent interactions between folded domain
and intrinsically disordered region or peptide substrates with atomic-level resolution.

5.2 Investigation of Ess1 substrate binding
In chapter two, we studied the structure and substrate binding of the yeast prolylpeptidyl isomerase (PPIase) Essential 1 (Ess1). In yeast, Ess1 regulates DNA
transcription by catalyzing the cis/trans conversion peptide bonds within the intrinsically
disordered carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II
(Pol II), RPB1 (Hanes, 2014). Using solution NMR, we found that Ess1 has a rigid
backbone with a well-folded α-helical linker connecting its substrate binding (WW) and
catalytical (PPIase) domains. This contrasts with its human counterpart PIN1, which has
an intrinsically disordered, flexible linker (Bayer et al., 2003).
As the rigid linker restricts the domain-domain orientation in Ess1, we hypothesized
that the yeast enzyme requires more specific substrates, whereas the flexibility of the
human enzyme would allow it to sample and catalyze the isomerization on a wider
spectrum of substrates. We studied the interactions between Ess1 and CTD peptides of
different lengths and found that in order for the enzyme to bind CTD substrates
bivalently through both the WW and PPIase domains, the peptides need to be at least
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four-repeats long. A five-repeat peptide allows the enzyme to bind without
conformational strain and provides sufficient substrate length for the cis-trans
isomerization of the targeted peptide bond (Namitz et al., 2021). Therefore, our results
suggest that Ess1 indeed requires longer substrates for bivalent binding compared to
Pin1 (Namitz et al., 2021; Smet et al., 2005). Given that the human cellular environment
is more complex compared to yeast, the human protein may have abolished the rigid
linker to obtain a wider substrate spectrum for additional regulatory functions. Following
the same logic, we can speculate that intrinsically disordered regions (IDRs) are
sometimes preferred over structured domains in higher organisms for structural
flexibility and functional versatility.
In this work, we used CTD peptides of different lengths with phosphorylation on the
outmost repeats to study the length-dependence of Ess1:CTD binding (e.g.,
phosphorylation only on the first and fifth repeat on the five-repeat peptides). A
worthwhile future experiment can compare Ess1 binding with CTD peptides of fixed
length and variable phosphorylation positions to complement our results. Theoretically,
a five-repeat CTD peptide with phosphorylation on the second and fifth repeat, or the
first and fourth repeats should be similar to our four-repeat peptides, as the WW and
PPIase domains require the pSer-Pro motif for binding (Hanes, 2014). However, the
extra length of the overhang repeat, despite not having the motif, may affect binding
through other mechanisms. This experiment is especially relevant considering the long
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yeast RNA pol II CTD (up to 26 repeats) (Hanes, 2014; Jasnovidova and Stefl, 2013),
which provides ample opportunity for overhang when Ess1 binds to the phosphorylated
CTD repeats.
Furthermore, future studies should focus on directly comparing the isomerization
activities of Pin1 and Ess1 on a library of substrates. It would be interesting to see
whether there is any isomerization activity penalty that Pin1 has to pay for its potential,
additional promiscuity. Also, because Ess1 is essential for the survival of yeast cells, the
unique domain-domain orientation and the substrate specificity of the enzyme may be
exploitable for the development of highly specific inhibitors with anti-fungal activities.

5.3 Exploring the modulatory roles of folded domains in UBQLN2 LLPS
In the recent decade, protein liquid-liquid phase separation (LLPS) driven by
multivalent interactions has drawn tremendous interest among researchers (Aguzzi and
Altmeyer, 2016; Alberti et al., 2019; Brangwynne et al., 2009; Hyman et al., 2014; Lin et
al., 2015). In chapter three, we illustrated that the LLPS of UBQLN2 is mainly mediated
by its long, central IDR region. Using deletion and mutation constructs, we found that
the two folded domains of ubiquilin-2 (UBQLN2), the ubiquitin-like (UBL) and ubiquitinassociated (UBA) domains modulate the LLPS of UBQLN2 asymmetrically. Specifically,
by interacting with the IDR, the UBL domain inhibits UBQLN2 LLPS while the UBA
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enhances UBQLN2 LLPS.
Through NMR titrations, we compared the overall strengths of the UBL-UBA, UBLIDR, and UBA-IDR interactions and mapped the UBL-IDR and UBA-IDR interactions to
individual regions in the IDR. We found that the UBA-IDR interactions are significantly
weaker than both the UBA-UBL and UBL-IDR interactions. The UBL-IDR interaction
involves multiple parts of the IDR, including the STI1-I, several linker regions, and the
LLPS-mediating C-terminal part of the IDR, whereas the UBA domain mainly interacts
with a middle linker and the C-terminal regions of the IDR after STI1-II. We speculated
that the preferences of interacting regions and the vastly different interaction strengths
contribute to the asymmetric effects that the two domains have on UBQLN2 phase
separation.
Additionally, our results suggest a model where partners that bind to the UBL or
UBA domains would change the UBL-UBA-IDR interaction dynamics resulting in altered
UBQLN2 LLPS. More specifically, partners such as proteasome subunits Rpn10 and
Rpn13, when bound to the UBL domain, would decrease the UBL-IDR interactions
through competition. As the UBL-IDR interaction inhibits UBQLN2 LLPS, the partner
binding would result in increased UBQLN2 LLPS. Conversely, partners that bind to the
UBA domain, such as Ubiquitin, would decrease the LLPS-enhancing UBA-IDR
interactions and result in decreased UBQLN2 LLPS. Our model implies that binding
partners could modulate the membraneless organelle (MLO) associated functions of
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UBQLN2 in cells, as UBQLN2 LLPS is closely related to its involvement in MLOs (Dao
and Castañeda, 2020; Dao et al., 2018). UBQLN2 may shuttle substrates in or out of
MLOs by changing its own phase behavior upon binding to the substrates. Future
studies should test this model by characterizing UBQLN2 LLPS in vitro and the
involvement of LLPS in MLOs in vivo with relation to partner binding.

5.4 Characterizing UBQLN1 LLPS in vitro
In chapter four, we found that UBQLN1, a paralog of UBQLN2, also undergoes
LLPS in vitro. Despite sequence similarity, UBQLN1 and UBQLN2 C-terminal constructs
exhibit different temperature-dependent LLPS behaviors. Specifically, UBQLN1 387C
(referred to here as UBQLN1) exhibits upper critical solution temperature (UCST) phase
transition (condenses into droplets at low temperature and becomes homogeneous at
high temperature), whereas its UBQLN2 equivalent, 379C (referred to as UBQLN2),
exhibits both lower critical solution temperature (LCST) and UCST phase transitions
(solution is homogeneous at low and high temperature, forms droplets at intermediate
temperature).
After carefully comparing the sequences of UBQLN1 and UBQLN2, we discovered
that in addition to the PXX region, which only exists in UBQLN2, the biggest difference
between UBQLN1 and UBQLN2 is found in a small glycine-rich region. In this region,
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UBQLN1 contains a high percentage of polar amino acids, whereas UBQLN2 consists
of more hydrophobic amino acids. We designed a UBQLN2 PXX deletion construct as
well as a UBQLN1 chimera construct whose glycine-rich region is substituted with the
hydrophobic-amino-acid-rich sequence from UBQLN2. We characterized the LLPS of
the constructs and found the PXX region did not seem to affect the temperaturedependent LLPS behaviors since the UBQLN2 PXX deletion construct followed the
same temperature-dependent trends as the wild-type. Instead, the contrasting amino
acid compositions of the glycine-rich region in UBQLN1 and UBQLN2 are likely
responsible for the different temperature-dependence of their phase behaviors since the
UBQLN1 chimera construct now exhibits trends similar to UBQLN2 under certain
conditions. Importantly, despite a few polar residues substituted by hydrophobic amino
acids in the chimera construct, the overall amino acid composition of the chimera
protein is only marginally different from wild-type UBQLN1.
Previous studies have found that the temperature-dependent LLPS behavior of a
protein is largely determined by its overall amino acid composition (Dignon et al., 2019;
Martin and Mittag, 2018). Here, we showed that small regions could also modulate the
temperature-dependent LLPS behavior of a protein without significantly impacting its
overall amino acid composition. Also, in this chapter, we obtained a series of UBQLN1
deletion constructs, including a near full-length construct that contains most domains
and regions of UBQLN1 (residue 32-589). These constructs can be used in future
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studies to investigate the domain contributions of UBQLN1 LLPS, as well as partner
bindings to the different regions of the protein. Finally, we expect that the LLPS of
UBQLN1 to be biologically relevant. Future studies should investigate UBQLN1’s
involvement in membraneless organelles in cells and determine whether the LLPS
difference between UBQLN1 and UBQLN2 is related to their respective functions.

5.5 Future directions
In cells, RNA Pol II enters biomolecular condensates called transcription factories
(Boehning et al., 2018). Recent evidence suggests that LLPS of the CTD constitute the
molecular mechanism underlying Pol II condensate formation (Boehning et al., 2018;
Guo et al., 2019; Portz and Shorter, 2020). Post-translational modifications such as
phosphorylation in the CTD modulate LLPS and transcription factory assembly (Guo et
al., 2019). Similar to phosphorylation, proline isomerization modifies the backbone and
sidechain geometry of the CTD (Jasnovidova and Stefl, 2013). We speculate that
proline cis-trans isomerization catalyzed by PPIases such as Ess1 and Pin1 could
mediate the LLPS of CTD in vitro and Pol II condensates formation in cells. Future
studies should first determine whether PPIase binding directly alters Pol II CTD LLPS
behavior. Next, the LLPS of cis- and trans-proline CTD isomers should be characterized
and compared; a possible approach is to incorporate chemically locked proline
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analogues and compare the LLPS of cis-locked and trans-locked CTD isoforms (Wang
et al., 2003; Yogesha et al., 2014). Additionally, using the locked CTD isomers, future
studies can investigate and compare Ess1 binding to the individual isomers to identify
potential conformational preferences. As proline isomerization impacts co-factor binding
to the CTD (Jasnovidova and Stefl, 2013), it would also be interesting to see whether
the PTM alters the LLPS of the CTD in the presence of other binding partners.
To date, the LLPS studies in the field have largely omitted the complexity of the
cellular environment in favor of a more reductionist approach. In the cells where
biomolecular condensates such as stress granules are found, ligands and co-factors coexist in a crowded environment, and their concentrations are subject to dynamic
changes (Alberti et al., 2019). Therefore, current LLPS models do not mimic
biomolecular condensates well. It wasn’t until recently that studies began to focus on
binding partners and their impact on protein LLPS (Dao et al., 2018; Ruff et al., 2021;
Zheng et al., 2021). As a variety of binding partners have been identified to interact with
different parts of the UBQLNs (Zheng et al., 2020), future studies should take
advantage of the excellent opportunities that UBQLN1 and UBQLN2 present in this
area. For example, we can study UBQLN LLPS in the presence of proteasome subunits
to determine how their binding to the UBQLNs impacts LLPS and if proteasome
subunits are recruited into UBQLN droplets. This can serve as a proxy for investigating
how the proteasome interacts with UBQLN-containing condensates and what function
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UBQLNs serve in the condensates. Additionally, including more than one binding
partner in future experiments will show us how the hierarchy of binding affinities for
different partners can work together and modulate the overall phase behavior of the
system.
Admittedly, some interactions within the UBQLNs presented in this work have not
been quantitatively analyzed in detail. For example, we do not know the binding
affinities for UBQLN2 STI1-II self-interaction or the UBL-IDR interaction. We don’t have
much information about the interaction strengths among stickers in UBQLN2 or how
much weaker they are compared to ligand binding. Part of the challenge here comes
from the limitations of the methods that we used as well as the transient and complex
nature of the interactions. Future studies should explore complementary methods such
as isothermal titration calorimetry and analytical ultracentrifugation to quantitatively
characterize some of the interactions above. The additional data will help us further
establish the hierarchy of the interactions within the UBQLNs and provide key
parameters for future computational studies on our system.
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